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ABSTRACT
Four experiments were carried out to investigate the effects of the dietary antagonists 
molybdenum (Mo) or iron (Fe) on copper (Cu) metabolism and physiology of sheep. In 
experiment 1, dietary Mo or Fe was provided in diets of Charollais cross growing lambs to 
investigate the effects on Cu status and performance. Dietary Mo or Fe had no effect on 
lamb performance but there were significant effects on Cu status. Plasma copper (Pl-Cu) 
concentrations were significantly higher in lambs that received dietary Mo (P<0.001) and 
ceruloplasmin (CP) activities were significantly lower (P<0.01) in lambs that received 
dietary Mo. Dietary Mo significantly altered the CP:Pl-Cu ratio in addition to significantly 
reducing liver Cu concentrations. No clinical symptoms were observed. In experiment 2, 
the effect of dietary Mo or Fe on immune responses of Charollais cross growing lambs 
were investigated. Cell mediated and humoral immunity were not affected by dietary 
treatment despite liver Cu concentrations being significantly lower (P<0.001) in lambs fed 
dietary Mo. In experiment 3, dietary Mo or Fe was provided in diets to Charollais cross 
growing lambs to investigate the effects on Cu status and trace element accumulation in the 
pituitary, ovary, cerebellum and liver. In addition, effects on pituitary function and ovary 
morphology were investigated. Dietary Mo significantly (P<0.001) reduced Cu 
concentrations in the liver in addition to significantly increasing (P<0.001) Mo 
concentration in the liver and ovary. Dietary Mo was found to significantly increase 
retention of ACTH in the pituitary gland. There were no conclusive effects of dietary 
treatment on pituitary or ovary histology. In experiment 4, dietary Mo or Fe was provided 
in the diets of Scottish Blackface wethers to determine the effects on Cu status and hepatic 
CP mRNA expression. CP mRNA expression was found to be unaffected by dietary 
treatment. These studies confirmed that dietary Mo was a more potent antagonist on Cu 
metabolism and physiology in sheep than dietary Fe.
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Literature Review
1.1. Introduction
At least twenty-two mineral elements are believed to be ‘essential’ for higher forms of 
animal life (Underwood, 1977). Of the essential elements, all have been shown to have one 
or more metabolic functions and have been classified as being ‘essential’ to maintain 
normal cellular metabolism (Spears, 1999; Lee et al, 2002). An essential mineral element 
has previously been defined as:
“one that is required to support adequate growth, reproduction and health 
throughout the life cycle when all other nutrients are optimal”
(O’Dell and Sunde, 1997)
The essential mineral elements are classified as either major or trace elements depending 
upon their concentration in the animal or the amounts required in the diet. Major elements 
are expressed in g kg’  ^and trace elements are expressed in mg kg"\ The major elements 
include calcium (Ca), phosphorus (P), potassium (K), sodium (Na), chlorine (Cl), sulphur 
(S) and magnesium (Mg) and the trace elements include iron (Fe), zinc (Zn), copper (Cu), 
molybdenum (Mo), selenium (Se), manganese (Mn), cobalt (Co) and iodine (I) (Judson 
and McFarlane, 1998). Elements including arsenic (As), nickel (Ni), silicon (Si) and 
vanadium (V) may also be required in the diet, but no specific biochemical function has yet 
been identified for them (Judson and McFarlane, 1998).
Inadequate and excessive intakes of mineral elements may lead to deficiency or toxicity 
respectively. For example, inadequate intakes of Cu may induce a primary Cu deficiency. 
Additionally, a mineral element may be metabolically unavailable due to other antagonistic 
dietary components that interact with the element and reduce its’ availability (Suttle, 
1991). A secondary Cu deficiency may arise due to the complex antagonistic interactions
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of dietary Mo and S (Suttle, 1975). In addition, dietary Fe and S are known to affect Cu 
metabolism (Suttle et ah, 1984; Bremner et al, 1987). This review will discuss the 
nutritional, physiological and biochemical role of Cu and its’ interactions between Mo 
and/or S and Fe and S in ruminant animals.
1.2. Properties of copper
1.2.1. Physical and chemical properties o f copper
Copper is a d-block transition element with the atomic number of 29 and an atomic weight 
of 63.546 daltons. It occurs in the environment as one of three oxidation states: Cu® 
(copper metal), Cu^  ^(cuprous ion) or Cu^  ^ (cupric ion) (Georgievskii et a l, 1982). The 
cuprous state (+1) is easily oxidised to the higher oxidation state and is stable only in very 
insoluble compounds. Therefore, in most compounds, Cu is present as Cu^  ^(Linder, 1991).
1.2.2. Dietary Sources
Copper is a natural element and is widely distributed in feedstuffs as illustrated in Table
1.1. Sources rich in Cu are whole grains, nuts, legumes, seeds, seed by-products and 
shellfish. Grasses tend to have a lower Cu contents than legumes, and grains tend to be 
higher than leaves or stems (Hartmans and Bosman, 1970; McDowell, 1992).
Dietary source Copper content (mg kg'^)
Barley grain 5-9
Barley straw 3-5
Brewers grains 21
Citrus pulp 5-7
Fresh grass 7-8
Grass silage (early) 11
Grass silage (late) 3
Grass hay (good quality) 9
Maize 2.5
Rape seed 5-7
Soyabean meal 25
Sugar beet pulp (molassed and dried) 11-13
Turnips 21
Wheat grain 5-7
Wheat straw 4
Sources: McDowell (1992), McDonald et al. (1995) and NRC (1985)
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Suttle (1983a) found that Cu is well absorbed from foodstuffs low in fibre such as cereals 
(Acu 9.1 %) but poorly absorbed from fresh herbage including grass (Acu 1 4 -  2.5 %). 
Conservation of grass as hay or silage generally improves Cu availability (Suttle, 1983a). 
In most circumstances, Cu concentrations decline as plants mature, and are lower from 
alkaline soils (McDowell, 1985). The most influential factor affecting Cu metabolism from 
feedstuffs in ruminants is the presence of Mo in association with S (see section 1.2.3) (Lee 
and Grace, 1997).
1.2.3. Soil and herbage influences on copper metabolism
The Cu content of crops can be related to geographical location, soil Cu levels (Beeson et 
al, 1947), plant species, stage of maturity, yield, seasonal and temporal climatic factors, 
soil pH, fertiliser application and soil fertility (McFarlane et al, 1990; MacPherson, 2000). 
Contamination of the soil due to Cu toxicity may arise from sewage sludge, deposition of 
industrial wastes and industrial pollution (Pais and Jones, 1997). Although many soil types 
in the UK have adequate Cu contents (normal range 2 -  60 mg kg'^)(Thomton, 1983), 
liming or reseeding to ‘improve’ growth of upland pastures causes a reduction in 
availability of Cu in soils due to a rise in pH. Therefore, Cu uptake from plants is pH 
dependent (McFarlane et al, 1990). The increase in alkalinity of the soil caused by the 
application of lime to pastures may result in increased uptake of Mo by pasture plants 
(Mengal and Kirkby, 1987). An increase in liming of lakes, wetlands and pastures to 
counteract the effects of acid rain in south-west Sweden, has been attributed to an increase 
in a secondary Cu deficiency-type disease in moose, observed since the mid 1980’s (Frank, 
1998; Frank et al, 2000a, 2000b).
Molybdenum availability is increased by liming, with Mo concentrations in soils averaging 
between 1-2 mg kg'  ^ (Cannon et al, 1978). Acidic soils are often deficient in Mo whilst 
alkaline shale and other sedimentary related soils contain high concentrations of Mo 
(Mengal and Kirkby, 1987). Humus rich peat soils contain high levels of Mo such as the
‘teart’ pastures of Somerset (Ferguson et al, 1943). Ferguson et al (1943) first noted 
clinical symptoms attributable to a secondary Cu deficiency by an increased incidence of 
scouring and change in coat colour of Red Devon cattle when put out to graze on the ‘teart 
pastures’ containing between 20-100 mg kg'* Mo (see section 1.6.1).
Animals ingest soil as they graze (Suttle et al, 1975) and it has been estimated that cattle 
and sheep may ingest between 100-300 g soil kg"^  herbage DM respectively on short 
pastures (Dewes, 1996). Soils known to contain low levels of Cu include leached sandy 
soils, calcerous sands and soils with low organic matter contents. Soil ingestion may 
increase intakes of Mo or Fe subsequently altering Cu metabolism (Suttle et al, 1975). 
Soil ingestion may also increase in areas of poor drainage or where pasture growth is poor. 
Also, soil ingestion may increase when feeding root crops covered in mud or dust or in 
areas with high stocking densities (Dewes, 1996).
Iron contents of soils vary considerably with pasture contents ranging fi*om 250-400 mg 
kg'* Fe, with very high levels indicative of soil contamination (>6000 mg kg'*) (Judson and 
McFarlane, 1998). High dietary intakes of Fe may be due to soil consumed directly, in 
feedstuffs or from mineral supplements containing iron oxides. Increased intakes of Fe 
may occur from grazing short pastures resulting in an increase in soil intake, soil 
contamination during ensiling or during fodder crop harvesting. In New Zealand, pasture 
Fe concentrations have been categorised according to the level of soil contamination: 
severe (>6000 mg kg'* Fe DM), high (3000-6000 mg kg'* Fe DM) or moderate (500-3000 
mg kg'* Fe DM) (Judson and McFarlane, 1998). Suttle et al (1982) found that Cu 
absorption was reduced by 50% in ewes supplemented with either a chalky or clay soil 
containing 2400 and 1400 mg kg'* Fe DM respectively compared to a sandy soil containing 
140 mg kg'* Fe DM.
Dietary Fe intakes may also affect Cu absorption according to the presence of S within the 
soil or feedstuff. The use of high S-containing fertilisers to improve pasture productivity 
may therefore exacerbate the antagonistic effects of Fe on Cu metabolism (see section
1.4.3.).
1.3. Copper metabolism
Copper metabolism involves the effective absorption, transport, distribution, storage, 
utilisation and excretion of the element to maintain homeostasis (Mercer, 1997). 
Differences in Cu metabolism have been found to exist among ruminants; within the same 
species (Wiener and Woolliams, 1983; Du et al, 1996), between sheep and cattle (ARC, 
1980), between sheep and deer (Freudenberger et al, 1987) and in moose and goats (Frank 
et al, 2000c).
Studies of Cu metabolism have been achieved using nutritional balances, whole animal 
compositional analyses and radioisotope tracer studies to quantify the fraction of the 
element that is consumed, absorbed, retained and excreted (Lee et al, 2002). Numerous 
authors have attempted to represent kinetic models of Cu metabolism using Cu stable 
isotopes or radioisotopes to represent quantitative ‘routes’ of Cu flow through the body 
(Buckley, 1991). Stable isotopes have the advantage over Cu radioisotopes in that they 
may be studied for longer periods of time. ^  Cu in sheep (Weber et al, 1980; 1983), ^Cu 
in lactating dairy cows (Buckley, 1991) or ^^Cu in sheep (Gooneratne et al, 1989c) have 
previously been used in studies of Cu metabolism. Weber et al (1980) proposed in a short­
term Cu metabolism model in sheep that there were three ‘pools’ of Cu present. Pool one 
represented the circulating Cu in the whole blood and pools two and three represented 
temporary stored compartments of Cu by the liver (before excretion into the bile, or after 
incorporation into ceruloplasmin). Buckley (1991) represented the metabolism of Cu 
through the body in more detail using seven Cu stores including the liver, milk, plasma and 
faeces, and found similar results to Weber et al (1980) including the small proportion of 
Cu (<1%) present in the hfine after ^Cu administration.
1.3.1. Copper absorption
In most animal species, Cu is poorly absorbed and the extent of absorption is influenced by 
a number of factors including the chemical form (Underwood, 1977), age of the animal 
(Suttle, 1975), species and breed (Wiener et al, 1978) and other dietary factors such as 
antagonistic mineral interactions (as described in sections 1.4.1 to 1.4.3. respectively). 
Linder (1991) stated that the absorption of Cu appeared to be enhanced by dietary proteins 
and amino acids and by other chelating agents, possibly from enhanced water solubility. In 
general, Cu carbonate (CuCOg) and the water-soluble forms, Cu sulphate (CUSO4), Cu 
nitrate (Cu(N03)2 and chloride (CuCL), are absorbed to a greater extent than Cu oxide 
(CuO) (NRC, 1985). Copper sulphate is the most standard source of Cu in animal 
feedstuffs.
The anatomical site of absorption of Cu in ruminant animals occurs primarily in the 
duodenum (Cousins, 1985) but may also occur to a lesser extent in the jejunum and ileum 
(Bremner, 1980). The large intestine has also been found to be a significant site for Cu 
absorption in ruminant animals (Grace, 1975). Differences in the absorption of Cu along 
the gastrointestinal tract may be due to variations in pH along the lumen which may affect 
solubility of the Cu in the digesta (Bremner, 1980; Linder, 1991).
The amount of Cu absorbed is partially regulated by the content of Cu within the diet; the 
efficiency of absorption decreasing with high dietary Cu intakes and increasing when Cu 
intake is low to maintain homeostasis (Tumland, 1998). Copper has been shown to be 
absorbed from the mucosal to the serosal side of the gastrointestinal tract by two 
mechanisms; active transport (Didonato and Sarkar, 1997) and simple diffusion (Bronner 
and Yost, 1985). Although a specific protein involved in intestinal Cu absorption has not 
been identified, the Cu importer protein CTRl (functional in hepatocytes) may be 
responsible for delivering Cu into the enterocyte (Moller et al, 2000). Another mechanism
of Cu absorption from the small intestine may be via the P-type ATPase, ATP7A (Llanos 
and Mercer, 2002). P-type ATPases are transmembrane proteins involved in the transport 
of cations (Mercer, 1997). Once in mucosal cells, a large proportion of Cu is bound to 
metallothionein (MT). MT’s are low molecular weight proteins containing Cu and zinc 
(Zn) which fimction in the homeostasis of Cu and Zn, and the subsequent storage, transport 
and detoxification of metals including Cu, zinc and cadmium (Evering et al, 1991; Kagi, 
1991). If Cu is bound to MT, it will remain within the enterocyte. Copper may then enter 
the portal circulation from the enterocytes via the action of an ATPase, ATP7A (see 
section 1.3.2.), although this has not been directly demonstrated (Llanos and Mercer, 
2002). Within the portal circulation, Cu is bound to carrier proteins, primarily to albumin, 
whereby it is then transported to the liver (Harris, 1991). Humans with Menkes Disease 
(MD), an x-linked neurodegenerative disease, have a low uptake of Cu across the small 
intestine due to a dysfunction of the ATP7A gene, suggesting that ATP7A is involved in 
the uptake mechanism of Cu into the portal circulation (Danks, 1995). After passing 
through the enterocytes, Cu then enters the portal circulation where it enters an 
exchangeable pool of Cu. Here, Cu is bound to albumin, histidine and other amino acids in 
the Cu^  ^form (Sarkar, 1999). Cu is then transported in the portal circulation to the liver 
(Harris, 1991) (see section 1.3.2.).
Genetic differences in metabolism of Cu have been described within and between breeds 
of sheep (Wiener and Field, 1971; Woolliams et al, 1982; Wiener and Woolliams, 1983) 
Breeds such as the North Ronaldsay and Texel accumulate more Cu in their liver than 
Blackface, cross breeds and Finnish Landrace (Woolliams et al, 1982), although the 
reason for this remains unclear. Cu absorption has also been found to vary between 
Holstein and Jersey breeds of cattle (Du et al, 1996) and between Simmental and Angus 
breeds (Gooneratne et al 1994; Ward et al, 1995; Mullis et al, 2003).
The age of the animal is also known to affect Cu absorption. In general, between 5-10% of 
the Cu in the diet is absorbed by adult ruminant animals. Young milk-fed lambs have been 
found to absorb 75% of ingested Cu but the weaned lamb may absorb less than 10% of 
ingested Cu (Suttle, 1975). Bremner and Dalgamo (1973) found that up to 14 weeks of 
age, calves retained over 50% of the ingested dietary Cu. Therefore, the pre-ruminant 
animal absorbs Cu as efficiently as monogastric species and more efficiently than the 
mature ruminant (McDowell, 1992).
Other minerals including zinc (Bremner et al, 1976), sodium (Wapnir and Stiel, 1987) 
selenium, calcium carbonate, lead, nickel and cadmium (Smith and White, 1997) are also 
believed to reduce Cu absorption but these complex interactions are beyond the scope of 
this review of the literature.
1.3.2 Copper transport and cellular uptake
The liver plays a central role in maintaining Cu homeostasis within the hepatocytes by 
regulating Cu uptake, supplying Cu to endogenous enzymes, incorporating Cu into the Cu- 
containing enzyme, ceruloplasmin (CP), secreting Cu into the blood for distribution to the 
brain, tissues, placenta or mammary glands, or may be subsequently excreted in the bile 
when in excess (Llanos and Mercer, 2002).
Cu uptake within the hepatocyte of humans is via a passive Cu transporter, hCtrl (Zhou 
and Gitschier, 1997). Once in the cytoplasm of the hepatocyte, Cu is distributed complexed 
to a variety of ligands or Cu chaperones, which shuttle Cu to Cu-dependent proteins 
(Fatemi and Sarkar, 2002) as illustrated in Fig. 1.1.
These Cu chaperones include:
ATOXl : SAH - ovine homologue of ATOXl (Lockhart and Mercer, 2000)
Delivers Cu to ATP7B in the transgolgi network (TON) for inclusion into 
Cu proteins including ceruloplasmin but may also deliver Cu to partially 
active ATP7A on TGN for incorporation into lysyl oxidase.
COX 17: Delivers Cu to the mitochondria for incorporation into cytochrome c
oxidase
CCS:
GSH:
Delivers Cu to Cu-Zn superoxide dismutase (Cu-Zn SOD or SODi) 
(Glutathione) Cu chaperone for inclusion of Cu into metallothioneins for 
metal detoxification
/ ) Hepatocyte
I A®J(} *
AIP7A Intestine
Avpm
Portal
Circulation
B ilisw y  E x c W w  o f  
Ltiw-MW Compicx»»
Fzg. 7.7.
(Fatemi and Sarkar, 2002) 
Diagrammatic overview o f copper transport in the hepatocyte
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Human disorders affecting Cu transport were identified by Menkes et al, (1962) (Menkes 
disease, MD) and Wilson (1912) (Wilson’s Disease, WD). These diseases led to the 
discovery in the 1990’s of the Cu ‘pumps’, the P-type ATPases. The known Cu ATPases, 
ATP7A (MD) and ATP7B (WD) are key proteins that regulate the flow of Cu in and out of 
hepatocytes (Llanos and Mercer, 2002). They are highly conserved in diverse organisms 
ranging fi*om bacteria and yeast to sheep and humans (Llanos and Mercer, 2002).
ATP7A is a Cu ATPase associated with the possible uptake of Cu from the small intestine 
and also for Cu transport across the blood-brain epithelium (Kodama, 1993). Menkes 
Disease (MD) is an x-linked neurodegenerative disease due to mutations on the ATP7A 
protein (Menkes et al, 1962). Human patients are not able to transport Cu fi*om the 
intestinal cells to the hepatic circulation, resulting in an accumulation of Cu in intestinal 
cells (Kodama, 1993). In addition, Cu cannot be reabsorbed from the epithelial cells of the 
proximal tubules in the kidney and therefore, high levels of Cu accumulate in the kidneys 
(Danks et al, 1972). Patients with MD may also have a defective transport of Cu across 
the blood-brain barrier, resulting in severe brain Cu deficiency and neural degeneration. 
Classical symptoms of MD include ‘steely hair’, hypopigmented hair, neurological defects 
and/or connective tissue abnormalities (Danks, 1995).
ATP7B is also a Cu ATPase and is expressed primarily in the liver (Schaefer et al, 1999). 
ATP7B traffics Cu from the cytoplasm of the hepatocyte into apo-ceruloplasmin located in 
the trans golgi network. It is subsequently incorporated into the holo-ceruloplasmin for 
secretion into the plasma and supplied to the extrahepatic tissues (Linder, 1991). During 
periods of Cu excess, ATP7B has been observed to redistribute copper from the trans-golgi 
network (TGN) to a vesicular compartment, rather than the plasma membrane, where it 
was proposed to function in the direct excretion of Cu as low molecular weight complexes 
in to bile by exocytosis (Schaefer et al, 1999). Wilson’s disease is an autosomal recessive
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inherited Cu toxicity disorder of humans affecting the liver and nervous system (Schilsky 
and Stemlieb, 1993). Due to the defective mutations of the protein ATP7B protein, Cu 
cannot be effluxed into the bile or incorporated in to ceruloplasmin (CP), resulting in 
excessive accumulation of Cu in the hepatocytes in the liver (Schaefer and Gitlin, 1999). 
WD causes necrosis of hepatocytes and low levels of holo-CP, but normal mRNA CP 
expression. Classical symptoms of WD include accumulation of Cu in extra-hepatic 
tissues, the central nervous system, Cu deposits in the eyes (Kayser-Fleischer rings) and 
dementia (Danks, 1995). Copper storage disorders may also occur in Long-Evans 
Cinnamon (EEC) rats (Li et al, 1991), toxic milk mouse (Rauch, 1984), Bedlington 
terriers (Haywood et al, 1996) and West Highland White Terrier dogs (Thornburg et al, 
1986).
Ceruloplasmin, a Cu-containing enzyme, is secreted from the hepatocyte into the plasma, 
whereby CP accounts for between 90-95% of circulating plasma Cu in mammals (Terada 
et al, 1995). The remaining 5-10% of circulating Cu is loosely bound to albumin and other 
proteins (Laurie and Pratt, 1986). The function of CP and albumin is to deliver Cu ions to 
specific organs and tissues (Laurie and Pratt, 1986) (see section 1.5.1.).
1.3.3. Copper distribution and storage
Normal liver Cu concentrations in ruminant animals range from 100 to 500 mg kg'^ (DM) 
although during periods of Cu toxicosis, liver Cu concentrations may range from 2,000 to 
3,000 mg kg'^ (Dick, 1954). Sheep are susceptible to Cu toxicosis (Lockhart and Mercer, 
2000) due to a reduced ability to excrete Cu in the bile, and even moderate dietary intakes 
of Cu may result in high liver Cu concentrations, resulting in liver failure and possible 
death (Ishmael et al, 1971). Within the liver, the highest proportion of Cu is distributed in 
the nuclear fraction (Gooneratne et al, 1979) within the mitochondria, microsomes, 
cytosol and lysosomes (Kelleher and Ivan, 1986). Distribution within the organelles of the
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hepatocyte may vary with age (Lai and Sourkes, 1971), species and Cu status of the animal 
(Gooneratne et al., 1979). After removal of Cu from the hepatocyte by the Cu ATPase 
ATP7B, Cu circulates within the blood plasma. Within the plasma, 90-95% of Cu is within 
CP (Terada et al, 1995) which ftmctions to deliver Cu ions to specific organs and tissues 
where the Cu is incorporated into intracellular enzymes (Laurie and Pratt, 1986). Copper 
concentrations of other body tissue vary considerably, but in general, the heart, brain, 
kidney and intestines contain more Cu than the muscles, spleen, bone and pancreas 
(Underwood, 1977). Organs which contain very low concentrations of Cu include the 
endocrine organs, thyroid, pituitary and thymus (Underwood, 1977).
Haywood et al, (1998) investigated the systemic distribution and retention of Cu and Mo 
from subcutaneous TTM given to Cambridge and North Ronaldsay sheep provided with 
different levels of dietary Cu. This study found that Cu concentrations significantly 
increased in the cerebellum and medulla oblongata and were maintained after 
discontinuation of TTM treatment. In addition. Mo accumulated in all organs including the 
brain and pituitary gland. This study proposed that some displaced liver Cu may be also 
redistributed to the brain in a complexed form (Cu-TTM), where it is retained.
1.3.4. Copper excretion
The excretion of Cu from cells is important to control homeostasis. In ruminant animals, 
bile is the major route of Cu excretion (Evans, 1973; Cousins, 1985) although sheep have a 
reduced ability to excrete Cu in the bile and will accumulate excess Cu in the liver (Weber 
et al, 1980). Breed-specific differences in sheep have been suggested to reflect differences 
in the efficiency of Cu absorption in the gastrointestinal tract rather than differences in the 
efficiency of biliary Cu excretion (Woolliams et al, 1983). Sheep breeds such as the Texel 
have a high affinity of absorbing and retaining Cu within the liver, often leading to a Cu 
toxicity (Woolliams et al, 1982) whereas the Scottish Blackface breed are characterised by 
their poor ability at absorbing and retaining low levels of Cu within the liver and are
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therefore susceptible to hypocuprosis (Woolliams et al, 1986b). The cause of the variation 
in Cu excretion amongst ruminant animals has not been identified. The Cu ATPase ATP7B 
functions to remove Cu fi’om the hepatocyte (Bull et al, 1993) and therefore, if the Cu 
content of the liver is increased, under normal circumstances, ATP7B functions to increase 
the excretion of Cu into bile (Schaefer et al, 1999; Lockhart et al, 2000). Within the 
pathway of Cu excretion in bile, van der Sluis et al (2002) reported another protein 
essential for effective Cu excretion. The protein, MURRl, has been shown to be mutated 
in Bedlington Terriers (van der Sluis et al, 2002) but is not believed to be the cause of Cu 
toxicity in North Tyrolean Infantile Cirrhosis in humans (Müller et ah, 2003) or North 
Ronaldsay sheep (van der Sluis, unpublished data). Therefore, differences may occur due 
to the Cu ATPases within the hepatocyte.
Tetrathiomolybdate (TTM) has been used to treat human patients with WD (McQuaid and 
Mason, 1990; Brewer et al, 1994) and for treatment of chronic Cu poisoning cases in 
sheep (Humphries et al, 1986) due to its strong affinity to complex Cu and reduce the 
harmful effects of Cu toxicosis. Using an animal model of WD, the Long-Evans Cinnamon 
(EEC) rat, Cu was removed using TTM from the liver and was found to be predominantly 
excreted in bile (Komatsu et al, 2000). Studies with cannulated sheep also found that the 
intravenous administration of TTM enhanced biliary Cu excretion (Gooneratne and 
Christensen, 1984; Symonds and Ke, 1989) and subsequent faecal Cu excretion (Mason et 
al, 1988). Ke and Symonds (1989) found that in anaesthetised sheep, Cu excretion via bile 
was increased by 40.7-fold to 21.18 pmol 1'^  compared with non-treated sheep when given 
a 100 mg TTM intravenous injection. Similar results were obtained in cattle after 
intravenous TTM dosing (Gooneratne et al, 1988). High dietary intakes of Mo and S and 
the subsequent formation of TM within the rumen, may act in a similar way to intravenous 
TTM by effectively complexing Cu and increasing excretion via the bile. Bile excretion in 
cattle has found to be several-fold higher than in sheep given similar levels of Mo and S,
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which as a result, Gooneratne et al. (1994) suggested that cattle are more susceptible to Mo 
and S induced Cu deficiency than sheep.
Urinary Cu excretion is minimal under normal conditions as most of the circulating blood 
Cu is bound to CP or within erythrocytes and very little passes the glomerular capillaries 
(Didonato and Sarkar, 1997). During periods of Cu toxicity or when the biliary route is 
blocked, Cu excretion may increase via the urine (Symonds and Forbes, 1993).
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1.4. Metabolic interactions with other trace elements
1.4.1. Metabolic interactions o f copper with molybdenum and sulphur 
The biological interactions of Cu, Mo and S within the rumen have been studied 
extensively and reviewed by several authors (Dick et al, 1975; Clarke and Laurie, 1980; 
Mason, 1982; Clarke et al, 1987). Molybdenum is readily and rapidly absorbed from most 
diets (Mills and Davis, 1987) but may strongly inhibit the absorption of Cu in the presence 
of elevated concentrations of S compounds produced from microbial breakdown, 
especially from sulphur-containing amino acids or inorganic sources of sulphur 
(Chidambaram et al, 1984). Sulphur containing compounds are reduced to sulphide and 
readily combine with Mo in the feed to form a thiomolybdate (TM) complex within the 
solid phase of the ruminant digesta (Dick et al, 1975; Suttle, 1974a).
TM are produced from a series of compounds by the progressive substitution for sulphate 
and oxygen in the molybdate anion (MoO/’), when hydrogen sulphide and Mo04 '^ interact 
at neutral pH and form a series of mono, di, tri and tetrathiomolybdates (Mills et al, 1978). 
Tetrathiomolybdate (TTM) is more significant in reducing Cu absorption in ruminant 
animals than mono, di or tri-thiomolybdates (Suttle, 1974b; Mills et al, 1978). The 
formation of thiomolybdates, MoO„SV-/' {n = 0,1,2,3 or 4) from molybdate and sulphide 
salts in aqueous media have been studied under conditions which simulate the anaerobic 
fluid phase in the rumen (Clarke and Laurie, 1980) with the sequential replacement of 0 '^ 
by S '^ (as shown below):
Mo04 '^ + H^ + HS" H2O + MoOgS^" Monothiomolybdate
MoOgS '^ + H^ + HS' H2O + Mo02S2^ ' Dithiomolybdate
Mo02S2^ ' + H" + HS' H2O + MoOSg '^ Trithiomolybdate
MoOSg '^ + IT" + HS' H2O + MoS4^ ' Tetrathiomolybdate (TTM)
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The thiomolybdate complexes bind Cu to form Cu-TM complexes that are not readily 
absorbed by the animal but are excreted in the faeces. At high Mo intakes (>8 mg kg~^  Mo 
DM) or low CuiMo ratios (<1) in sheep, TM leave the rumen in absorbable forms (Price et 
ah, 1987). If Cu availability within the rumen is low, TM complexes may be absorbed into 
the blood and tissues, where they sequester the Cu from Cu containing enzymes and lower 
tissue Cu concentrations. This formation and absorption of TM complexes may therefore 
act systemically and induce clinical symptoms in the ruminant animal (see section 1.6.).
In vitro studies have shown that TTM inhibit Cu-dependent enzyme activities including 
superoxide dismutase, ceruloplasmin, cytochrome oxidase and tyrosinase (Chidambaram et 
al, 1984). Mason et al (1982) foimd that both duodenal and intravenous infusions of tri 
and TTM produced rapid decreases in plasma ceruloplasmin activity in sheep. Work by 
Chidambaram et al (1984) suggested that TTM was an irreversible inhibitor of 
ceruloplasmin, but later work by Kelleher and Mason (1986) and Lannon and Mason 
(1986) refuted this idea, proving that di, tri and tetrathiomolybdate were reversible 
inhibitors of ceruloplasmin in vitro. The discrepancy between these observations can be 
attributed to the buffer and pH in which the reactions were carried out, rather than any 
ambiguity in the inhibition itself (D. Illingworth, personal communication).
Ammonium TTM has been effectively used to treat human patients with Wilson’s Disease 
(WD) (Walshe, 1992) and sheep with chronic Cu toxicity (Gooneratne et al, 1981a). 
Because of the effective binding capacity of TTM to Cu and the systemic effect of 
depleting Cu stores, Gooneratne et al (1981a) found that the intravenous administration of 
TTM was effective in lowering liver Cu levels, and thus, preventing chronic Cu poisoning 
in sheep. Work by Haywood et al (1993) found that Cu-TTM given to relieve Cu 
poisoning in a flock of Bleu de Maine sheep was redistributed to the brain and pituitary 
gland. Additional evidence supporting the claim that TM is absorbed was proved after 
infiision into the rumen of sheep with ^ ^Mo-labelled dithiomolybdate and trithiomolybdate.
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An insoluble fraction was subsequently found in the plasma of sheep (Mason et ah, 1982) 
and cattle (Hynes et al., 1984). The administration of ^ ^Mo-TTM either into the rumen or 
intravenously produced insoluble fractions in the plasma, giving the first conclusive 
evidence of TM formation and absorption in vivo in sheep (Mason et al, 1982).
1.4.2. Metabolic interactions o f copper with sulphur
Sulphur is contained in feedstuffs in various inorganic forms (mainly inorganic sulphate) 
as well as in organic compounds (mainly S-containing amino acids and proteins) (Spais et 
al, 1968). During digestion, S compounds including organic and inorganic sulphate, are 
reduced within the reticulo-rumen by micro-organisms to produce sulphides (Lewis, 1954). 
Increasing dietary S intakes as sulphate or S-amino acids (methionine and cysteine) have 
been found to reduce Cu absorption due to the formation of insoluble Cu-sulphide 
complexes in the gastrointestinal tract (Suttle, 1974a), although it is unlikely that S will 
exhibit significant effects on Cu metabolism independently, compared with the Mo x S 
interaction. Increased dietary S may increase concentrations of free sulphides within the 
digestive tract, forming insoluble Cu-sulphide compounds, which are not absorbed, but 
excreted in the faeces (Suttle, 1974a). Suttle (1986) found that only small increases in 
herbage molybdenum and sulphur concentrations caused major reductions in Cu 
availability (Fig. 1.2). Dick (1954) found that by increasing S intakes of sheep from 0.04 to
2.4. g kg'* S, Cu concentration within the liver was reduced by up to 30%. Studies by 
Grace et al (1997) found contradictory findings to Suttle (1974a) and Dick (1954). When 
S intakes for grazing lambs were increased from 3.9-7.9 g S day'*, there was no significant 
effect on Cu status of the lambs when grazing pastures containing similarly low levels of 
Mo (<0.5 mg kg'* Mo DM) (Suttle, 1974a). Although increasing S intakes reduced Cu 
entering the duodenum, adequate amounts of Cu were still being absorbed as assessed by 
liver Cu concentration.
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Fig. 1.2 Estimating the availability o f copper in herbage from its molybdenum and 
sulphur concentrations: the dijference o f 3 mg molybdenum and 0.5 g 
sulphur/kg DM between pastures A and B is sufficient to reduce availability 
from 2.6 to 1.3 per cent, doubling the grazing animals requirement o f 
copper from the pasture.
(Suttle, 1986)
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1.4.3. Metabolic interactions o f copper with iron
High levels of dietary Fe are known to cause antagonistic interactions with Cu, but less 
attention has been paid to the precise mechanism as to how dietary Fe may act as a Cu 
antagonist in comparison to Mo. It has been suggested that high dietary intakes of Fe may 
complex with S within the rumen and produce an insoluble FeS complex, which binds with 
Cu but is not absorbed (Suttle et al, 1984). In contrast to TTM, the FeS complex has a 
high affinity for complexing Cu in the rumen but is not absorbed. Work by Humphries et 
al. (1983), Bremner et al (1987) and Phillippo et al (1987a) found that dietary Fe 
inclusion to cattle produced no clinical symptoms of a secondary Cu deficiency when 
compared to Mo supplemented animals. In addition, Phillippo et al (1987b) also found 
that Fe supplemented heifers exhibited no alterations in fertility compared to Mo 
supplemented cattle (See section 1.6.6.). These findings suggest that a FeS complex 
reduces Cu absorption only within the rumen environment. Combined Fe and Mo 
supplements to calves were not found to have any more of an additive effect than the 
antagonists seperately (Humphries et al, 1983).
Copper status, as measured by plasma and liver Cu concentrations in cattle have been 
found to be reduced by varying dietary intakes of Fe (Standish et al, 1969; Humphries et 
al, 1983; Bremner et al 1987; Phillippo et al 1987a; Chase et al, 2000). Humphries et al. 
(1983) found that 890 mg kg'^ Fe DM was sufficient to lower Cu status in calves, but 
increasing supplements of Fe had no additional effect on reducing Cu status. The effect of 
Fe supplementation has been found to greatly reduce liver and plasma Cu levels in weaned 
calves but not in the pre-ruminant calf (Bremner et al, 1987). This may suggest that 
differences occur due to the efficiency of absorption depending upon the development of 
the digestive tract or may be due to the additive effect of S in the developed rumen (Suttle 
eta l, 1984).
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1.5. Copper enzymes
Copper is an essential component of a number of proteins and enzymes involved in 
metabolism (Linder, 1991) and therefore, research has been directed at measuring Cu 
containing “cupro-enzymes” following Cu deficiency (Prohaska, 1990). These include 
ceruloplasmin, superoxide dismutase, lysyl oxidase, amine oxidase, cytochrome oxidase 
and tyrosinase. Most examples of altered enzyme activity following either a primary or 
secondary Cu deficiency involve lowered enzyme activities. Some of these enzymes are 
ubiquitous enzymes for Cu regulation in all animal cells, whilst other cupro-enzymes have 
more specialised functions and are unique to certain cells (Prohaska, 1990).
1.5.1. Ceruloplasmin (CP)
Ceruloplasmin (CP), also known as ferroxidase (EC 1.16.3.1), is a blue Cu metalloenzyme 
with oxidase activity, first described by Holmberg and Laurell (1948). It is a single-chain 
polypeptide of 1046 amino acids to which several carbohydrate chains are attached (Linder 
et al., 1998). CP is found in the plasma of most vertebrate species and is synthesised in the 
liver at a constitutive rate (Gitlin et al, 1992). Under normal conditions, it is secreted in 
the plasma as holo-ceruloplasmin, where CP accounts for between 90-95% of circulating 
plasma Cu in mammals (Terada et al, 1995). The amount of Cu per protein molecule has 
been reported to vary between 5.5 and 7 Cu atoms per molecule for the human protein 
(Fee, 1975), whilst bovine and ovine CP contain 6-8 Cu atoms per molecule (Calabrese et 
al. 1983). Bovine and ovine CP has a molecular weight of approximately 132 000 daltons 
and a turnover of two to three days (Linder, 1991).
Ceruloplasmin is necessary for the oxidation of Fe, allowing it to bind with the Fe transport 
protein, transferrin (McDowell, 1985). The ferroxidase activity of CP enables iron to be 
mobilised from its stored ferrous state in the liver and intestinal mucosa (as Fe^^) to a ferric 
state (Fe^^ whereby it is then transported in the bloodstream via transferrin (Frieden,
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1970). During periods of Cu deficiency, when CP concentrations fall very low, there is a 
gradual accumulation of Fe in liver and other organs (Tran et al, 1999). Ceruloplasmin is a 
polyfimctional protein which is also involved in free radical scavenging and anti-oxidant 
activity (Goldstein and Charo, 1982), Cu and Fe transport (Linder and Hazegh-Azam, 
1996), incorporation of Fe into the storage protein, ferritin (Saenko et al, 1994) and as an 
important acute-phase reactant involved vrith inflammation (Linder and Hazegh-Azam, 
1996). Ceruloplasmin also acts as a transport protein for Cu, the function being to deliver 
Cu to the cell membrane receptor (Saenko et al, 1994).
Many other tissues other than the liver have shovm CP expression and possibly secrete it, 
particularly those involved in producing proteins for other body fluids, including sertoli 
cells, mammary gland, and the choroid plexus of the brain (Linder and Hazegh-Azam, 
1996). Ceruloplasmin concentrations are known to fluctuate extensively in numerous 
diseases and hormonal states, and in man, CP has been utilised diagnostically for a variety 
of clinical and pathological conditions including rheumatoid arthritis, liver disease, chronic 
infections and genetic diseases including WD (Scheinberg and Gitlin, 1952) or Menkes 
Disease (Danks et al, 1972).
In ruminant animals, CP has been used diagnostically as an indicator of Cu status 
(Mackenzie et al, 1997) (see section 1.7). Ceruloplasmin activity has been found to 
decrease with nutritional Cu depletion of ruminant animals during a primary Cu deficiency 
(Blakey and Hamilton, 1985) and during exposure to high dietary intakes of Mo 
(Humphries et al, 1983). Although the precise mechanism by which CP activity is reduced 
due to dietary Mo is unknown, the formation of TM complexes vrithin the rumen may act 
systemically due to the absorption of TM (as their ammonium salts), and subsequently 
reduce CP activity. Mason et al (1982) found that both duodenal and intravenous infusions 
of tri and tetra TM produced rapid decreases in CP activity in vivo in sheep but TM were
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reversible inhibitors of CP activity in vitro. An alternative theory may be that TM may 
directly alter the effectiveness of the Cu chaperone, ATOXl (see section 1.3.2.) within the 
hepatocyte, causing a reduction in Cu incorporation into the apo-CP and subsequent 
decrease in Cu incorporation into the holo-enzyme. The reduction in CP activity during a 
secondary Cu deficiency requires further investigation.
1.5.2. Superoxide Dismutase (SOD)
Superoxide dismutase (SOD) (EC 1.15.1.1.) was first isolated from bovine red blood cells 
and liver by Mann and Keilin (1938). SOD is a Cu dependent antioxidant enzyme 
(McCord and Fridovich, 1969) which is ubiquitous amongst aerobic organisms and is 
essential in catalyzing the convertion of the two superoxide radicles (O2' ) normally 
produced during aerobic metabolism to the lesser reactive hydrogen peroxide and oxygen 
(Fridovich, 1975) and to prevent cellular membrane damage:
2 O2' + 2H^  --------► H2O2 + O2
(Fridovich, 1975)
Two types of SOD are known to exist in eukaryotes. These contain either two atoms of Cu 
and two atoms of Zn (CuZnSOD) (Bossa et al, 1980) referred to as SODi, or one 
manganese atom per subunit (MnSOD) (SOD2). SODi is found primarily in the cytosolic 
fraction of the cell (Chang et al, 1988), whilst SOD2 is within the mitochondria (Slot et 
al, 1986). Commercial kit assays for SOD activity do not distinguish between these two 
isoforms of the enzyme and therefore, the generic term SOD has been used. However, 
SODi is the predominant isoform and therefore, generic SOD activity may still reflect Cu 
status.
SOD is enhanced in many intercellular reactions including oxidative stress, during 
phagocytosis and from the membranes of leucocytes and therefore the role of SOD is to
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prevent the destruction of membrane lipids and intercellar structures (Sies, 1993). SOD’s 
also prevent the conversion of oxyhaemoglobin to methemoglobin preventing erythrocyte 
fragility (Lynch etal, 1976; Goldberg and Stem, 1977).
Studies in sheep have indicated that oxidative stress induces or enhances the activity of 
SOD (Sansinanea et al, 1997). The only factor known to reduce SODi activity in sheep is 
a primary Cu deficiency (Suttle and McMurray, 1983).
SOD activity has previously been used as an indicator of Cu status in ruminant animals as 
it has been suggested to be a more useftd indicator of Cu status than other current methods 
as it less sensitive to short-term changes in dietary Cu (Suttle and McMurray, 1983) (see 
section 1.7).
1.5.3. Amine Oxidase
Amine Oxidase (AO) (EC 1.4.3.6.) is a Cu-dependent enzyme involved with catalysing the 
oxidative deamination of biogenic amines and the cross-linking of collagen and elastin 
(Bachrach, 1985). Work by Mulryan and Mason (1987; 1993) and Kelleher and Mason 
(1979) found that AO activity was strongly inhibited by molybdate and TM in vitro. 
Further work by Mason (1986; 1990) supported the hypothesis that a secondary Cu 
deficiency may enhance TM production in vivo and could directly affect Cu 
metalloenzymes including AO. Amine oxidase activity in plasma has also been found to 
decline during a primary Cu deficiency in sheep, cattle and pigs (Paynter, 1987). Plasma 
AO levels have been found to be extremely variable due to their apparent resistance to 
reductions in Cu intake and as such, activity declines at a relatively late phase (Claypool et 
al, 1975).
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1.5.4. Lysyl oxidase
Lysyl oxidase (EC 1.4.3.13) is a Cu-dependent enzyme present in high concentrations in 
dense connective tissue including the skin, teeth, heart, bones and cartilage cells and is 
responsible for the maturation and cross-linking of collagen and elastin. (Rucker et al, 
1996; 1998). Lysyl oxidase cross-links polypeptide chains of elastin and also collagen 
fibres to produce a three dimensional matrix which gives the body elasticity and 
mechanical strength (Linder, 1991; Rucker et al, 1996). Reduction in lysyl oxidase 
activity due to a primary Cu deficiency may incur defects including defects in elastic tissue 
formation, leading to aneurysms and spinal curvature, pulmonary disease, increased 
proportions of soluble collagen and other defects of connective tissue (collagen and elastin) 
and bone formation (O’Dell, 1976).
1.5.5. Cytochrome Oxidase
Cytochrome oxidase (COX) or cytochrome c oxidase (EC 1.9.3.1) is found primarily in the 
membranes of the mitochondria (Chance and Leigh, 1977). The enzyme contains two Cu 
atoms and is the terminal enzyme in the electron transport chain (Green et a l, 1956). The 
enzyme is important for energy generation through oxidative phosphorylation and cell 
respiration (Linder, 1991). It reduces O2 with four electrons (fi’om cytochrome c) to form 
two molecules of water. It was confirmed by Okunuki et al. (1958) that the enzyme 
contained Cu, Fe and heme. During periods of primary Cu deficiency, tissue COX activity 
has been found to be reduced in the sheep (Mills and Williams, 1962), pigs (Gubler et al, 
1957) and calf (Mills and Dalgamo, 1970).
Swayback disease, also known as enzoonotic ataxia, is a neuro-degenerative disorder that 
involves motor in-coordination of the hind limbs in lambs and kids (Howell et al, 1964). 
In the foetal lamb, Cu levels have been found to be depleted in the central nervous system 
and the neurons (Mills and Williams, 1962; Fell et al, 1965). A primary Cu deficiency was 
found to reduce the COX activity in the mitochondria in the brain of diseased sheep (Mills
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and Williams, 1962; Smith et al, 1976; Alleyne et al, 1996) and hence, a decreased ATP 
activity which enhanced abnormalities in the central nervous system (Alleyne et al, 1998). 
Depletion of COX has been shown to occur in cerebral cortex, brain stem and spinal cord 
of ataxic lambs (Howell and Davison, 1959; Mills and Williams, 1962). In addition, 
mitochondria isolated from livers of swayback-diseased animals have revealed an unusual 
structure and uncharacteristic kinetics in COX (Gallagher et al, 1973; Alleyne et al, 
1998). Alleyne et al (1996) found that lambs with swayback had lower than normal COX 
content of mitochondria, lipid depleted mitochondria and different protein composition of 
the COX enzyme.
1.5.6. Tyrosinase
Tyrosinase (EC 1.14.18.1) is a Cu-dependent enzyme involved with catalysing the 
oxidation of tyrosine to the black pigment melanin (Davis and Mertz, 1987). During a 
secondary Cu deficiency, ruminant animals with dark pigmented coats incur a change in 
coat or fleece colour (achromotrichia). Lack of pigment production in black fleeced sheep 
and greying of black or bleaching of brown hair in cattle, especially around the eyes 
(“spectacles”), are common clinical symptoms observed in ruminant animals (Underwood, 
1977). The pigmentation process is so susceptible to changes in Cu concentration, that 
alternating bands of pigmented and unpigmented wool fibres can be produced accordingly 
as Cu is added or withheld from the diet (Underwood, 1977). Loss of hair colour in cattle 
was observed in cattle that received dietary Mo but not in cattle that received dietary Fe 
even though both types of deficiency were equally as severe as determined by the Cu status 
of the animal (Phillippo et al, 1987a, b). These findings may have been due to the 
systemic effect of absorbed TM on the tyrosinase enzyme in the Mo-supplemented cattle.
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1.6. Clinical symptoms of a secondary copper deficiency
The systemic effect of absorbed TM may induce clinical symptoms of a secondary Cu 
deficiency. In animals that do exhibit clinical symptoms, the degree of severity of these 
clinical symptoms may vary within a species or between species and may be dependent on 
the Mo content of the diet (Humphries et al, 1983; Phillippo et al, 1987a). The onset of 
clinical symptoms may be ascribed to the inactivation of Cu-dependent enzymes within the 
blood due to the antagonistic effect of absorbed TM within the blood and tissues.
Significant findings by Humphries et al (1983) and Phillippo et al (1987a) found that 
clinical symptoms (including changes in hair texture and colour) and a decrease in 
production in cattle was more prevalent when Mo was present in the diet compared to 
dietary Fe. Dietary Fe greatly altered Cu metabolism (as measured by Cu status) but had no 
effect on clinical appearance or growth. Therefore, alterations in clinical symptoms and 
performance do not occur when Cu status is low (Phillippo et al, 1987a) but when 
increased intakes of dietary Mo enhance the formation and absorption of TM complexes 
resulting in a systemic decrease in Cu availability.
1.6.1. Scouring or diarrhoea
The role of Mo in the development of diarrhoea in ruminants is unknown. Severe diarrhoea 
or ‘scouring’ was described by Ferguson et a l (1943) in cattle grazing the Mo rich ‘teart’ 
pastures in Somerset, UK. Severe diarrhoea in cattle often occurs with a rapid onset in 
animals grazing pastures containing high Mo concentrations, often leading to lethargy and 
dehydration and a reduction in performance. Low levels of Cu do not cause diarrhoea to 
such an extent as when high levels of Mo are present in the diet (Ward, 1978). The 
differences in susceptibility to diarrhoea in grazing cattle and sheep are unknown. 
Histochemical and ultrastructural changes have been observed in the small intestinal 
epithelium of animals with severe diarrhoea (McDowell, 1992).
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1.6.2. Depigmentation o f hair or wool
The loss of pigment in hair or wool (achromotrichia) is a common characteristic of a 
secondary Cu deficiency in ruminant animals. Cattle with dark/black coats may exhibit a 
browning or gingering effect to the coat. Alterations in pigmentation of the hair or wool 
may be due to the inactivation of the enzyme tyrosinase as described in section 1.5.6. 
Studies by Moeini (1997) showed that in a series of experiments involving repeated 
depletion and repletion of dietary Cu to Hebridean sheep presented vrith diets containing 
dietary Mo, altering pigmented and unpigmented bands could be identified in the wool 
fibres due to the inactivation / activation of Cu-containing enzymes. Formation of black 
hair or wool can be prevented within two days if the level of dietary Cu is low and if 
dietary Mo and S intakes have been increased (Underwood, 1977). Changes in hair colour 
were also observed in cattle fed diets containing dietary Mo but not in Fe treated cattle 
(Humphries et al, 1983; Phillippo et al, 1987a,b).
1.6.3. Altered kératinisation o f hair or wool
Altered keratinistaion of wool and hair have been observed in ruminants with a low Cu 
intake (Suttle and Angus, 1976) but not directly as a result of high intakes of dietary Mo. 
The polypeptide chains of keratin fibres are cross-linked by disulphide bonds which are 
formed by the oxidation of -SH groups of the cysteine residues present in the polypeptide 
chain (Linder, 1991). A lack of ‘crimp’ in fleece or hair results in a reduction in tensile 
strength producing straight “steely” wool. Alopecia may occur, elastic properties are 
abnormal and wool will lie permanently if stretched (Marston, 1946).
1.6.4. Skeletal abnormalities
Copper is essential for maturational cross-linking of elastin and collagen as it is the 
cofactor for lysyl oxidase (Harris et al, 1980). In the absence of Cu, there is impaired 
formation of cross-linkages and a reduction in the strength of collagen fibres (Harris et al,
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1980). Skeletal abnormalities due to Cu deficiency have been reported in a variety of 
species including lambs (Suttle et al, 1972), calves (Suttle and Angus, 1978), farmed red 
deer (Thompson et al, 1994), moose (Rehbinder and Petersson, 1994) and bison calves 
(Woodbury et al, 1999). Abnormalities in the skeleton have included osteoporosis (Suttle 
et al, 1972), reduced osteoblastic activity (Parry et al, 1993), enlargement of the 
epiphyseal cartilage (Suttle and Angus, 1978), lameness (Irwin et al, 1974) and 
spontaneous fractures and brittle bones (Cunningham, 1950; Suttle et al 1972). Bone 
lesions due to a secondary Cu deficiency have been described in cattle (Irwin et al, 1974), 
sheep (Hogan et al, 1971) and moose (Frank et al, 2000a, d). Parry et a l (1993) found 
that when TTM was provided in diets to Hooded Lister rats, femur length and cell 
proliferation in the growth plate was markedly reduced compared with Mo-only 
supplemented rats. The same antagonistic effect of absorbed TM may account for skeletal 
abnormalities observed in ruminant animals receiving diets containing Mo.
7.6.5. Neonatal Ataxia
Neonatal ataxia, also known as ‘swayback’ is a nervous disorder observed in lambs, goats 
and deer (McDowell, 1992). Swayback is a clinical condition resulting fi’om a lack of or 
degeneration of the myelin sheath in the spinal cord and nerve fibres and is associated with 
low levels of Cu in the foetal brain and liver (Underwood, 1977). The condition may occur 
as one of two forms; as an acute form in newborn animals or as a delayed condition, 
manifesting itself weeks or months after birth. All affected animals show in-coordination 
of movement, staggering or an inability to stand or walk. The delayed condition has been 
reproduced experimentally in primary (Suttle et al, 1970) and in secondary Cu deficiency 
induced by Mo and S in lambs (Suttle and Field, 1969). The role of Cu in neonatal ataxia 
and the relationship with cytochrome oxidase is described in section 1.5.5.
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1.6.6. Fertility
Impaired reproductive performance associated with a secondary Cu deficiency in sheep 
and cattle have been confirmed by several authors (du Plessis et al, 1999a,b; Phillippo et 
al, 1987b; Van Niekerk and Van Niekerk, 1989b). Early suggestions of a possible effect o f 
Mo on fertility were by Munro (1957). Cattle grazing Mo rich peat soils in East Anglia that 
had low fertility rates were significantly improved by appropriate Cu supplementation. 
Similarly, a Mo-induced subfertility in cattle has been found to be improved with Cu 
supplementation (Black and French, 2000). Mackenzie et al (2001) showed that treatment 
with a Cu bolus reduced the insemination to conception rate of dairy cattle from 2.5 to 1.7 
for control and Cu-treated animals respectively. Other reports of alterations in reproductive 
performance due to a secondary Cu deficiency have included embryonic loss (O’Gorman 
et al, 1987), reduced or absent oestrus (Phillippo et al, 1987b), delayed onset of puberty 
(Phillippo, 1987b), reduced luteinising hormone release (du Plessis et al, 1999a), 
reduction in size and function of ovaries (du Plessis et al, 1999a) and lack of signs of 
behavioural oestrous in sheep (du Plessis et al 1999b). Phillippo et al (1987b) found that 
heifers supplemented with Mo showed delayed puberty, a reduction in percentage 
conception rate and a reduction in pulsatile LH release compared to Fe supplemented 
heifers.
At a herd level, fertility in the UK dairy herd is declining (Royal et al, 2000) although 
cattle vrith infertility problems often have normal plasma Cu concentrations (above 12 
pmol 1'^ ). Therefore, the systemic effect of absorbed TM may have direct effects on 
altering the reproductive performance in ruminant animals, although the precise 
mechanism by which this may occur has not been established. Dietary Mo in the form of 
TM may exert direct effects on ovarian steroid secretion (Kendall et al, 2003) or impair 
reproductive hormone release (FSH or LH) (Mofibr and Rodway, 1991).
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1.6.7. Growth retardation
Reports of Mo or Fe affecting growth rate have produced inconsistent findings within the 
literature. Most commonly, growth retardation has been associated with low Cu:Mo ratios 
(<3.0) (Underwood and Suttle, 1999). Moffor and Rodway (1991) found that intravenous 
TTM reduced live weight gains and delayed the onset of puberty in lambs compared to the 
respective control groups (268 days versus 245 days respectively). Phillippo et al. (1987a, 
b) found that heifers supplemented with Mo grew significantly slower after 16 weeks on 
trial compared to control or Fe supplemented heifers. These results are also in accordance 
with work by Humphries et al (1983) and Smith et al (1975) in calves. Although Fe is 
known to affect Cu metabolism it has not been shown to have a such a dramatic effect on 
growth rate as Mo (Humphries et al, 1983; Phillippo et aï., 1987a).
1.6.8. Immune function
Cu deficiency has been associated with reduced immune function and increased 
susceptibility to disease and infection (Stabel and Spears, 1989) although the effects of 
dietary Mo on different aspects of the immune system have produced inconsistent findings. 
Woolliams et al. (1986a) found that microbial infections produced greater mortality 
amongst lambs grazing improved pastures compared to Cu supplemented lambs. Calves 
bom to dams fed diets containing Mo were also more susceptible to diseases whilst nursing 
their dams than calves from Cu adequate cows or cows fed a high Fe diet (Gengelbach et 
al, 1997).
Numerous techniques have been applied to assess effects on immune responses by dietary 
antagonists, including lymphocyte proliferation tests (Ward et al, 1993; Arthington et al, 
1996), humoral immune responses (Gengelbach and Spears, 1998; Stabel et al, 1993), 
superoxide dismutase activity (Boyne and Arthur, 1986) and neutrophil phagocytic 
function (Xin et a/., 1991).
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Gengelbach and Spears (1998) found that calves receiving dietary Mo had a lowered serum 
antibody responses to porcine erythrocytes than calves fed a control diet (containing no Cu 
or Mo). Boyne and Arthur (1986) reported that neutrophils from cattle supplemented with 
Mo had a reduced ability to kill ingested Candida albicans compared to cattle 
supplemented with dietary Fe or Cu supplemented cattle. Also, neutrophils from steers 
supplemented with Mo had a reduced ability to kill Staphlococcus aureus compared to 
unsupplemented control animals (Xin et al, 1991).
It is clear from these reports that dietary antagonists. Mo and S, can alter the immune 
function in ruminants via a Cu dependent mechanism. However, this mechanism has not 
been fully established although Boyne and Arthur (1986) proposed that this may be 
attributed to alteration in SOD activity and antioxidant capacity.
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1.7. Determination of copper status
Although significant progress has been made over the past fifty years to determine the 
mechanisms by which dietary Mo or Fe alter Cu metabolism in ruminant animals, 
accurately determining Cu status still remains problematic.
The most common diagnostic aids currently used to assess Cu status are blood Cu 
concentrations, including plasma Cu (PFCu) concentration and ceruloplasmin (CP) 
activity. Normal Pl-Cu reference ranges for ruminant animals are 12-24 pmol with 
marginal levels between 8-12 pmol T^  and deficiency levels below 8 pmol 1'^  (Illingworth, 
personal communication). However, normal or high Pl-Cu concentrations do not always 
indicate that the animal has biologically ‘available’ circulating Pl-Cu as the Cu may be 
complexed to circulating TM (Suttle, 1980) producing a misleading Cu status of the 
individual. Pl-Cu concentrations have been found to increase due to high dietary Mo and/or 
S intakes (Dick, 1953; Bremner and Young, 1978; Van Niekerk and Van Niekerk, 
1989a,b) reinforcing the underlying inadequacy of using Pl-Cu concentration 
independently as a diagnostic test of Cu status.
CP has previously been used as a diagnostic aid as CP accounts for 90-95% of circulating 
Pl-Cu (Terada et al, 1995) and has been found to be very sensitive to dietary Mo intakes 
(Humphries et al, 1983). However, CP activity may increase due to infections, stress or 
pregnancy (Linder, 1991). Therefore, the use of a CP:Pl-Cu ratio was advocated by 
Mackenzie et al (1997) to be a more useful indicator than Pl-Cu or CP alone to assess the 
functional Cu status of ruminant animals. No diagnostic test currently takes into 
consideration TM that may be absorbed into the blood and reduce Cu availability. A 
theoretical ratio of CP:Pl-Cu of 2:1 (CP in mg/dL and Pl-Cu in pmol f^) was proposed by 
Mackenzie et al (1997) for a normal ruminant animal with a ratio of <2.0 indicating that 
TM was being absorbed into the blood, thus, reducing the availability of Cu in the blood 
and tissues and reducing the activities of the Cu enzymes. Ratios of 1.0-1.5 may indicate a 
definite TM problem and <1.0, a serious TM problem. The validity of this ratio was
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confirmed by Moeini (1997) and Mackenzie et al. (2001) who found that animals 
diagnosed with low CP:Pl-Cu ratios benefited from Cu supplementation as measured in 
their responses to improvements in fertility rates. In addition, Kendall et al. (2001) 
reported an increase in the CP:Pl-Cu ratio in cattle with Cu supplementation.
Liver Cu concentration is also commonly used as a diagnostic aid to determine Cu status of 
ruminant animals but does not take into consideration the effect of dietary Mo and the 
systemic effects of TM. Increased Pl-Cu concentrations have been observed in association 
with decreases in liver Cu concentrations (Van Niekerk and Van Niekerk, 1989a). A 
decrease in liver Cu concentration suggests a homeostatic mechanism by the liver by 
regulating Pl-Cu concentrations when a high proportion of Cu is bound to TM. Pl-Cu 
concentration alone is not closely related to liver Cu stores and has been recommended to 
not be used as the only diagnostic indicator of Cu status (Vermunt and West, 1994). The 
use of liver biopsies to determine Cu status are also expensive, invasive and time 
consuming (Minatel and Carfagnini, 2002).
Superoxide dismutase (SOD) has often been used as an indicator for diagnosing Cu 
deficiency due to the long lifespan of erythrocytes (92 days) and slow decrease in enzyme 
activity compared to Pl-Cu during Cu depletion (Suttle and McMurray, 1983). Therefore, 
SOD may be a more useful diagnostic aid indicative of a severe or prolonged Cu 
deficiency (Paynter, 1987), although little is known about the systemic effects of TM on 
SOD activity.
Amine oxidase (AMOX) activity has been shown to be induced by a primary deficiency in 
cattle (Mills et al, 1976). Work by Kelleher and Mason (1979) showed that AMOX 
activity of CP was inhibited by sodium TTM in vitro, with later studies by Mulryan and 
Mason (1987) showing that AMOX activity was depressed by dithiomolybdate. No known 
studies to date have investigated the effect of a secondary Cu deficiency on AMOX 
activity in ruminant animals.
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Hair and fleece Cu have been used as diagnostic indicators of Cu status but may only be 
useful as a diagnostic tool after prolonged periods of Cu deficiency (Suttle and McMurray, 
1983). Hair Cu has been found to decline relatively slowly during a primary Cu depletion 
in bovine (Suttle and Angus, 1976).
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1.8. Conclusion
After extensive reviews of literature on the effects of Mo and Fe on Cu metabolism, it is 
apparent that there are two divergent views on the aetiology of clinical Cu deficiency. One 
view, postulated by Suttle (1991) is that the mechanism by which clinical Cu deficiency 
occurs is due to a lack of Cu, either as a primary deficiency or by Mo, S and Fe preventing 
absorption in the small intestines. The second mechanism proposed by Phillippo et al. 
(1987a, b) suggested that clinical Cu deficiency was rarely due to a lack of Cu, either as a 
primary deficiency or due to the prevention of Cu absorption. From their work, Phillippo et 
al. (1987a, b) showed differential effects on clinical signs attributed to Mo and Fe, 
suggesting that clinical Cu deficiency may have been attributable to toxic systemic effects 
of TM produced within the rumen and their subsequent absorption. Although the 
mechanism by which dietary Mo enhances TM formation within the rumen has been 
established, the systemic effect of absorbed TM on Cu-containing enzymes remains 
unknown. In addition, variations in responses of dietary Mo or Fe on Cu metabolism 
remain confusing. Even after extensive research, a reliable diagnostic test to diagnose a 
secondary Cu deficiency in ruminant animals which takes into consideration absorbed TM 
still remains to be found, although the CP:Pl-Cu ratio as proposed by Mackenzie et al. 
(1997) requires further validation. A molecular approach to determine how TM may alter 
expression of Cu-containing enzymes may provide novel and fundamental answers in the 
pathogenesis of a secondary Cu deficiency. Therefore, this thesis will attempt to 
investigate the effects of dietary Mo or Fe on Cu metabolism and physiology of sheep, 
with the aim of producing novel research to help elucidate the mechanism by which these 
dietary antagonists affect ruminant animals.
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Chapter 2
Materials and Methods
2.1. Proximate Analysis
All methods were carried out in accordance with the methods of MAFF (1986). All feed 
samples were analysed in duplicate for content of dry matter (DM), ash, crude protein 
(CP), ether extract (EE), neutral detergent fibre (NDF) and neutral detergent cellulase 
gamanase (NCDG) as described in sections 2.1.1 to 2.1.6 respectively.
2.1.1. Dry Matter
Dry matter (DM) content was determined on all concentrate feeds by oven drying 100 g of 
sample into a previously weighed aluminium tray at 100°C until a constant weight was 
achieved. The content of dry matter was then calculated firom the equation:
I  Weight of diy sample (g) 1 ^ j ^  kg ' )
[ Weight of original sample (g) J
2.1.2. Ash
Ash content was determined by accurately weighing 1 g of dried concentrate feed into a 
pre-weighed porcelain crucible and then ashing in a muffle furnace (Gallenkamp Muffle 
Furnace, size 3, GAFSE 620) to 450°C for 16 hours. The ash remaining in the crucible was 
then cooled in a dessicator to room temperature and reweighed. The content of ash was 
then calculated firom the equation:
I  Weight of ash (g)------- 1 ^   ^Q Q Q  _ content (g kg'  ^DM)
[ Weight of original sample (g) J
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2.1.3 Crude Protein
Crude protein (CP) was determined using an automated Kjeldahl digestion procedure on a 
decator 1035 autoanalyser (Foss UK Ltd, Oxon, UK). Samples weighing approximately 1 
g were placed in folded nitrogen-free Whatman filter papers (Whatman no 1) and placed in 
clean Kjeldahl tubes. Two kjeltab catalyst tablets (3.5 g K2SO4 and 0.4 g CUSO4.5H2O; 
Thompson and Capper Ltd.) and 20 ml of concentrated sulphuric acid (6N) was added to 
each tube and then all tubes were transferred to a digestion block and boiled at 420°C for 
45 minutes in a fume cupboard. Samples were then cooled for 20 minutes and 75 ml of 
deionised water added to each tube. All tubes were placed individually in the auto analyser 
and digests were made alkali by the addition of 50-65 ml sodium hydroxide. All samples 
were distilled in a solution of 4% boric acid before titration with 0.2M hydrochloric acid 
performed by the Kjeltec 1035 autoanalyser (Foss UK Ltd, Oxon, UK). The nitrogen 
content and crude protein content of the sample (calculated using the sample weight and 
the volume of acid required to neutralise the ammonia) was calculated from the equation :
1ml of O.IM HCl = 0.0014g Nitrogen
.1. 11.4 X volume of HCl 1Nitrogen (g kg-)= . ,
( Sample weight (g) J
Nitrogen (g kg'^) x 6.25 = Crude protein content (g kg'^)
2.1.4. Ether extract
Ether extract (EE) was determined by weighing approximately 1 g DM of feed into a pre­
weighed cellulose extraction thimble (Whatman International Ltd., Maidstone, UK). The 
thimble was then plugged with de-fatted cotton wool and placed in the extraction unit 
(Tecator Soxtec 1043, Foss UK Ltd., Oxon, UK). Extraction cups were weighed and 
placed into the cup holder. Total fat was extracted by boiling samples in 25 ml of 
petroleum ether (solvent) for 1 hour. Samples were removed from the solvent and rinsed 
for a further 15 minutes. Final traces of petroleum ether were evaporated off, the extraction
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cups were removed from the apparatus, cooled in a fume cupboard and re-weighed when 
cool.
Ether extract content was calculated from the equation:
EE (g kg ' DM) -- f cup + fat weight) - (extraction cup weight)]
[ (thimble + sample weight) - (thimble weight) J
2.1.5. Neutral Detergent Fibre
Neutral detergent fibre (NDF) content of the feed was determined using the method of Van 
Soest et al. (1991). NDF reagent was previously prepared using 93 g disodium ethylene 
diamine tetra-acetate dihydrate (EDTA) and 34 g sodium borate dissolved in distilled water 
using gentle heating. One hundred and fifty g sodium lauryl sulphate and 50 ml 2-ethoxy 
ethanol were then added. In a separate flask, 22.8 g of anhydrous disodium hydrogen 
phosphate was dissolved in distilled water. The two solutions were then mixed and diluted 
to 5 litres with distilled water. The pH was adjusted to pH 6.9-7.1.
Approximately 0.5 g ground sample was weighed into a previously dried and weighed 
Fibretec crucible (PI). The crucible was then secured in the Fibretec apparatus (Tecator 
Fibretec 1020, Foss UK Ltd., Oxon, UK) and 25 ml of cold NDF reagent added to each 
sample as well as 0.5 ml Octanol (anti-foaming agent). All samples were brought to boiling 
point and then digested for a further 30 minutes at a reduced temperature. The heat was 
then turned off and a further 25 ml of cold NDF reagent added to each crucible and 2 ml a- 
amylase solution (BDH Laboratory Supplies, Poole, Dorset, UK) (2 g a-amylase was
dissolved into 90 ml of distilled water, filtered and 10 ml 2-ethoxy ethanol added and
stored at 4°C). The samples were then brought to boiling point and digested for a further 30 
minutes at a reduced heat. The heat was then turned off and the samples washed (vacuum 
filtered) three times using 20 ml of hot (80°C) distilled water. After filtration, a further 25 
ml of distilled water and 2 ml of a-amylase were added to each crucible and allowed to 
stand for 15 minutes before being washed (vacuum filtered) three times with hot distilled
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water (80°C) and finally with 20 ml of acetone. All crucibles were removed fi*om the 
Fibretc apparatus and oven dried at 100°C overnight, cooled in a dessicator and reweighed. 
Crucibles were then placed in a muffle fiimace (Gallenkamp Muffle Furnace, Size 3, 
GAFSE 620) and ashed at 550°C for 4 hours, cooled in a dessicator and reweighed. The 
NDF content of the feed was calculated as:
NDF (g) = (crucible + dry fibre weight) -  (crucible + ash weight)
NDF (g kg ' DM) = I — — 1 X1000 
[Sample weight (g) DM j
2.1.6. Neutral cellulase gamanase digestibility
Neutral cellulase gamanase digestibility (NCDG) was determined according to the method
of MAFF (1986). The same methodology was performed on the feed samples using the
method described in section 2.1.5. AJfter the final washing (vacuum filter) stage with hot
(80°C) distilled water and the addition of 20 ml acetone, the crucibles were removed from
the Fibertec apparatus. Subseals were moistened in distilled water and carefully placed into
the bottom of each crucible. To each crucible, 25 ml of cellulase/gamanase solution was
added (buffered cellulase solution prepared by weighing 20 g cellulase, (BDH Laboratory
Supplies, Poole, Dorset, UK) and 0.1 g of chloramphenicol (Sigma- Aldrich, New Road,
Gillingham, Dorset, UK) into a 2 litre wide necked flask. One litre of buffer solution was
added (1.36 g sodium acetate dissolved into 500 ml of distilled water, with 0.6 ml glacial
acetic acid and diluted to 1 litre, adjusted to pH 4.8), shaken and incubated for
approximately 1 hour until dissolved). Cellulase solution and gamanase (Novo Nordisk,
2880 Baysvaerd, Denmark) were mixed in the proportions 9:1 to give a cellulase solution
containing 10% gamanase. Suba-seal caps were placed on top of each crucible and shaken
to mix crucible contents. All crucibles were then incubated at 40°C for 24 hours, shaking
firequently. The cap and suba-seal were removed and each crucible was placed in the
Fibretec apparatus and washed (vacuum filtered) three times with hot (80°C) distilled water
and once with 20 ml of acetone. All crucibles were removed from the Fibretc apparatus
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and oven dried at 100°C overnight, cooled in a dessicator and reweighed. Crucibles were 
then placed in a muffle furnace (Gallenkamp Muffle Furnace, Size 3, GAFSE 620) and 
ashed at 550°C for 4 hours, cooled in a dessicator and reweighed. NCGD was determined 
using the indigestible organic matter (lOM) and the ash in the sample:
lOM (g) = (crucible wt + dry fibre wt) - (crucible wt + ash wt)
IOM(%)
Ash (g)
Ash(% )
[ lOM wt (g) ]
[Sample weight (g) J
xlOO
(crucible wt (g) + ash wt (g))- (crucible wt (g))
J  =^hwt(g) 1
[ Sample wt(g) J
NCGD (%) = 1 0 0 -  (lOM (%) + ash (%))
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2.2. Blood sample collection
Blood samples were collected from lambs or wethers via jugular venepuncture using a 20 
gauge 1.5" needle (Becton Dickinson Vacutainer Systems, Plymouth, UK) into 10 ml 
vacutainer tubes (Becton Dickinson Vacutainer Systems, Plymouth, UK). Tubes containing 
the anticoagulant heparin were used for collection of whole blood products haematocrit 
(He), haemoglobin (Hb) or erythrocyte superoxide dismutase (SOD) activities and plasma- 
copper concentration after centrifugation. Silicone coated tubes were used for collection of 
serum and subsequent analysis of ceruloplasmin (CP) and amine oxidase (AMOX). 
Following haematocrit determination, the remaining blood samples collected in heparin 
tubes were inunediately centrifuged at lOOOg for 15 minutes (Beckman Avanti 30 
centrifuge). The supernatant was pipetted off with disposable pipettes and stored in 7 ml 
bijou tubes (Sarstedt Ltd., Leicester, UK) for storage at -20°C. Blood samples collected in 
no additive, silicone coated tubes (Becton Dickinson Vacutainer Systems, Plymouth, UK) 
were refrigerated at 4°C and left to coagulate overnight. All tubes were subsequently 
centrifuged at lOOOg^  for 15 minutes (Beckman Avanti 30 Centrifuge), and the supernatant 
pipetted off with plastic disposable pipettes and aliquated into micro-centrifuge tubes and 
the remainder stored in 7 ml bijou tubes (Sarstedt Ltd., Leicester, UK) for storage at -20°C. 
Prior to analysis, all serum and plasma containing tubes were left to defrost to room 
temperature and vortexed using a MT-20 vortex-mixer (Philip Harris Ltd., Shenston, UK) 
to provide a uniform sample.
2.2.1. Haematocrit
Haematocrit (He) was determined using fresh whole blood. Heparinised capillary tubes (10 
X 100mm) (Hawksley and Sons Ltd., Marlborough Road, Lancing, Sussex, UK) were filled 
with heparinised blood and sealed at one end with Cristaseal (Hawksley and Sons Ltd., 
Marlborough Road, Lancing, Sussex). They were then placed in a micro-haematocrit 
centrifuge (Centurion Scientific Ltd, Weston-Super-Mare, Somerset, UK). All capillary
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tubes were centrifuged at 3000^ for 15 minutes. The haematocrit (%) was determined on a 
micro-haematocrit reader (Hawksley and Sons Ltd, Marlborough Road, Lancing, Sussex), 
with the haematocrit being the proportion of packed cells as a percentage of the total 
volume.
2.2.2. Haemoglobin (manual method)
Haemoglobin (Hb) concentration was determined for all lambs as described in chapter 3
(Procedure number 525 : Sigma Aldrich Ltd., St. Louis, USA). Working standards were
prepared by accurately pipetting and mixing thoroughly into 10 ml round bottomed glass
test-tubes Drabkins reagent (product no. 525-2) (100 parts sodium bicarbonate, 20 parts
potassium ferricyanide and 5 parts potassium cyanide, plus an additional 0.5 ml 30% Brij-
35 solution to make Drabkins solution), cyanmethemoglobin (reconstituting hemoglobin
standard no. 525-18 with 50 ml Drabkins solution) and hemoglobin standard (product no.
525-18, Sigma Aldrich Ltd., St. Louis, USA) used as an internal standard for all samples at
a known concentration of 18 g/dL. A calibration curve was determined by accurately
pipetting haemoglobin standard into plastic micro cuvettes and reading the absorbance
using a Unicam 8625 Ultra Violet spectrophotometer (Unicam Ltd., York St., Cambridge,
UK) at a wavelength of 530-550 nm using the given concentrations:
Tube Cyanmethemoglobin Drabkins Blood Hb
____________standard solution fmlf Solution fml) fg/dLf
1 0.0 6.0 0.0
2 2.0 4.0 6.0
3 4.0 2.0 12.0
4 8.0 0.0 18.0
Haemoglobin concentrations of all samples were determined from a calibration curve of 
absorbance values (nm) against blood haemoglobin levels (g/dL). Intra assay coefficient of 
variations were calculated and described in chapter 3. Hb concentration was determined as 
g/dL.
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2.2.3. Haemoglobin (Cobas Mira Plus Method)
Haemoglobin (Hb) analysis for all animals as described in chapters 4 to 6 inclusive was 
determined using a Total Hemoglobin kit (procedure no. 525, Sigma-Aldrich Ltd., St 
Louis, USA) adapted for the Cobas Mira Plus (ABX Diagnostics, Shefford, Bedfordshire, 
UK). Whole blood samples were defrosted to room temperature and vortexed using a MT- 
20 vortex-mixer (Philip Harris Ltd., Shenston, UK). Into a 1 ml micro-centrifuge tube, 20 
pi of whole blood was accurately pipetted into 180 pi red cell lysing agent (Sigma-Aldrich 
Ltd., St Louis, USA) and vortexed using a MT-20 vortex-mixer (Philip Harris Ltd., 
Shenston, UK). Samples were then carefully transferred into Mira cups (ABX Diagnostics, 
Shefford, Bedfordshire, UK), and placed into reagent racks and analysed by an automated 
method on the Cobas Mira Plus (ABX Diagnostics, Shefford, Bedfordshire, UK). For 
control of precision and accuracy, pooled whole blood was stored in frozen micro- 
centrifuge tubes at -20°C and defrosted to room temperature and subsequently used as an 
internal standard against all samples. Intra assay coefficient of variations were calculated 
and described in respective chapters where appropriate. Haemoglobin concentrations were 
determined as g/dl.
2.2.4. Ceruloplasmin activity
Ceruloplasmin (CP) activity was determined using an adapted method of Henry et al.
(1974) for use on the Cobas Mira Plus (ABX Diagnostics, Shefford, Bedfordshire, UK). 
The ability of CP to act as a general oxidase is utilised in this method, where CP will 
oxidise p-phenylenediamine (PPD) to produce purple products that have an absorption 
peak between 530-550 nm. As PPD is also oxidised by any copper or iron present in 
serum, a blank (CPB) must be run in which sodium azide inhibits the CP activity, and the 
results subtracted from the test (CPT). Individual serum samples were pipetted into Mira 
cups (ABX Diagnostics, Shefford, Bedfordshire, UK) and placed in the required reagent 
rack on the Cobas Mira Plus. A O.IM solution of PPD (BDH Laboratory Supplies, Poole,
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Dorset, UK) was prepared in 100 ml of O.IM acetate buffer and adjusted to pH 6.0. 
Sodium azide (BDH Laboratory Supplies, Poole, Dorset, UK) was prepared using 0.1% 
solution in pH 6.0 acetate buffer. A test (CPT) reagent was prepared by adding 20 ml 
acetate buffer pH 6.0 and 10 ml PPD solution pH 6.0. A blank (CPB) reagent was prepared 
by adding 10 ml acetate buffer pH 6.0, 10 ml PPD solution pH 6.0 and 10 ml sodium azide 
solution. The activity of the ceruloplasmin (mg/dl) was calculated as:
CPT -  CPB = Ceruloplasmin activity (mg/dl)
For control of precision and accuracy, pooled serum was stored in frozen micro-centrifuge 
tubes at -20°C and defrosted to room temperature and subsequently used as internal 
standards against all samples. Intra assay coefficient of variations were calculated and 
described in respective chapters where appropriate.
2.2.5. Super oxide Dismutase activity
Superoxide dismutase (SOD) activity was determined using an adapted method of Misra 
and Fridovich (1977) for use on the Cobas Mira Plus (Ransod SD125, Randox 
Laboratories, County Antrim, UK). This method employed xanthine and xanthine oxidase 
(XOD) to generate superoxide radicals that react with 2-(4-iodophenyl)-3-(4-nitrophenol)- 
5-phenyltetrazolium chloride (I.N.T.) to form a red formazan dye. The SOD activity was 
then measured by the degree of inhibition of this reaction. Frozen heparinised blood 
samples were defrosted (to enhance lysing of cells) and vortexed using a MT-20 vortex- 
mixer (Philip Harris Ltd., Shenston, UK). Into a 1 ml micro-centrifuge tube (Sarstedt Ltd., 
Leicester, UK), 250 pi of whole blood was accurately pipetted and a further 750 pi of 
purite water was added. The sample was vortexed and 10 pi of this sample was then added 
to 490 pi of 0.01 mol f* phosphate buffer, pH 7.0 (Ransod, Randox laboratories. County 
Antrim, UK) into a micro-centrifuge tube and vortexed thoroughly. Samples were then 
carefully transferred into Mira cups (ABX diagnostics, Shefford, Bedfordshire, UK), and
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placed into reagent racks and analysed by an automated method on the Cobas Mira Plus 
(ABX Diagnostics, Shefford, Bedfordshire, UK).
SOD activity (U/g Hb) was calculated as: 
f  SOD units/ml of whole blood 1
[ g haemoglobin/ml J
= SOD units/g haemoglobin
For control of precision and accuracy, pooled whole blood was stored in frozen micro­
centrifuge tubes at -20°C and defrosted to room temperature, to be subsequently used as 
internal standards against all samples. Intra assay coefficient of variations were calculated 
and described in respective chapters where appropriate.
2.2.6. Plasma Copper concentration
Plasma copper (Pl-Cu) concentrations were determined on a Pye Unicam SP9 Atomic 
Absorption Spectrophotometer with a 10 cm slot burner head using background correction 
for copper at a wavelength of 324.8 nm. Plasma samples were defrosted to room 
temperature and thoroughly mixed using a MT-20 vortex-mixer (Phillip Harris Ltd., 
Shenston, UK) and 1:10 dilutions were prepared using purite water. Samples were 
vortexed and read on the atomic absorption spectrophotometer. For control of precision 
and accuracy, stock plasma samples were stored in frozen bijou tubes at -20°C and 
defrosted to room temperature and used as an internal standard against all samples. 
Working standards were prepared by dilution of a copper sulphate solution (1000 ppm 
Spectrosol, BDH Laboratory Supplies, Poole, Dorset, UK) in purite water using a standard 
curve. Intra assay coefficient of variations were calculated and described in respective 
chapters where appropriate. Plasma copper concentration was determined as pmol 1"\
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2.2.7. Serum Amine Oxidase activity
Serum amine oxidase (AO) was determined using an adapted method of Mulryan and 
Mason (1992) for use on the Cobas Mira Plus automated analyser (ABX Diagnostics, 
Shefford, Bedford, UK). This method employed /7-dimethylaminobenzylamine as a 
substrate and one unit of AO activity was defined as the amount of enzyme required to 
produce an absorbance change of 1 x 10’^  OD (355nm) per minute.
Individual serum samples were carefully pipetted into Mira cups (ABX Diagnostics, 
Shefford, Bedfordshire, UK) and placed in the required reagent rack on the Cobas Mira 
Plus. A O.IM potassium phosphate buffer was prepared by dissolving 1.36 g of KH2PO4 in 
80 ml deionised water, adjusted to pH 8.0 with l.OM NaOH and made up to 100 ml with 
deionised water. Amine oxidase activity was measured using /7-dimethyl- 
aminobenzylamine solution (3.6mM) mixed in with O.IM potassium phosphate buffer, pH 
8.0 at 25“C. The reaction was started with the addition of 28 pi of serum to 252 pi of 
reagent (1:10 dilution). The product /?-dimethylaminobenzaldehyde was measured at a 
wavelength of 355 nm for 17 minutes.
One unit of AO activity was defined as the amount of enzyme required to produce an 
absorbance change of 1x10'^ (OD 355nm) per min at 25°C:
„ f  Aabsorbance/min 1 f  Total vol.of reaction mixture 1Umts/1 serum = <-------------- :-------- --------------- ------------------ ------- )
[ 1x10' J [ Vol. of serum used J
For control of precision and accuracy, stock serum samples were stored in frozen bijou 
tubes at -20°C and defi*osted to room temperature and used as an internal standard against 
all samples. Intra assay coefficient of variations were calculated and described in 
respective chapters where appropriate.
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2.2.8. Liver copper determination (atomic absorption method)
Livers were collected from all lambs as described in chapter 3 from a commercial 
slaughterhouse. Fresh liver samples were collected from all lambs and placed into clean 
plastic bags and stored at -20°C for subsequent analysis. Liver copper concentration was 
determined using the method of AOAC (1990) using a Smith-Hieftje 1000 atomic 
absorption spectrophotometer (Thermo Jarrell Ash Corporation, Franklin, MA, USA) with 
a 10 cm burner head and using background correction at a wavelength o f324.8 nm.
All glassware was washed thoroughly: O.IM HCl (BDH Laboratory Supplies, Poole, 
Dorset, UK) for two days, rinsed thoroughly in purite water, a further two days rinsing in 
O.IM HNO3 (BDH Laboratory Supplies, Poole, Dorset, UK) and a final thorough rinse in 
purite water, drained and oven dried.
Frozen livers were defrosted to room temperature and a 1 g section of liver was accurately 
weighed out and placed into a 15 ml plastic screw capped digestion tube (Sarstedt Ltd., 
Leicester, UK). Into each tube, 5 ml of concentrated HNO3 (69% ANALAR: BDH 
Laboratory Supplies, Poole, Dorset, UK) was carefully pipetted, the screw cap tightened 
and all tubes placed in a ventilated oven at 60°C for 12 hours until complete digestion had 
occurred. After 12 hours, all tubes were removed from the oven and the lids removed in a 
fume cupboard and allowed to cool to room temperature. Samples were carefully 
transferred into a 25 ml volumetric flask and made up to volume using purite water. 
Working standards were prepared by dilution of a copper sulphate solution (1000 ppm 
Spectrosol, BDH Laboratory Supplies, Poole, Dorset, UK) in purite water. Samples were 
analysed on the atomic absorption spectrophotometer (AAS) and a stock liver sample used 
as an internal standard against all samples for precision and accuracy. Intra assay 
coefficient of variation was calculated as described in chapter 3. Liver copper 
concentration was determined in mg kg'  ^DM.
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2.2.9. Trace element determination o f tissue samples (ICP-MS)
Tissue samples obtained in chapter 5 were collected from major organs including liver, 
cerebellum, ovary and pituitary gland at the slaughterhouse. Fresh liver samples were 
collected from lambs and wethers as described in chapters 3 to 6 inclusive, into clean 
plastic bags and stored at -20°C for subsequent analysis. The brain was removed for 
necropsy according to the procedure of McCumin and Bassert (2002) and separated into 
four parts using sterile scalpel blades for cerebrum, cerebellum, hypothalamus and medulla 
oblongata. The cerebellum, pituitary gland and ovary were stored in 10% buffered formalin 
for tissue preservation (HD Supplies, Aylesbury, Bucks, UK) and subsequently analysed 
for trace element determination.
All 28 ml pyrex glass tubes and glass marbles were washed thoroughly: O.IM HCl (BDH 
Laboratory Supplies, Poole, Dorset, UK ) for two days, thoroughly rinsed in purite water, a 
further two days rinsing in O.IM HNO3 (BDH Laboratory Supplies, Poole, Dorset, UK) 
and a final thorough rinse in purite water, drained and oven dried.
Livers were thoroughly defrosted and triplicate samples of approximately 0.5 g liver were 
accurately weighed and transferred into individual bijou tubes (Sarstedt Ltd., Leicester, 
UK). These were then transferred into a freeze drier (Edwards Modulyo, Crawley, West 
Sussex, UK) for 72 hours. Dried samples were then weighed again for dry matter 
determination and transferred into a clean 28 ml pyrex glass tube. Two ml of concentrated 
HNO3 was pipetted into each pyrex tube containing the liver sample, covered with a glass 
marble and heated at 70°C in a ventilated oven for 12 hours until complete digestion had 
occurred. All samples were allowed to cool and subsequently made up to 10 ml in 
volumetric flasks using purite water. For pituitary gland, ovary and cerebellums, 
approximately 0.4 g, 0.8 g and 0.6 g respectively of tissue sample was used with 2 ml 
concentrated HNO3 and made up to 10 ml final volume in a volumetric flask with purite 
water. Further dilutions were prepared where appropriate. Using an Inductively Coupled 
Plasma Mass Spectrophotometer (ICP-MS) (Elan 6100, Perkin Elmer Instruments,
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Norwalk, CT, USA), copper, molybdenum, iron, and zinc concentrations were obtained 
(parts per million, ppm). Merck standards were prepared and a Bovine Liver Standard 
Reference Material (1577b) (National Institute of Standards and Technology, 
Gaithersburg, MD, USA) was used for precision and accuracy.
2.3. Trace element determination o f feeds
Trace element composition of all basal diets in chapters 3 to 6 respectively were 
determined by ICP-Emission Spectroscopy (Track-scan, Thermo-Jarrell Corporation, 
USA) following concentrated nitric acid-hydrogen peroxide digestion of all samples. All 
samples were analysed by a commercial laboratory (Frank Wright Ltd., Ashbourne, 
Derbyshire, UK).
2.4. Liveweight determination
Lamb weights were recorded once weekly as specified for each experimental chapter using 
a standard operating procedure with weigh scales (LAE Scales, Leek, Staffordshire, UK), 
and calibrated using metric standard weights (F.J. Thornton and Co. Ltd., Wolverhampton, 
UK) for precision and accuracy.
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Chapter 3
The effect of dietary molybdenum or iron on copper status and
performance of growing lambs
3.1. Introduction
Secondary copper (Cu) deficiency in ruminant animals is caused by high dietary intakes of 
molybdenum (Mo) and sulphur (S) (Suttle, 1991). Within the anaerobic conditions of the 
rumen. Mo and S complex to form a series of thiomolybdates (TM) which were first 
implicated in the aetiology of a secondary Cu deficiency by Suttle (1974b) and Dick et al
(1975). TM complexes are known to have a high affinity for Cu, and as a consequence, 
may form CuTM within the digestive tract of the animal, preventing absorption from the 
small intestines (Dick et al, 1975; Mason, 1986; Mason et al, 1982; Mills et a l 1978). If 
insufficient dietary Cu is available in the rumen, TM may be absorbed as their ammonium 
salts into blood and tissues, leading to a systemic reduction in Cu available for Cu- 
dependent enzyme activities. It is the systemic effect of absorbed TM that affects Cu 
metabolism and may not be a reduction in Cu availability for absorption that may 
ultimately produce clinical symptoms. Clinical symptoms attributable to dietary Mo have 
included changes in coat texture and colour and reductions in growth rate (Humphries et 
al, 1983; Phillippo et al, 1987a), skeletal abnormalities (Humphries et al, 1983) and 
acute diarrhoea (Ferguson et al, 1943). Dietary Mo has also been shown to have 
significant effects on fertility in cattle (Phillippo et al, 1987b) and sheep (Van Niekerk and 
Van Niekerk, 1989b; du Plessis et al, 1999a, b).
Early studies by Munro (1957) and Littlejohn and Lewis (1960) suggested that there was 
no correlation between fertility and Cu status in dairy cattle (as measured by serum Cu 
status alone), as serum Cu concentration and fertility rate were highly variable. Phillippo et 
al (1982) confirmed studies of Case et al (1973) by suggesting that dietary Mo, rather
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than Cu deficiency per se, may be the cause of poor reproductive performance in cattle. 
Dietary Mo was found to significantly reduce the rele^e of luteinizing hormone, reduce 
conception rate, delay the onset of puberty and cause an increase in anoestrous and 
anovulation in cattle compared to control or iron (Fe) supplemented cattle (Phillippo et ah, 
1987b).
The onset of clinical symptoms have also been found to vary within individual animals and 
within herds. Wentink et al. (1999) found that heifers supplemented with saturated CUSO4 
solution in water (1 g CuS04/kg DM) and respective control heifers had very low blood Cu 
levels (<3 pmol 1'^ ) and liver Cu concentrations (<6 mg kg" )^ although no animal showed 
any clinical symptoms, normally presumed to be indicative of a Cu deficiency. Humphries 
et al. (1983) also found that both dietary Mo and Fe reduced Cu concentrations in the 
plasma, liver and Cu-containing enzymes, although only animals that received dietary Mo 
produced clinical symptoms.
The antagonistic effect of dietary Fe in reducing Cu availability has been well documented 
in cattle (Humphries et al, 1983; Bremner et al, 1987; Phillippo et al, 1987a), although 
the mechanism by which Cu absorption is reduced due to high Fe intakes is believed to be 
different to the Cu x Mo x S interaction. Work by Phillippo et al. (1987a) found that four 
month old calves supplemented with 500 mg kg'^ Fe had reduced plasma and liver Cu 
concentrations after 32 weeks on trial, but there was no reduction in growth rate or clinical 
symptoms as seen in calves fed the same basal diet containing 5 mg kg‘^  Mo.
Therefore, accurately diagnosing the true Cu status of a ruminant animal has proven to be 
problematic as there is often a lack of association between Cu status and clinical 
symptoms. Current methods of assessing Cu status in ruminant animals include plasma Cu 
(Pl-Cu) or liver Cu concentrations but these methods do not take into consideration the
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effect of dietary Mo and the subsequent reduction in Cu availability due to TM. Rather, 
they define total Cu within the plasma or liver alone and may not provide a true indication 
of the Cu status of the individual. In cattle, low blood Cu concentrations may indicate a Cu 
deficiency, however, normal or high Cu concentrations do not necessarily indicate that the 
animal has a sufficient amount of Cu (Claypool et al, 1975). Unfortunately, at present 
there is no blood test that is currently available to determine whether Pl-Cu is biologically 
available or not (Herdt et al, 2000). The sensitivity of the Cu-dependent enzyme, 
ceruloplasmin (CP) has frequently been used as an indicator of Cu status (Humphries et al, 
1983) as CP accounts for 90-95% of plasma Cu (Terada et al, 1995). Therefore, a CP to 
Pl-Cu ratio (CP:Pl-Cu) for ruminant animals was proposed by Mackenzie et al (1997) as 
being a more usefiil biochemical indicator of Cu status than other current methods when 
assessing animals suffering from TM problems. This ratio assumed that Cu present in CP 
accounted for approximately 90% of Pl-Cu. The model predicted an ideal CP:Pl-Cu ratio 
of 2:1, postulating that a ratio less than 2:1 may indicate free TM being absorbed into the 
blood, which may reduce Cu availability for subsequent metabolic purposes and Cu- 
dependent enzyme activity. The ratio could potentially identify herds with TM problems 
and identify animals that may benefit from Cu supplementation.
Therefore, the aim of this study was to investigate the effect of the dietary antagonists. Mo 
or Fe on Cu status and performance of growing lambs. Copper status was assessed using 
current diagnostic techniques, including Pl-Cu, CP, superoxide dismutase, amine oxidase 
and liver Cu concentration in addition to determining the effects of Mo and Fe on the 
CP:Pl-Cu ratio.
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3.2. Materials and methods
2.2.1. Experimental Design and Animals
Fifty-four Charoliais x (Suftblk x Mule) female lambs of approximately 10 weeks of age 
and with an initial mean live weight of 23.2 kg (s.e.d. 0.89) were used in this study. Six 
representative lambs were slaughtered at the start of the trial to assess liver Cu 
concentration. The remaining 48 lambs were allocated by live weight to one of four dietary 
treatments (twelve lambs per treatment) (see section 3.2.2.) using a completely randomized 
design for a period of ten weeks. Lambs were housed in individual pens on elevated metal 
floors in a ventilated bam throughout the experimental period. Prior to the start of the trial, 
lambs were adapted from a pelleted lamb creep feed (S.C. Feeds, Stone, UK) containing 
18% protein, 10% fibre, 4.5% oil and 8.5% ash during a seven day adaptation period. The 
creep feed was gradually replaced with the basal diet (see Table 3.1).
3.2.2. Diet formulation
The raw materials used for this study were chosen because of their published low Cu and 
Mo contents (MAFF, 1992). Based on this information, diets formulated were predicted to 
provide a Cu content of <5 mg kg'  ^ DM. The basal diet was formulated to provide the 
metabolisable energy (ME) and metabolisable protein (MP) requirements of a 25 kg female 
lamb to grow at 200 g day’^  (AFRC, 1993) and had a predicted effective mmen degradable 
protein (ERDP) of 107.42 kg'  ^ DM and an fermentable metabolisable energy (FME) of 
9.99MJkg^ DM.
Lambs were allocated by live weight to one of four dietary treatment groups which were: 
Treatment one: Basal diet (Control)
Treatment two: Basal diet + 500 mg kg"^  DM iron and 2 g kg"^  DM sulphur (Fe)
Treatment three: Basal diet + 5 mg kg'  ^DM molybdenum and 2 g kg'* DM sulphur (5 Mo) 
Treatment four: Basal diet +10 mg kg'* molybdenum DM and 2 g kg'* DM sulphur (10 
Mo)
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Feed samples were obtained from separate tote bags once weekly. All feed samples were 
analysed for dry matter, ash, crude protein, ether extract, neutral detergent fibre and neutral 
cellulase gamanase digestibility as described in sections 2.1.1. to 2.1.6 respectively. The 
raw material and chemical composition of the basal diet is presented in Table 3.1. 
Additional mineral inclusion per treatment diet is presented in Table 3.2.
Table 3.1: Diet formulation and analysed chemical composition o f the basal diet (DM)
Ingredient (g kg'*) Basal diet
Straw pellets (NaOH treated) 350
Whole barley 247
Rapeseed meal 153
Citrus pulp 100
Soyabean meal 50
Molasses 60
Mineral/vitamin premix* 40
Total 1000
Dry matter (g kg'* DM) 880.6
Metabolisable energy (MJ kg'* DM) 10.6*
Crude protein (g kg'* DM) 148.7
Neutral detergent fibre (g kg'*DM) 381.2
Ether extract (g kg'*DM) 13.6
Ash (g kg"*DM) 89.9
NCDG (gkg'*DM) 733.7
♦Predicted values from equations given in AFRC (1993). 
^Mineral premix -  see Table 3.2
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Table 3.2. Additional mineral inclusion for the control, iron and molybdenum 
treatment diets (kg ton'^)
Treatment diet 
Ingredient Control Fe 5 Mo 10 Mo
Ammonium molybdate (kg) - 0.008 0.016
Iron sulphate (kg) 2.15 - -
Ammonium sulphate (kg) 6.06 7.078 7.078
Urea (kg)  ^ 3.2 0.46 - -
Sand (kg) 6.8 1.33 2.914 2.906
Mineral premix (kg)^ 20 20 20 20
Salt (kg) 5 5 5 5
Ammonium chloride (kg) 5 5 5 5
Total (kg) 40
1 7 7  . . . .  " .  . . . . .  .  .
40 40 40
 ^Mineral Premix (20 kg ton'*) (Roche, Basel, Switzerland) containing 500,000 lU/kg Vit A, 100,000 lU kg'* 
Vit D3, 7,500 mg kg'* Vit E, 15 mg kg'* selenium, 32.3 % calcium, 3.9 % sodium and 2.04 % phosphorus.
The mineral composition of the basal diet was determined by ICP-ES (see section 2.3) and 
is presented in Table 3.3. Molybdenum was supplemented as reagent grade ammonium 
molybdate (NH4)6Moy O24 . 4 H2O, iron was supplemented as reagent grade iron sulphate 
(FeS04 . 7H2O) and sulphur was supplemented as reagent grade ammonium sulphate 
(NH4)2S04 (all BDH Laboratory Supplies, Poole, Dorset, UK). The nitrogen content of the 
mineral mix was balanced with urea (Trouw Nutrition, Northwich, Cheshire, UK) and sand 
was used as an inert material to balance mass.
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Table S.3 Analysed mineral composition o f the basal diet
Element Quantity
Calcium (g kg" )^ 8.60
Phosphorus (g kg'^) 3.00
Sulphur (g kg'^) 2.20
Magnesium (mg kg‘^ ) 1.60
Copper (mg kg"^ ) 5.47
Molybdenum (mg kg" )^ 1.29
Iron (mg kg'^) 167.35
Zinc (mg kg'^) 97.44
Cobalt (mg kg'^) 0.52
Selenium (mg kg‘^ ) 0.0065
Manganese (mg kg'^) 98.12
Fresh water was offered ad libitum and the copper content of the water was 38 pg/1, iron 
<20 pg/1 and no detectable molybdenum (Meridian Science, South Staffordshire Water 
PLC, UK).
3.2.3. Experimental Routine
All lambs were fed at 08:00 and 15:00 daily into individual feed boxes to prevent mineral 
contamination. Feed intake was rationed in order to achieve a growth rate of 200 g day"\ 
All feed was weighed into individual feed buckets using metric scales and calibrated using 
metric standard weights (F.J. Thornton and Co. Ltd., Wolverhampton, UK). Food refusals 
were weighed back twice weekly to determine individual lamb food intakes. The quantity 
of the feed offered was recalculated weekly according to the live weight of the animal 
taken on the day of live weight determination (see section 3.2.3.1.).
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3.2.3.1. Live weight determination
All lambs were weighed once weekly on Mondays at 11:00 using the Standard Operating 
Procedure as described in section 2.3. Daily liveweight gain (DLWG) was calculated using 
regression analysis.
3.2.3.2. Blood collection and analysis
Blood samples were collected once weekly on Tuesdays at 10:00 as described in section
2.2. Fresh whole blood was used to assess haematocrit (section 2.2.1.) and the remaining 
blood prepared as described in section 2.2. and stored at -20°C for subsequent analysis. 
Frozen samples were thoroughly defrosted and whole blood was subsequently analysed for 
superoxide dismutase activity (SOD) (section 2.2.5.) and haemoglobin (Hb) (section
2.2.2.), plasma analysed for plasma copper concentration (Pl-Cu) (section 2.2.6.), and 
serum analysed for ceruloplasmin activity (CP) (section 2.2.4.) and amine oxidase activity 
(AMOX) (section 2.2.7.). The intra assay coefficient of variation for respective standards 
were: SOD 4.83 %, Pl-Cu 3.42 %, CP 10.15 %, Hb 0.63 % and AMOX 6.65 %.
3.2.4. Liver copper concentration
All forty-eight lambs were sent to a commercial slaughterhouse on day 73 of the trial. All 
lambs including the six initial slaughter lambs killed on day 0 were killed using the same 
slaughter procedure in which they were stunned with a captive bolt pistol and killed by 
exsanguination. All livers were collected immediately and were frozen at -20°C. Liver Cu 
concentration was determined using the method from the Official Methods of Analysis 
(AOAC, 1990) using an atomic absorption spectrophotometer (section 2.2.8.). The intra 
assay coefficient of variation for the liver sample standard was 2.53 %.
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3.2.5. Statistical analysis
Statistical analysis was performed using Genstat version 5.0. All haematology and enzyme 
parameters were analysed by analysis of variance (ANOVA) and repeated measures 
(where appropriate) using a completely randomized design. Daily liveweight gain 
(DLWG) was calculated by regression analysis and analysed by ANOVA. In all graphs, 
error bars represent 2x s.e.d. Differences between treatment means was calculated using a 
protected least significant difference (LSD) (Snedecor and Cochran, 1989).
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3.3. Results
3.3.1. Growth rate and performance characteristics
There was no significant effect of 500 mg kg'^ Fe or 5 or 10 mg kg'^ Mo on lamb live 
weight at any weekly time point (Fig. 3.1.). There was no significant effect of 500 mg kg'  ^
Fe or 5 or 10 mg kg"^  Mo on total gain, daily live weight gain (DLWG), daily dry matter 
intake (DMI), total dry matter intake (DMI) or food conversion efficiency (FCE) (Table
3.4.). The DLWG for all treatment groups was higher than the predicted DLWG of 200g 
day"^  as formulated by AFRC (1993).
Table 3.4 Effect o f molybdenum or iron supplementation on growth rate and
Treatment
Control Fe 5 Mo 10 Mo s.e.d. Significance
Initial liveweight 25.9 2&5 25.1 26.3 1.22 NS
Slaughter weight 45.2 45.3 44.7 46.2 1.77 NS
Total Gain 19.3 18.8 19.6 19.9 1.20 NS
DLWG (kg day-') 0.28 0.26 0.27 0.28 0.016 NS.
Daily DMI 1.54 1.54 1.50 1.59 0.059 NS
Total DMI 110.8 110.7 108.0 114.4 4.23 NS
FCE* 0.17 0.17 0.18 0.17 0.550 NS
*FCE calculated as Total Gain (kg) divided by Total DMI (kg)
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Figure 3.1. Effect o f molybdenum or iron supplementation on live weight o f
growing lambs
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3.3.2. Haematocrit
All haematocrit (He) levels were considered to be within the normal reference ranges for 
sheep (22-40%) (see Appendix 1). There was no significant effect of 500 mg kg'  ^ Fe or 5 
or 10 mg kg'^ Mo on He (%) of growing lambs over the experimental period (Table 3.5). 
There was a trend for He (%) to decrease in all experimental treatment groups over the ten 
week experimental period. Repeated measures analysis indicated that there was an effect 
(P<0.001) of time on He (%) as seen by a gradual decrease in all treatments. There was no 
effect of treatment or treatment x time interaction on He (%) of growing lambs 
supplemented with 500 mg kg"^  Fe or 5 or 10 mg kg'  ^Mo.
Table 3.5. Effect o f  molybdenum 
growing lambs
or iron supplementation on haematocrit (%) o f
Treatment
Control Fe 5 Mo 10 Mo s.e.d. Significance
Week
0 38.0 31.6 38.3 37.2 1.06 NS
1 37.1 36.3 36.7 35.8 0.97 NS
2 34.9 34.6 34.4 34.5 0.95 NS
3 35.8 34.6 34.1 34.8 0.88 NS
4 36.9 35.4 35.3 34.5 0.87 NS
5 35.0 34.8 34.1 33.9 0.94 NS
6 35.2 34.5 34.1 34.3 0.91 NS
7 34.4 34.4 34.0 33.5 0.72 NS
8 34.3 34.3 33.9 33.8 0.86 NS
9 34.2 34.1 33.5 33.6 0.74 NS
10 34.2 33.0 33.3 32.8 0.70 NS
Repeated Measures Analysis: Treatment effect 
Time effect
P=N S 
P = <0.001
Time X Treatment effect P = NS
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3.3.3. Haemoglobin concentration
All haemoglobin (Hb) concentrations were considered to be within the normal reference 
ranges for sheep (8-16 g/dl) (see Appendix 1). There was no significant effect of 500 mg 
kg'  ^ Fe or 5 or 10 mg kg'^ Mo on Hb concentration in growing lambs except at week 9 
(Table 3.6.). At week 9, the lambs that received the control dietary treatment had a 
significantly higher Hb concentration compared to all other dietary treatments. Repeated 
measures analysis indicated that there was an effect (P<0.001) of time due to fluctuations 
in Hb concentration by all treatment groups but no significant treatment effect or treatment 
X time interaction on Hb concentration.
Table 3.6. Effect o f molybdenum or iron 
concentration (g/dl) in growing lambs
supplementation on haemoglobin
Treatment
Week
Control Fe 5 Mo 10 Mo s.e.d. Significance
0 11.1 11.8 11.6 10.7 0.62 NS
1 12.6 12.6 12.5 12.3 0.39 NS
2 11.1 11.4 11.2 11.4 0.56 NS
3 12.2 12.3 12.1 12.2 0.40 NS
4 13.2 12.4 12.7 12.4 0.32 NS
5 11.8 11.0 10.4 10.7 0.67 NS
6 12.3 12.3 11.9 12.1 0.55 NS
7 12.4 12.5 12.5 12.0 0.32 NS
8 11.5 11.6 11.0 11.4 0.45 NS
9 13.2'’ 123* 12.5* 11.9* 0.32 ***
10 12.2 11.8 11.8 11.7 0.28 NS
* <0.05, **<0.01, *** <0.001 
Repeated Measures Analysis: Treatment effect P = NS
Time effect P = <0.001
Time X Treatment effect P = NS
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3.3.4. Plasma Copper concentration
At week 1 and week 2, the lambs that received the 10 mg kg'  ^ Mo dietary treatment had 
higher (P<0.01) Pl-Cu concentrations compared with the lambs that had received the 
control or 500 mg kg'^ Fe dietary treatments (Fig 3.2.). At week 1, the lambs that received 
the 5 mg kg'^ Mo dietary treatment had higher (PO.Ol) Pl-Cu concentrations compared 
with the lambs fed the control or 500 mg kg'  ^Fe dietary treatments. At week 2, lambs that 
received the 500 mg kg’^  Fe dietary treatment had lower Pl-Cu concentrations compared to 
the lambs that received the 5 mg kg'  ^Mo dietary treatment. From weeks 3 to 10 inclusive, 
the lambs that received the 10 mg kg’  ^ Mo dietary treatment had higher (P<0.001) Pl-Cu 
concentrations compared to the lambs that received the 500 mg kg'  ^ Fe dietary treatment. 
From weeks 1 to 10 inclusive (albeit week 5), lambs fed the 5 mg kg'^ Mo dietary 
treatment had higher (P<0.001) Pl-Cu concentrations compared with the lambs fed the 500 
mg kg"^  Fe dietary treatment. There were no differences at any weekly time point in Pl-Cu 
concentrations of the lambs that received the 5 mg kg'^ Mo or 10 mg kg'^ Mo dietary 
treatments. The lambs that received the control treatment diet had higher (P<0.001) Pl-Cu 
concentrations compared with the lambs that received the 500 mg kg‘  ^Fe dietary treatment 
during weeks 3, 9 and 10. Pl-Cu concentrations of lambs that received the control 
treatment diet were lower (P<0.001) compared with the lambs fed 10 mg kg'^ Mo (week 4), 
5 mg kg'  ^Mo and 10 mg kg‘^  Mo (week 6), 10 mg kg'  ^Mo (week 7) and 10 mg kg"^  Mo 
(week 8).
Repeated measures analysis indicated that there was an (P<0.001) effect of treatment on 
Pl-Cu concentration due to the 10 Mo dietary treatment having the highest Pl-Cu 
concentration throughout the experimental period and the lowest Pl-Cu concentrations in 
the Fe treatment. There was no effect of time but there was an effect (P<0.05) on the time x 
treatment interaction as described for the treatment effect.
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Figure 3.2. Ejfect o f molybdenum or iron supplementation on plasma
copper concentrations o f growing lambs
Repeated Measures Analysis: Treatment effect 
Time effect
P = <0.001 
P=N S
Time X Treatment effect P = <0.05
65
5.3.5. Ceruloplasmin Activity
At weeks 2 and 10, lambs that received the control dietary treatment had higher (P<0.01) 
CP activities compared with the lambs that received the 500 mg kg’^  Fe, 5 mg kg“^ Mo or 
10 mg kg'  ^Mo dietary treatments (Fig. 3.3.). At weeks 7, 8 and 9, lambs that received the 
control dietary treatment also had higher (P<0.001) CP activities compared with the lambs 
that received the 500 mg kg"^  Fe, 5 mg kg"^  Mo or 10 mg kg'  ^ Mo dietary treatments. 
There was no difference in mean CP activity between lambs that received 500 mg kg'^ Fe, 
5 mg kg'  ^ Mo or 10 mg kg’^  Mo dietary treatments at any time point. Repeated measures 
indicated that there was an effect of dietary treatment (P<0.01) due to the control treatment 
having higher CP activities compared to all other dietary treatments throughout the 
majority of the experimental period. There was an effect of time (P<0.001) as described for
the treatment interactions but no treatment x time interaction on CP activity.
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Figure 3.3. Effect o f molybdenum or iron supplementation on ceruloplasmin 
activity o f growing lambs
Repeated Measures Analysis: Treatment effect P = <0.01
Time effect P = <0.001
Time X Treatment effect P = NS
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3.3.6. Ceruloplasmin to Plasma Copper Ratio {CP:Pl-Cu ratio)
From week 1 to week 10 inclusive, lambs that received the control treatment diet had 
higher CP:Pl-Cu ratios (PO.OOl) compared to lambs that received 5 mg kg’  ^Mo or 10 mg 
kg'^ Mo (Table 3.7). Lambs that received 10 mg kg"^  Mo had lower (P<0.001) CP:Pl-Cu 
ratios compared to Iambs which received 500 mg kg"^  Fe from week 1 to week 10 
inclusive. CPrPLCu ratios were higher in the control lambs compared to the lambs that 
received 500 mg kg'  ^ Fe at weeks 6, 8, 9 and 10. Ratios of <1 (see Table 3.7) were 
calculated for the lambs given an additional 10 mg kg"^  Mo during weeks 7 to 9, indicative 
of a serious TM problem. The ratio was also beneficial in identifying significant 
differences in the CP:Pl-Cu ratio between lambs fed either 5 mg kg‘  ^Mo or 10 mg kg"^  Mo 
from weeks 2 to 10 inclusive.
Table 3.7. Effect o f molybdenum or iron supplementation on a ceruloplasmin to
Treatment
Control Fe 5 Mo 10 Mo s.e.d. Significance
Week
0 1.92 1.75 1.82 1.67 0.099 NS
1 1.92'’ 1.66'’' 1.41"' 1.28" 0.131 ***
2 1.78'’ 1.68'’ 1.45' 1.23" 0.106 4" 4"
3 1.37'’ 1.30'’' 1.16' 0.98" 0.072 4* 4* 4"
4 1.48'’ 1.46'’ 1.10' 1.04"' 0.073 ***
5 1.50'’ 1.45'’ 1.14' 1.03"' 0.108 ***
6 1.66' 1.49*’ 1.22" 1.16" 0.063 ***
7 1.44' 1.35' 1.06^ 0.92" 0.057 s);
8 i.so' 1.26' 1.06*’ 0.89" 0.047 ***
9 1.45' 1.24'’ 1.00" 0.94" 0.068 ***
10 1.73' 1.54'’ 1.14"*’ 1.20" 0.088  ^^
*  <0.05, **<0.01, *** <0.001
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3.3.7. Superoxide Dismutase Activity
There was no significant effect of 500 mg kg'  ^ Fe, 5 mg kg'^ Mo or 10 mg kg'^ Mo on 
superoxide dismutase (SOD) activity of growing lambs over the ten week trial period, 
except at week nine (Fig 3.4.). At week nine, the lambs fed the control diet had higher 
(P<0.05) SOD activities compared with lambs that received the 5 mg kg"^  Mo and 10 mg 
kg'  ^ Mo dietary treatments. Lambs fed the 500 mg kg"* Fe dietary treatment had higher 
(PO.Ol) mean SOD activities compared with the lambs that received the 10 mg kg'* Mo 
dietary treatment. Repeated measures analysis indicated that there was no effect of dietary 
treatment and no effect of a time x treatment interaction. There was an effect of time 
(PO.OOl) as seen by a decrease in SOD activity amongst all treatment groups by the end 
of the experimental period (Fig. 3.4).
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Figure 3.4. Effect o f molybdenum or iron supplementation on superoxide
dismutase activity o f growing lambs
Repeated Measures Analysis: Treatment effect P = NS
Time effect P = <0.001
Time X Treatment effect P = NS
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3.3.8. Serum Amine Oxidase activity
At weeks 2, 3, 5 and 6 inclusive, lambs that received the control treatment diet had higher 
(P<0.05) AMOX activity compared with lambs that received the 10 mg kg’^  Mo dietary 
treatment (Fig. 3.5.). At week 6, lambs that received the control treatment diet also had 
higher (P<0.05) AMOX activity compared with lambs that received 500 mg kg'^ Fe. There 
were no differences in AMOX activity between the lambs supplemented with 5 mg kg“^ 
Mo or 10 mg kg'^ Mo at any time point. Repeated measures analysis indicated that there 
was an effect (P<0.001) of time, with a gradual increase in AMOX activity in all treatment 
groups. There was no effect of treatment or time x treatment interaction on AMOX 
activity.
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Figure 3.5. Effect o f molybdenum or iron supplementation on serum amine oxidase
activity o f growing lambs
Repeated Measures Analysis: Treatment effect P = NS
Time effect P = <0.001
Time X Treatment effect P = NS
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3.3.9. Liver copper concentration
Mean liver Cu concentration in the initial slaughter group lambs was 216.7 mg kg’^  DM. 
Lambs that received the control treatment diet for the ten week trial period had higher 
(P<0.001) liver Cu concentrations compared with the pre-treatment group (278.1 mg kg'  ^
DM). After the ten week trial period, lambs that received the control treatment diet had 
higher (P<0.001) liver Cu concentrations compared with lambs that received 500 mg kg'  ^
Fe, 5 mg kg'  ^ Mo or 10 mg kg'  ^ Mo (Fig. 3.6.). Liver Cu concentrations in the lambs that 
received 500 mg kg'  ^ Fe dietary treatment had higher (P<0.001) liver Cu concentrations 
compared with the lambs that received 10 mg kg'  ^ Mo. There were no differences in liver 
copper concentrations between the lambs that received 5 mg kg'  ^Mo or 10 mg kg'* Mo.
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Figure 3.6. Effect o f molybdenum or iron supplementation on liver copper
concentration o f growing lambs
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3.4. Discussion
Chemical composition of the experimental diets were very similar to the values predicted 
during diet formulation (Table 3.1.) and were within normal ranges, as given in MAFF
(1992). Copper content of the basal diet was 5.47 mg kg’* which was marginally higher 
than the predicted Cu requirement during diet formulation of <5 mg kg’*. The Mo content 
in the basal diet (1.29 mg kg’* DM Mo) was lower than the normal recommendations of 2-3 
mg kg’* DM Mo (ARC, 1980) and selenium content of the basal diet was also very low.
Dietary Mo or Fe had no significant effect on lamb growth rate or performance 
characteristics. These results are in accordance with the work of Phillippo et al. (1987a) 
and Bremner et al. (1987). In this study, DLWG was higher than the formulated 200 g day’ 
* as predicted from AFRC (1993) although DMI was almost identical to the predicted 
intake of 1.5 kg day *. The high DLWG for growing lambs in this trial may have been due 
to a breed effect that is not accounted for in prediction equations provided by AFRC
(1993).
Dietary Mo produced no clinical symptoms in this study. These findings confirm those of 
Wentink et al. (1999) who suggested that low levels of Cu within the blood and tissues 
may not produce any clinical symptoms. Work by other authors found that calves receiving 
diets containing 800 mg kg’* and 500 mg kg’* Fe DM respectively were found to show no 
clinical symptoms (Humphries et al., 1983; Phillippo et al, 1987a) similar to lambs in this 
study. Therefore clinical symptoms may not be dependent on Cu status alone.
Low Hb or He in ruminant animals is often associated with anaemia due to mineral 
deficiencies, imbalances or if a Cu deficiency has been severe or prolonged (Suttle and 
Angus, 1978; Gooneratne et al, 1989a). The inclusion of Mo or Fe in this study had no 
significant effect on haematocrit (He) or haemoglobin (Hb) in accordance with Galbraith et
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al (1997) in goats. Although the 5 mg kg'* Mo dietary supplement was considered to be 
relatively high for growing lambs (ARC, 1980), they may not have been severe or 
prolonged enough to alter Hb concentration within a ten week trial period.
The antagonistic effects of Mo and Fe on Cu metabolism in growing lambs were clearly 
identified in this study. Studies by other authors found dietary Mo to reduce PFCu 
concentrations (Humphries et al, 1983; Phillippo et al, 1987a; Xin et al, 1991). However, 
dietary Mo has also been extensively reported to markedly increase Pl-Cu concentrations 
(Dick, 1953; Suttle and Field 1968; Bremner and Young, 1978), in accordance with results 
obtained in this study. It is also known that the liver is the main storage organ of Cu 
(Underwood, 1977) and that CP is produced at a constitutive rate within the liver (Gitlin et 
al, 1992). Therefore, factors should be taken into consideration when determining 
alterations in Pl-Cu and liver Cu concentration. The increase in Pl-Cu concentration as 
observed in this study may have been due to the presence TM complexes in the blood as 
described by Suttle (1980). TM complexes have been reported to circulate in the blood 
stream and due to their high affinity for Cu, act systemically, sequestering Cu from the Cu 
enzymes and tissues. Copper bound to TM within the blood is biologically unavailable, but 
may result in misleadingly high Pl-Cu concentrations due to the Cu bound to the TM 
(Suttle, 1980). These misleadingly high Pl-Cu concentrations are often mis-interpreted as 
being within ‘normal’ reference ranges for ruminant animals as suggested by Claypool et 
al (1975). To maintain Cu homeostasis within the body, as Cu reserves become depleted 
in the blood and tissues, more Cu is released from the liver, to regulate blood Cu 
concentrations (Dick, 1956). Although the liver acts as the main storage organ of Cu, it 
may become depleted due to dietary Mo (Van Ryssen and Stielau, 1981). Dick (1956), 
Marcilese et al (1969) and Van Niekerk and Van Niekerk (1989a) all found that liver Cu 
concentrations were drastically decreased in ewes or rams fed Mo alone or Mo in 
combination with S.
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This study confirms that dietary Mo reduced liver Cu concentrations. Lambs that received 
the dietary Mo treatment diets had significantly reduced liver Cu concentrations, although 
Pl-Cu concentrations increased, compared to the lambs that received the control diet. 
Interestingly, Pl-Cu concentrations decreased in the dietary Fe treatment groups at a very 
early stage of the study and remained lower than all other treatment groups throughout the 
trial period. Although Cu absorption is known to be inhibited by dietary Fe (Humphries et 
al, 1983; Bremner et al, 1987; Phillippo et al, 1987a), normally, the liver would have an 
adequate short term storage of Cu. It has been suggested that high Fe intakes may reduce 
Cu absorption by insoluble Fe x Cu compounds (Suttle and Peter, 1985). If dietary Fe 
becomes complexed to Cu, then the Mo content of the basal diet, although relatively low, 
may also be absorbed and have an additional inhibitory effect on Cu metabolism. 
Inhibition of Cu absorption may also be dependent on the S content in the rumen (Bremner 
et al, 1987). The reduction in liver Cu concentration in Fe supplemented animals in this 
study is in accordance with steers (Humphries et al, 1983), calves (Humphries et a l, 
1985) and heifers (Phillippo et a l, 1987a). Phillippo et al (1987a) found that liver Cu 
concentrations were significantly reduced in heifers fed diets containing the same dietary 
Fe concentrations as in this study compared to control fed heifers.
Mechanisms for the release of Cu fi*om the liver either arise fi*om ceruloplasmin (CP) 
which accounts for 90-95% of circulating plasma Cu (Terada et al, 1995) or are due to the 
systemic effects of TM which increase biliary excretion and deplete hepatic Cu stores 
(Gooneratne et al, 1989b; Symonds and Ke, 1989). The results from this study clearly 
indicate that dietary Mo significantly reduced CP activity in growing lambs and that this 
decrease in CP activity was mirrored by a decrease in liver Cu concentration. Ovine CP is 
known to only have a half-life of approximately 2-3 days (Linder, 1991). Therefore, TM 
may be complexing Cu with such a strong affinity that Cu in the CP protein is not being
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recycled back to the liver and broken down, and as such the half-life of CP may be altered, 
resulting in a reduction in liver Cu concentration.
Another possible explanation for the observed reduction in the active CP enzyme may have 
been due to the direct inhibition by TM. Suttle (1980) suggested that TM complexes in the 
rumen may cause a reduction in Cu availability. Although CP is known to be constitutively 
expressed within the liver (Gitlin et al, 1992), work by Chidambaram et al (1984) 
reported that TM produced irreversible inactivation in vitro of the CP enzyme, although 
later work by Lannon and Mason (1986) found that inactivation of CP was reversible in 
vivo in Jersey steers. Therefore, TM may directly affect the expression rate of the CP 
protein or cause an increase in the release of the apo-form of the protein, rather than the 
holo-protein. The increased release of the apo-CP protein may produce a pool of 
circulating CP that is less biologically active than the holo-protein. Similar to Pl-Cu, CP 
levels which appear to be within the “normal” range for ruminants should also be viewed 
with caution as it is not known if the CP measured was the apo or holo form. CP can also 
act as an acute phase protein and high levels may not be indicative of a ‘normal’ Cu status 
but may also be a reflection of stress, infection or parasitism (Mulryan and Mason, 1992).
Work by Ogra et al (1999) using Wistar rats proposed a different mechanism by which CP 
may be altered by TM. Intraperitoneal injections of tetrathiomolybdate (TTM) significantly 
reduced the activity of CP in serum due to a reduced Cu incorporation into the Cu 
chaperones in the liver rather than a direct removal of Cu from the CP enzyme in the 
serum. Recent work has identified an intracellular Cu chaperone, Sheep Atxl Homologue 
(SAH), which has been found to be important in delivering Cu in the hepatocytes from the 
cytoplasm to ATP7B in the transgolgi network where Cu is incorporated into CP (Lockhart 
and Mercer, 2000). This important finding has shown that Cu incorporation into CP is not 
a passive process but involves specific Cu chaperones within hepatocytes. The homologue 
of ATP7B in the gram-positive bacterium Enterococcus hirae has also been found to be
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inhibited by TTM in vitro (Bissig et al, 2001). Therefore, a more precise understanding of 
where TM may be altering CP expression in ruminant animals is required. It is not known 
whether a reduction in CP activity may be attributable to defects in the Cu chaperone 
protein SAH as a consequence of TM involvement or if a reduction in CP activity is due to 
the control of gene expression.
The CP:Pl-Cu ratio as proposed by Mackenzie et al (1997) clearly identified animals that 
had reduced CP:Pl-Cu ratios due to dietary Mo. Ratios obtained for lambs that received the 
10 mg kg’* Mo dietary treatment were significantly lower compared to control fed lambs. 
According to ratios proposed by Mackenzie et al (1997), ratios obtained in this study for 
the lambs that received either of the Mo dietary treatments were indicative of TM problems 
(ratio of 1.0 -  1.5) although fi-om week 7 to 9 inclusive, lambs that received the 10 mg kg’* 
Mo dietary treatment had CP:Pl-Cu ratios indicative of serious TM problems (<1.0). The 
mechanism by which high dietary Fe reduces Cu absorption is not fully understood but the 
CP:Pl-Cu ratio identified the lambs that received Fe as having a reduced CP:Pl-Cu ratio, 
possibly due to a similar systemic mechanism to that of TM. This requires fiirther 
investigation.
Superoxide dismutase has often been used as an indicator for diagnosing Cu deficiency 
due to the long lifespan of erythrocytes (Kerr, 2002) and the slow decrease in enzyme 
activity (Suttle and McMurray, 1983) compared to the sensitivity and decreases observed 
in CP. Results firom this study indicate that there was no significant time x treatment 
interaction on SOD activity, which may have been due to the relatively short experimental 
period of this trial. SOD appears to be more tolerant of dietary Mo or Fe compared to CP 
or Pl-Cu, and hence, a decrease in SOD activity may only be indicative of a severe or 
prolonged Cu deficiency (Paynter, 1987). Ogra et al (1999) found that intraperitoneal 
injections of TTM in rats reduced Cu in SOD due to the removal of Cu from the Cu in the
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chaperones within the liver rather than direct removal of Cu from the SOD enzyme. The 
same biological scenario may be true of SOD in the liver of ruminant animals.
Amine oxidase activity has shown to be reduced in experimentally induced primary Cu 
deficiency in cattle (Mills et al 1976). Although Cu is contained within the active site of 
amine oxidase, it is rarely used as an indicator of Cu deficiency. Kelleher and Mason 
(1986) showed that AMOX activity of CP was inhibited by sodium TTM in vitro but few 
studies have shown reductions in AMOX activity in vivo due to dietary Mo. In this present 
study, AMOX activity was significantly lower in the lambs that received dietary Mo 
compared to control lambs. This may be due to the systemic effect of TM or a teduction in 
the ability of a Cu chaperone to incorporate Cu into the active site as suggested for SOD 
and CP by Ogra et al (1999). Lambs supplemented with Fe in this study also had 
significantly lower AMOX activity compared to the control lambs.
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3.5. Conclusion
The results from this study indicate that dietary Mo may significantly alter Cu metabolism 
in growing lambs. Therefore, a reduction in Cu for Cu dependent enzymes is not as a result 
of low Cu intakes but is rather a result of elevated intakes of dietary Mo. The effects of 
dietary Mo and the subsequent systemic effects on Cu parameters within the blood and 
tissues may be explained by the formation of insoluble TM complexes within the rumen, 
although these were not measured in this study. The increase in Pl-Cu concentration 
confirms that Pl-Cu concentration is not a useful independent indicator of Cu status in 
ruminant animals. Ceruloplasmin and AMOX activity were affected by dietary Mo but the 
CP:Pl-Cu ratio was a more useful indicator in distinguishing those animals which may 
have been affected by TM. The significant reductions in liver Cu concentration in lambs 
that received dietary Mo may have also been attributable to TM and the resultant 
homeostatic mechanism of the liver in releasing Cu. Alterations in Cu concentrations in the 
blood and tissues due to dietary Mo or Fe did not produce any clinical symptoms. In 
addition, the results from this study did not confirm if the differences observed in Fe 
supplemented lambs occurred within the digestive tract or due to a systemic effect.
To conclude. Mo was a more potent antagonist on Cu metabolism than Fe. Mineral levels 
and the time period chosen in this study did not affect physical performance, although 
more research needs to be undertaken to elucidate both cellular aspects and physiological 
responses of dietary Mo or Fe on Cu metabolism in ruminant animals.
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Chapter 4
The effect of dietary molybdenum or iron on innate and adaptive
immune responses of growing lambs
4.1. Introduction
An increased susceptibility to disease has previously been observed in grazing lambs 
following pasture improvement (Woolliams et a l, 1986a). Woolliams et a l (1986a) found 
a higher rate of mortality in lambs which had previously grazed improved pastures due to a 
range of bacterial infections following post-mortem examination compared to Cu 
supplemented lambs grazing on the same pasture. Therefore, this would suggest that Cu is 
an essential nutrient required for an effective immune system in ruminant animals.
In chapter 3, dietary Mo was found to lower CP activity in association with an increase in 
Pl-Cu, possibly due to the presence of absorbed TM having a systemic effect within the 
blood and tissues. Therefore, the systemic effect of absorbed TM may also alter immune 
function. Dietary Mo has previously been shown to alter immune responses in ruminant 
animals by reducing cell mediated immune responses to phytohemagglutinin (PHA) in 
steers (Ward et al, 1993), reduce antibody responses to porcine erythrocytes (IgG and 
IgM) in calves (Gengelbach and Spears, 1998) and reducing phagocytic ability of 
neutrophils to kill ingested Candida albicans (Boyne and Arthur, 1986) or Staphlococcus 
aureus (Xin et al, 1991) in heifers and steers respectively.
In chapter 3, intakes of dietary Fe were also found to alter Cu metabolism. Dietary Fe has 
previously been found to alter immune responses in ruminant animals. Fe-supplemented 
calves have been found to have lower secondary antibody responses to porcine 
erythrocytes compared to control calves (Ward et al 1997). Lymphocyte proliferation tests 
using PHA have shown a lower secondary in vitro viability in Fe-supplemented calves
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compared to control calves (Ward et al, 1997). Iron supplemented cattle and calves were 
also been found to have reduced SOD activities compared to the respective control groups 
after twenty eight weeks of dietary treatment (Boyne and Arthur, 1986) in addition to 
lower leucocyte counts in calves (Gengelbach et al, 1997). The phagocytic ability of 
neutrophils to kill Candida albicans in vitro has also been found to be lower in Fe- 
supplemented calves compared with control calves (Boyne and Arthur, 1986).
As shown in chapter 3, the Cu antagonists Mo and Fe produced differential effects on the 
biochemical assessments of Cu status in growing lambs after ten weeks on trial which may 
indicate a systemic and/or gut effect of absorbed dietary Mo within the blood and tissues. 
Therefore, the aim of this study was to investigate the effects of dietary Mo and Fe on the 
innate and adaptive immune response in growing lambs.
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4.2. Materials and methods
4.2.1. Experimental Design and Animals
Twenty-four Charollais X Friesland lambs (four male and four female per treatment) of 
approximately 14 weeks of age were used in this study. Lambs had an initial mean live 
weight of 31.0 kg (s.e.d. 1.75) and were randomly allocated to one of three dietary 
treatment groups based on live weight (see section 4.2.2.). All lambs were housed on straw 
bedding and divided into their three treatment groups by metal partitionings (approx. 7m^ 
area) in an open-ventilated bam for a period of 12 weeks. Prior to the start of the trial, all 
lambs were adapted from an ad libitum pelleted lamb creep feed (S.C. Feeds, Stone, UK) 
based on 18% protein, 10% fibre, 4% oil and 8.5% ash onto the basal control diet (see 
section 4.2.2.) over a fourteen day adaptation period.
4.2.2. Diet formulation
The raw materials used for this study were chosen because of their published low Cu and 
Mo contents (MAFF, 1992). Based on this information, the diets formulated were 
predicted to provide a Cu content of <5 mg kg’* DM. The basal diet was formulated to 
provide the metabolisable energy (ME) and metabolisable protein (MP) requirements of a 
25 kg lamb growing at 200 g day’* when fed ad libitum (AFRC, 1993) and had a predicted 
ERDP of 94.55 g kg’* DM and an FME of 9.92 MJ kg’* DM.
Lambs were allocated by live weight to one of three dietary treatment groups which were: 
Treatment one: Basal diet (Control)
Treatment two: Basal diet + 500 mg kg’* DM iron and 2 g kg’* DM sulphur (Fe)
Treatment three: Basal diet + 5 mg kg’* DM molybdenum and 2 g kg’* DM sulphur (5
Mo)
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Feed samples were obtained from separate tote bags once weekly. All feed samples were 
analysed for dry matter, ash, crude protein, ether extract, neutral detergent fibre and neutral 
cellulase gamanase digestibility (NCGD) as described in sections 2.1.1. to 2.1,6 
respectively. The raw material and chemical composition of the basal diet is presented in 
Table 4.1. Additional mineral inclusion per treatment diet is presented in Table 4.2.
Ingredient (g kg'^) Basal Diet
Straw pellets (NaOH treated) 400
Rolled barley 300
Rapeseed meal 200
Molasses 65
Mineral premix^ 35
Total 1000
Dry Matter (g/kg DM) 860.9
Metabolisable energy (MJ kg'  ^DM) 10.5*
Crude protein (gkg'^DM) 137.6
Neutral detergent fibre (g kg'  ^DM) 464.1
Ether extract (g kg"^  DM) 14.3
Ash (g kg’^  DM) 97.8
NCGD(gkg'^DM) 722.9
* Predicted values from equations given in AFRC (1993) (see appendix 2) 
^Mineral Premix -  see Table 4.2.
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Table 4.2. Additional mineral inclusion for the control, iron and molybdenum treatment 
diets (kg'  ^ton)
Ingredient Control
Treatment diet 
Fe 5 Mo
Ammonium molybdate (kg) - - 0.008
Iron sulphate (kg) - 2.15 -
Ammonium sulphate (kg) - 6.06 7.078
Urea (kg)^ 3.2 0.46 -
Sand (kg) 6.8 1.33 2.914
Mineral premix^ 25 25 25
Total (kg)
1 , .  .... ■ : . ....................  .
35 35 35
Mineral premix (25 kg'  ^ ton) commercial lamb vitamin/mineral premix (Frank Wright Feeds Ltd, 
Ashbourne, Derbyshire, UK) containing 500,000 lU Vit A, 100,000 lU Vit D3, 7500 mg kg'* Vit. E, 15 mg 
kg'* selenium, 32.3 % calcium, 3.9 % sodium and 2.04 % phosphorus.
The mineral composition of the basal diet was determined by ICP-ES (see section 2.3) and 
is presented in Table 4.3. Molybdenum was supplemented as reagent grade ammonium 
molybdate (NH4)6Mo7024-4H20, iron was supplemented as reagent grade iron sulphate 
(FeSO4.7H20) and additional sulphur was supplemented as reagent grade ammonium 
sulphate (NH4)2S04 (all BDH Laboratory Supplies, Poole, Dorset, UK). The nitrogen 
content of the mineral mix was balanced with urea (Trouw Nutrition, Northwich, 
Cheshire,UK) and sand was used as an inert material to balance mass.
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Table 4.3. Analysed mineral composition o f basal diet
Element Content
Calcium (g kg'^) 10.60
Phosphorus (g kg'^) 4.50
Sulphur (g kg"') 3.00
Magnesium (mg kg"') 2.00
Copper (mg kg"') 8.59
Molybdenum (mg kg"') 0.88
Iron (mg kg ') 197.18
Zinc (mg kg"') 67.90
Cobalt (mg kg ') 1.65
Selenium (mg kg"') 0.076
Manganese (mg kg ') 86.51
Fresh water was offered ad libitum and the copper content of the water was 35 pg/1 and no 
detectable molybdenum (Dee Valley Group Laboratory, Rhostyllen, Wrexham, UK).
4.2.2. Experimental Routine
All lambs were routinely checked twice daily. Feed was replenished daily into feed troughs 
at 08:00 to maintain ad libitum feed requirements.
4.2.3.1. Live weight determination
All lambs were weighed once weekly on Mondays at 11:00 using the Standard Operating 
Procedure as described in section 2.3., calibrated using metric standard weights (F.J. 
Thornton and Co. Ltd., Wolverhampton, UK.). Daily live weight gain was calculated using 
regression analysis.
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4.2.2.2. Blood collection and analysis
Blood samples were collected from all lambs on Tuesdays at 11:00 as described in section
2.2. Fresh whole blood was used to assess haematocrit (He) (section 2.2.1.) and the 
remaining blood prepared as described in section 2.2 and stored at -20°C for subsequent 
analysis. Frozen samples were thoroughly defrosted and whole blood was subsequently 
analysed for superoxide dismutase activity (SOD) (section 2.2.5.) and haemoglobin (Hb) 
(section 2.2.3.), plasma analysed for plasma copper concentration (Pl-Cu) (section 2.2.6.), 
and serum analysed for ceruloplasmin activity (CP) (section 2.2.4.), haptoglobin (section
4.2.4.) and anti-KLH IgG and IgM (section 4.2.T.4.). The intra assay coefficient of 
variation for respective standards were; SOD 5.64 %, Pl-Cu 6.6 %, Hb 3.08 % and CP 7.36 
%. During weeks 6, 9 and 12 of the trial, additional blood was taken from 12 selected 
lambs (four per treatment) on two consecutive days (all 24 lambs) into lithium heparin 
vacutainers (Becton Dickinson Vacutainer Systems, Plymouth, UK) for the lymphocyte 
transformation test (LTT) (see section 4.2.5.). During weeks 8, 10 and 12, blood was also 
collected into lithium heparin vacutainers (Becton Dickinson Vacutainer Systems, 
Plymouth, UK) for the neutrophil function test (see section 4.2.6.).
4.2.4. Haptoglobin
Haptoglobin was analysed using a Phase™ Acute Phase Assay kit (Tridelta Development 
Ltd., County Kildare, UK) based on an adapted method of Eckersall et al. (1999). The 
assay was performed in a Cobas Mira Plus autoanalyser (ABX Diagnostics, Shefford, 
Bedfordshire, UK) at 37°C. The principle of the assay was based on the binding of 
haptoglobin to haemoglobin present in the specimen that preserves the peroxidase activity 
of haemoglobin at a low pH. Preservation of the peroxidase activity of haemoglobin was 
proportional to the amount of haptoglobin present in the specimen. Serum samples were 
defrosted to room temperature and prepared according to the Haptoglobin Kit method. The 
intra assay coefficient of variation for the standard was <0.1 %.
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4.2.5. Lymphocyte Transformation Test (LTT)
The Lymphocyte Transformation Test (LTT) assay used isolated blood mononuclear cells 
isolated by density gradient centrifugation. All steps were performed in a laminar flow 
cabinet to maintain aseptic conditons. A tétrazolium salt, MTT (3(4,5-dimethylthiazoyl-2- 
yl) 2,5 diphenyltetrazolium bromide) (Sigma Aldrich, Gillingham, Poole, Dorset, UK) was 
used to study transformed lymphocytes using an adapted method of Mosmann (1983). 
Heparinised whole blood was diluted 1:1 with phosphate buffered saline (PBS) (Hudson 
and Hay, 1989) (Appendix 2). Subsequently, 6 ml of diluted blood was layered onto 6 ml 
of 62.5% Percoll and centrifuged at 400g for 40 minutes at 4°C. Cells were carefully 
collected from the interface and then washed three times in PBS by repeated re-suspension 
and centrifugation. Viable mononuclear cells were counted using an improved Neubauer 
haemocytometer (Weber Scientific International Ltd., Middlesex, UK) using 0.2 % 
Nigrosine solution (BDH Laboratory Supplies, Poole, Dorset, UK) and diluted to a 
concentration of 0.5 x 10^  mononuclear cells (MNC) per ml with tissue culture medium 
(TCM). The TCM contained 5 % heat inactivated neonatal calf serum (NCS), 20 mM 
sodium bicarbonate, 2 mM L-glutamine, 2 |xg/ml Amphoteracin B, and 100 |xg/ml 
Gentamycin Sulphate made up in RPMI 1640 (all products obtained from Sigma Aldrich, 
Gillingham, Poole, Dorset, UK).
To each duplicate well, 180 pi of cell suspension was added to a 96-well, round-bottomed 
sterile micro-titre plate (Becton Dickinson, Poole, Dorset, UK). Each cell population was 
stimulated by the addition of 20 pi of RPMI 1640 solution (Sigma Aldrich, Gillingham, 
Poole, Dorset, UK) containing either 5 pg/ml Concanavalin A (ConA), 5 pg/ml Pokeweed 
Mitogen (PWM) or 25 pg/ml Keyhole Limpet Haemocyanin (KLH) giving a final optimal 
concentration of 20 pg/ml. Control wells contained 180 pi cell suspension and 20 pi RPMI 
prepared in duplicate wells. The same batch of each mitogen was used throughout the 
experiment. All plates were incubated at 37°C in a humidified 5% CO2 incubator (Sanyo 
Gallenkamp PLC, Leicester, UK) for 48 hours. To each culture well, 20 pi of 5 mg/ml 3-
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(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tétrazolium bromide (MTT) (Sigma Aldrich, 
Gillingham, Poole, Dorset, UK) in PBS was added and incubated at 37°C in 5 % CO2 for a 
further 4 hours. Plates were then centrifuged at 300g for 5 minutes and the supernatant 
aspirated off and discarded. To each well, 200 pi of dimethyl sulfoxide (DMSO) (BDH 
Laboratory Supplies, Poole, Dorset, UK) working solution (1:10 IM HCL to DMSO) was 
added. All plates were left to stand for 15 minutes. All plates were read on ELISA reader 
(Benchmark microplate reader, Bio-Rad, Hemel Hempstead, Herts, UK) at a wavelength of 
570 nm (OD570) and a reference wavelength of 630 nm (ODeso).
4.2.6. Neutrophil Function Test
Two different neutrophil function tests were performed for this study. Assay one was based 
on the ability of peripheral blood neutrophils to attach and phagocytose yellow fluorescent 
carboxylate beads (phagocytosis) similar to the method of Oda and Maeda (1986). Assay 
two was based on internally generated reactive oxidants from neutrophils (Flaminio et al. 
2000).
4.2.6.1. Neutrophil Isolation
Blood samples were taken from all lambs as described in section 2.2. at weeks 8, 10 and 
12. One ml of fresh whole blood was obtained from a lithium heparin vacutainer tube (see 
section 2.2.), added to 20 ml of Lysis buffer (4.13g NH4CI, 0.5g KHCO3 and 0.017 g 
Na4EDTA in 0.5 L distilled water) and incubated at 37°C for 10 minutes. Cell suspensions 
were centrifuged for 7 minutes at 2500g and the remaining pellet washed three times by 
repeated centrifugation and resuspension in 1 ml PBS in a micro centrifuge tube. The pellet 
was then centrifuged for a further 5 minutes at 7000g. The remaining cell suspension was 
re-suspended in 500 pi PBS and left at 4“C until required.
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4.2.6.2. Assay one -  carboxylate beads
Three pi of a 1:10 dilution of yellow carboxylate beads (Molecular Probes Inc., Eugene, 
Oregon, USA) was pipetted into 100 pi of cell suspension (see section 4.2.6.1.). To a 
comparative control sample, 3 pi of PBS was added. All cells were incubated for 30 
minutes at 37°C and were subsequently washed twice by centrifugation and resuspension 
using 1 ml of lOmM EDTA in PBS. 50 pi of cell-fix (Becton Dickinson, Oxford, UK) was 
added to the 500 pi of cell suspension and left at 4°C until required. Neutrophil activity 
was assessed using a FACScan (see section 4.2.6.4.).
4.2.6.3. Assay two - Internally generated reactive oxidants
Into a micro-centriftige tube, D-632 (Sigma Aldrich, Gillingham, Poole, Dorset, UK) was 
dissolved in DMSO to give a 20 pM solution. A further 1:2 dilution was then prepared 
using PBS. To a test sample, 10 pi of the 1:2 D-632 was added to 100 pi of cell suspension 
(see section 4.2.6.1.). To a comparative control sample, 10 pi of PBS was added to a 100 pi 
cell suspension. All cells were incubated for 5 minutes at 37°C. To the test sample, 1 pi of 
0.1 mg/ml Phorbol Myristate Acetate (Sigma Aldrich, Gillingham, Poole, Dorset, UK) 
(PMA) diluted 1:2 with PBS was added to the cell suspension and 1 pi PBS was added to 
the control sample. All cells were incubated for 20 minutes at 37°C. Into each micro- 
centrifuge tube, 50 pi of cell-fix (Becton Dickinson, Oxford, UK) was added to the 500 pi 
of cell suspension and left at 4°C until required. Neutrophil activity was assessed using a 
FACScan (see section 4.2.6.4.).
4.2.6.4. Flow cytometric evaluation
Flow cytometric evaluation was performed on all neutrophil populations using a FACScan 
flow cytometer (Becton Dickinson Immunocytometry Systems, San Jose, California, 
USA). Neutrophil populations were discriminated on the basis of forward scatter (FSC) 
versus side scatter (SSC) cytograms of peripheral mixed blood leukocyte cell populations
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(PMBL) as described by McTaggart et al. (2001). Fluorescence excitation was at 495 nm 
and emission at 525 nm. All collected data was analysed using WinMDI Version 2.5 
programme and the results expressed as the mean fluorescence intensity (MFI).
4.2.7. Assessment o f humoral immune responses in lambs
The lambs’ humoral immune responses to a novel antigen were determined by the 
procedure of Pollock et al. (1991).
4.2.7.1. Preparation o f Keyhole Limpet Haemocyanin (KLH)
Keyhole Limpet Haemocyanin (KLH) (Calibochem, Novabiochem, UK) was dissolved in 
PBS, pH 7.2 (Hudson and Hay, 1989) to give a 1 mg/ml solution and sterilised through a 
0.2 pm sterile acrodisc syringe filter (Pall Gelman Corporation, Michigan, USA) into 
sterile 30 ml universal tubes (Sarstedt, Boston Road, Leicester, UK). The solution was 
precipitated on alum by the method described by Hudson and Hay (1989). In brief, 0.45 ml 
of filter sterilised IM sodium bicarbonate (BDH Laboratory Supplies, Poole, Dorset, UK) 
was added to each ml of KLH solution followed by the slow addition of 1.0 ml filter- 
sterilised 0.2M aluminium potassium sulphate (BDH Laboratory Supplies, Poole, Dorset, 
UK). The suspension was allowed to stand at room temperature for 15 minutes before 
being centrifuged at 300g for 15 minutes. The precipitate was washed three times by 
centrifugation and resuspension with sterile PBS before being resuspended to the original 
volume in PBS. This suspension was considered to contain 1 mg/ml of KLH.
4.2.7.2. Immunisation protocol
All lambs were immunised with 1 ml of 1 mg/ml KLH injected subcutaneously using a 20 
gauge (1.5 cm) needle (Becton Dickinson Vacutainer Systems, Plymouth, UK) and a 2 ml 
syringe at a constant site above the ribs. Each site of injection was swabbed with 70 %
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ethanol on cotton wool prior to immunisation. The same procedure was performed for both 
immunisation timepoints at week 4 and 8.
4,2.7.3. Optimisation assay for anti-IgG and anti-IgM using ammonium sulphate 
precipitation o f ovine serum
Prior to analysis of test samples, the optimum concentration of monoclonal antibodies
(Mab) was assessed. Into a glass centrifuge tube, 4 ml of ovine serum was added. Whilst
being continuously stirred using a magnetic stirrer, 2.66 ml of saturated ammonium
sulphate (SAS) (BDH Laboratory Supplies, Poole, Dorset, UK) (450 g in 500 ml distilled
water) was slowly pipetted into the serum. The solution was continuously stirred for 5
minutes and then left to stand at 4°C for 15 minutes. The solution was centrifuged at 3000g
for 15 minutes and the supernatant removed. The precipitate was then resuspended in 6 ml
PBS and a ftirther 4 ml of SAS was slowly added to the suspension, with continuous
stirring. The solution was left for a further 20 minutes at 4°C and then centrifuged at 3000g
for 15 minutes. The precipitate was then dissolved in 1 ml purite water and dialysed
through a D9277 cellulose membrane (Sigma Aldrich, Gillingham, Poole, Dorset, UK) into
PBS (pH 7.4). After 16 hours, the protein was pipetted Jfrom the cellulose membrane into a
micro-centrifuge tube. A 1:2 dilution was prepared with PBS and the absorption of protein
concentration was assessed specrophotometrically (Beckman DU640, Fullerton,
California) at ODisonm and ODieonm using the following calculation:
Protein concentration (mg ml"') = (1.55 x A280) -  (0.77 x A260)
(Practical Biochemistry, 1994)
Using the above calculation, dilutions were prepared with PBS to produce a 5 pg/ml 
purified protein (y-globulin). To each well of a sterile 96-well ELISA plate (Becton 
Dickinson, Poole, Dorset, UK), 100 pi of a 5 pg/ml of purified protein was added. All 
plates were incubated at 37°C for 2 hours in a humified box in a 5% CO2 incubator (Sanyo 
Gallenkamp PLC, Leicester, UK). All plates were washed three times with PBS and 100 pi
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of 0.05% Tween (0.5 ml in 1 litre PBS) was added to each well. Into separate micro 
centrifuge tubes, 1:100 dilutions of mouse anti-ovine-IgG and mouse anti-ovine-IgM 
antibodies (Serotec Ltd., Kidlington, Oxford, UK) were prepared in PBS/Tween (Sigma 
Aldrich, Gillingham, Kent, UK). To each well in column one of the ELISA plate, 100 pi 
dilutions of mouse anti-ovine-IgG and mouse anti-ovine-IgM were added and serial 
dilutions were prepared across the plate (1:100 to 1:204,800). ELISA plates were incubated 
for one hour at 37°C and then subsequently washed three times in PBS/Tween. To all 
wells, 100 pi of 1:30,000 Sigma goat-anti-mouse alkaline phosphatase conjugate was 
added. All ELISA plates were incubated for one hour at 37°C and then subsequently 
washed three times in PBS/Tween. To all wells, 100 pi of Sigma phosphatase substrate 
(Sigma Aldrich, Gillingham, Kent, UK) (1 mg/ml in glycine buffer at pH 10.4) was added. 
Colour intensity was allowed to develop in the dark at room temperature and optical 
density was assessed using an ELISA reader (Benchmark microplate reader, Bio-Rad, 
Hemel Hempstead, Herts, UK) at a wavelength of OD405nm- Optimal IgG and IgM was 
estimated using a standard curve (Fig. 4.1.) and dilutions of 1:1600 were determined to be 
optimal for both IgG and IgM respectively.
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Fig. 4.1. Optimisation assay for IgG and IgM monoclonal antibodies using ovine 
serum
4.2.7.4. Preparation o f Anti-KLH ELISA
One hundred p.1 of 10 |xg/ml KLH in PBS was added to each well of a 96-well ELISA plate 
(Becton Dickinson Labware, New Jersey, USA). All plates were incubated at 37°C for one 
hour to allow the KLH to bind and then left overnight at 4°C. Plates were washed three 
times with PBS to remove any excess KLH. Uncoated plastic was blocked with 150 pi of 
0.1% Bovine Serum Albumin (BSA) (Sigma Aldrich, Gillingham, Poole, Dorset, UK) in 
PBS and incubated for a further two hours at 37°C. Plates were then washed three times 
with PBS containing 0.05% Tween 20 (BDH Laboratory Supplies, Poole, Dorset, UK) 
(PBS/T) and thoroughly dried. To duplicate wells, 100 pi of 1:50 diluted serum in PBS/T 
was added and all plates incubated at 37°C for one hour. Plates were then washed a further 
three times in PBS/T. To each appropriate well, 100 pi of 1:1600 dilutions in PBS 
monoclonal antibody (anti-ovine-IgG or anti-ovine-IgM) (Serotec, Kidlington, Oxford, 
UK) were added. Plates were then incubated for one hour at 37°C and then washed three
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times in PBS/T. Plates were thoroughly dried and 100 pi of 1:30,000 Sigma anti-mouse 
alkaline phosphatase conjugate (Sigma Aldrich, Gillingham, Poole, Dorset, UK) was added 
to each well. Plates were then incubated for a further one hour at 37°C and washed three 
times in PBS/T. To each well, 100 pi of Sigma S104 phosphatase substrate (1 mg/ml in 
glycine buffer, pH 10.4) (Sigma Aldrich, Gillingham, Poole, Dorset, UK) was added. All 
plates were then left in dark conditions to allow colour to develop. Optical densities were 
then read on an ELISA plate reader (Benchmark microplate reader, Bio-Rad, Hemel 
Hempstead, Herts, UK) at a wavelength of 405nm (OD405) until the internal standard had 
an CD of 1-1.2.
4.2.8. Liver copper determination
On day 84 (week 12), all lambs were sent to a commercial slaughterhouse and killed by 
electrical stunning and exsanguination. All livers were removed and immediately placed in 
individual clean plastic bags and frozen at -20°C. Liver trace element concentration was 
subsequently determined by ICP-MS (Section 2.2.9.).
4.2.9. Statistical analysis
Statistical analysis was performed using Genstat for Windows (Version 5.0). All 
haematology and enzyme parameters, trace element content of tissue samples, LTT, anti- 
KLH IgG and anti-KLH IgM responses were analysed by analysis of variance (ANOVA) 
and repeated measures (where appropriate) using a completely randomized design. 
Haptoglobin concentration was analysed by Kruskall Wallis (Snedecor and Cochran, 
1989). Daily liveweight gain (DLWG) was determined by regression analysis and analysed 
using ANOVA. In all graphs, error bars refer to 2x s.e.d. Differences between treatments 
was calculated using a protected least significant difference (LSD) (Snedecor and Cochran, 
1989).
92
4.3. Results
4.3.1. Growth rate and performance characteristics
There was no significant effect of 5 mg kg'^ Mo or 500 mg kg"^  Fe on lamb liveweight (Fig
4.2.) or daily live weight gain (DLWG) at any timepoint (Table 4.4.). The DLWG for all 
dietary treatment groups was very similar to the predicted DLWG of 200 g day'^ as 
formulated by AFRC (1993).
Table 4.4. Effect o f molybdenum or iron supplementation on growth rate
Control
Treatment diet 
Fe 5 Mo s.e.d. Significance
Initial LW 31.0 30.7 31.3 1.75 NS
Slaughter wt 48.3 46.4 49.3 3.08 NS
DLWG (kg/day) 0.197 0.184 0.198 0.0217 NS
*
0 1 2 3 4 5 6 7 8 9  10 11 12
s.e.d.
Control
Fe
5 Mo
Week
Fig 4.2. Effect o f molybdenum or iron supplementation on live weight o f
growing lambs
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4.2.2. Haematocrit
There was no significant effect of 5 mg kg"^  Mo or 500 mg kg"^  Fe on He (%) at weeks 1 
and 2 (Table 4.5.). Lambs that received the 500 mg kg‘  ^Fe dietary treatment had higher He 
(%) at week 3 (P<0.05), week 5 (P<0.01), week 6 (P<0.001) and week 7 (P<0.05) 
compared to lambs that received the control or 5 mg kg'^ Mo dietary treatments. Lambs 
that received the 500 mg kg'  ^ Fe dietary treatment had higher (P<0.05) He compared to 
lambs that received the control diet at week 4 and higher (P<0.05) He compared to lambs 
that received the 5 mg kg"^  Mo dietary treatment at week 10 respectively. There were no 
differences in He (%) between lambs that received the control or 5 mg kg‘  ^ Mo dietary 
treatments at any timepoint. Repeated measures analysis indicated that there was no effect 
of treatment on He. There was a time x treatment interaction (P<0.01) and effect of time 
(P<0.001) that occurred due to a decrease in He in the control and 5 Mo dietary treatments 
over time.
Table 4.5. Effect o f molybdenum or iron supplementation on haematocrit {%) o f
Treatment
Week Control Fe 5 Mo s.e.d. Significance
a 35.25 33.75 36.50 1.46 NS
1 34.00 35.63 35.75 1.14 NS
2 32.38 34.50 32.75 1.01 NS
3 33.00^ 35.00** 33.63" 0.77 *
4 32.25^ 35.13** 34.00"’* 1.01 *
5 31.75" 35.50** 32.63" 1.09 **
6 31.87" 35.75** 32.63" 0.88 ***
7 32.57" 35.50** 32.25" 1.08 *
8 33.50 34.25 32.00 1.41 NS
9 32.88 33.50 32.25 1.58 NS
10 32.88"-^ 34.88** 31.50" 1.20 *
11 31.75 33.25 32.38 1.14 NS
12 32.63 33.71 33.43 1.27 NS
* <0.05, **<0.01, ***<0.001
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Repeated Measures Analysis; Treatment effect P = NS
Time effect P = <0.001
Time X Treatment effect P = <0.01
4.3.3. Haemoglobin concentration
There was no effect of 5 mg kg'* Mo or 500 mg kg'* Fe on mean haemoglobin (Hb) 
concentration in growing lambs at week 1 and 2 (Table 4.6.). At weeks 3, Hb concentration 
of lambs that received the 500 mg kg'* Fe dietary treatment was higher (P<0.05) compared 
to the lambs that received the control dietary treatment. At week 5, mean Hb concentration 
of lambs that received the 500 mg kg'* Fe dietary treatment was higher (P<0.001) 
compared to the lambs that received the control or 5 mg kg'* Mo dietary treatments. Mean 
Hb concentration of lambs that received the 500 mg kg'* Fe dietary treatment was higher
than lambs that received either the control or 5 mg kg'* Mo dietary treatments at week 6
(P<0.05) and week 7 (P<0.01). At week 10, lambs that received the 500 mg kg'* Fe dietary 
treatment had a higher (P<0.05) Hb concentration compared to the lambs that received the 
5 mg kg'* Mo dietary treatment. There were no differences in mean Hb concentrations of 
the lambs that received the control or 5 mg kg'* Mo dietary treatments at any weekly time 
point. Repeated measures analysis indicated that there no effect of dietary treatment on Hb 
concentration, but there was an effect of time (P<0.001) and a time x treatment (P<0.001) 
interaction on Hb concentration. These effects were due to the gradual decrease in Hb 
concentration in all treatment groups over time.
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Table 4.6. Effect o f molybdenum or iron supplementation on haemoglobin concentration
Week
Treatment
Control Fe 5 Mo s.e.d. Significance
0 13.7 12.8 13.6 0.58 NS
1 12.0 12.5 13.4 0.57 NS
2 11.7 12.0 11.6 0.51 NS
3 13.1" 14.4'’ 13.8"’* 0.41 *
4 11.9 12.3 12.2 0.63 NS
5 12.1" 13.9'’ 11.6" 0.43 ***
6 11.2" 12.5'’ 11.3" 0.44 *
7 11.6" 13.3'’ 11.8" 0.46 **
8 12.8 13.1 12.2 0.50 NS
9 12.3 12.1 12.4 0.61 NS
10 12.5"’* 13.4'’ 11.7" 0.52 *
11 11.6 12.3 11.9 0.46 NS
12 10.9 11.4 12.0 0.43 NS
*  <0.05, **<0.01, *** <0.001 
Repeated Measures Analysis: Treatment effect P = NS
Time effect P = <0.001
Time X Treatment effect P = <0.001
96
4.3.4. Plasma Copper (Pl-Cu) concentration
The grand mean Pl-Cu concentration for ail treatment groups at week 0 was 18.4 pmol 1'*. 
Using week 0 as covariate, at week 3, lambs that received the control treatment diet had 
higher (P<0.05) Pl-Cu concentrations compared to lambs that received the 500 mg kg'* Fe 
dietary treatment (Fig 4.3.) At weeks 4 and 6, lambs that received the control dietary 
treatment had higher (P<0.01) PFCu concentrations compared to the lambs that received 
the 500 mg kg'* Fe dietary treatment. At weeks 4 and 5, lambs that received the 5 mg kg’* 
Mo dietary treatment had higher (P<0.01) Pl-Cu concentrations compared to lambs that 
received the 500 mg kg'* Fe dietary treatment. At weeks 6 and 1, lambs that received the 
control dietary treatment had higher (P<0.01) Pl-Cu concentrations compared to lambs that 
received the 500 mg kg'* Fe dietary treatment. Pl-Cu concentrations were higher (P<0.01) 
for the lambs that received the control dietary treatment compared to the lambs that 
received the 5 mg kg'* Mo dietary treatment at week 6. At week 7, lambs that received the 
500 mg kg'* Fe dietary treatment had lower Pl-Cu concentrations compared to the lambs 
that received the 5 mg kg'* Mo dietary treatment. At weeks 11 and 12, lambs that received 
the control dietary treatment had higher Pl-Cu concentrations compared to the lambs that 
received the 500 mg kg'* Fe dietary treatment. Repeated measures analysis indicated that 
there was a significant effect (P<0.01) of dietary treatment which was due to the decrease 
in Pl-Cu concentration in the Fe dietary treatment firom week 1 onwards. There was a 
significant effect of time (P<0.001) due to the low levels of Pl-Cu in the Fe group and the 
increase in Pl-Cu concentration in the 5 Mo dietary treatment group fi*om week 10 
onwards. There was no time x treatment interaction on Pl-Cu concentrations in grooving 
lambs.
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Figure 4.3. Effect o f molybdenum or iron supplementation on plasma copper
concentration o f growing lambs
Repeated Measures Analysis: Treatment effect P = <0.01
Time effect P = <0.001
Time X Treatment effect P = NS
98
4.3.5. Ceruloplasmin activity
Mean CP activity for all treatments at week 0 was 20.68 mg/dl. Using week 0 as covariate, 
at week 1, lambs that received the control treatment diet had higher (P<0.001) CP activity 
compared to lambs that received the 500 mg kg'^ Fe or 5 mg kg'^ Mo dietary treatments 
(Fig. 4.4.). At weeks 2 and 4, lambs that received the control dietary treatment had higher 
(P<0.01) CP activity compared to the lambs that received the 500 mg kg’^  Fe dietary 
treatment. Lambs that received the control treatment diet had higher CP activity compared 
to the lambs that received the 500 mg kg'^ Fe or 5 mg kg’  ^Mo dietary treatments at week 3 
(P<0.001), week 5 (P<0.05), week 6 (P<0.01) and week 7 (P<0.001) respectively. There 
were no differences in mean CP activity between lambs that received the 500 mg kg'* Fe or 
5 mg kg'* Mo at any time point. Repeated n^easures analysis indicated that there was a 
significant effect of treatment (P<0.001). There was a trend over the twelve week trial 
period for the control treatment group to have a higher mean CP level than bofii the 500 
mg kg'* Fe and 5 mg kg'* Mo dietary treatment groups (Fig 4.4.). This was reflected by an 
effect of time (P<0.05) but no time x treatment interaction on CP activity.
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Figure 4.4. Effect o f molybdenum or iron supplementation on ceruloplasmin
activity o f growing lambs
Repeated Measures Analysis: Treatment effect P = <0.001
Time effect P = <0.05
Time X Treatment effect P =  NS
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4.3.6. Ceruloplasmin to Plasma Copper Ratio {CP:Pl-Cu)
Mean CP:Pl-Cu ratio for all treatments at week 0 was 1.11. Using week 0 as covariate, at 
week 1, lambs that received the control diet had a higher (P<0.05) CP:Pl-Cu ratio 
compared to lambs that received the 500 mg kg'^ Fe or 5 mg kg'^ Mo (Table 4.7.). At week 
3 and 4, lambs that received the 5 mg kg'^ Mo dietary treatment had a lower (P<0.05) 
CP:Pl-Cu ratio compared to lambs that received either the control or 500 mg kg'^ Fe 
dietary treatments. Lambs that received the 5 mg kg'^ Mo dietary treatment also had a 
lower CP:Pl-Cu ratio compared to lambs fed either the control or 500 mg kg'* Fe dietary 
treatments at weeks 5 (P<0.001), week 6 (P<0.05), week 7 (P<0.001) and week 8 (P<0.05) 
respectively. There were no differences in the CPrPLCu ratio between lambs that received 
the control or 500 mg kg'* Fe dietary treatments at weeks 5 to 8 inclusive. At week 9, 
lambs that received the control dietary treatment had a higher CPrPLCu ratio compared to 
lambs that received either the 500 mg kg'* Fe or 5 mg kg'* Mo dietary treatments. There 
were no differences between treatments in CP:Pl-Cu ratio at weeks 10, 11 or 12. Repeated 
measures analysis indicated that there was an (P<0.01) effect of treatment, possibly due to 
the low CPiPLCu ratios in the 5 Mo treatment group compared to the control and Fe 
groups. There was no time or time x treatment interaction on CP:Pl-Cu ratio.
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Table 4.7. Effect o f molybdenum or iron supplementation on ceruloplasmin
Treatment
Week Control Fe 5 Mo s.e.d. Significance
1 1.34" 1.18" 1.17^ 0.064 *
2 1.02 0.93 0.85 0.100 NS
3 1.07" 0.97" 0.86= 0.071 *
4 1.17" l.Ol" 0.86= 0.101 *
5 1.17" 1.02" 0.74= 0.104 ***
6 1.16" 1.2l" 0.97= 0.080 *
7 1.60" 1.39" 1.06= 0.119 4»
8 1.32" 1.17" 1.00= 0.120 *
9 1.36" i.io" 1.11= 0.120
10 1.30 1.21 1.15 0.087 NS
11 0.98 1.12 1.01 0.111 NS
12 1.25 0.99 1.09 0.135 NS
 ^ Means within a row with different superscripts are significantly different (P<0.05)
* <0.05, **<0.01, ***<0.001
Repeated Measures Analysis: Treatment effect P -  <0.01
Time effect P = NS
Time X Treatment effect P ~ NS
1 0 2
4.3.7. Superoxide Dismutase (SOD) activity
There was no effect of dietary treatment until week 5 on SOD activity (Fig 4.5.). Lambs 
that received the control dietary treatment had higher SOD activities at week 5 (P<0.05), 
week 7 (P<0.01), week 9 (P<0.001) and week 12 (P<0.001) respectively compared to the 
lambs that received the 5 mg kg’  ^ Mo dietary treatment. There was a consistent trend for 
the control treatment group to have higher mean SOD activity compared to lambs that 
received the 500 mg kg‘  ^ Fe or 5 mg kg’^  Mo dietary treatments from week 7 onwards. 
Repeated measures analysis indicated that there was a effect of treatment (P<0.01) due to 
the SOD activity in the control group remaining higher than the Fe or 5 Mo treatment 
groups from week 7 to week 12. This was also reflected by an effect of time (P<0.001) but 
no significant time x treatment interaction.
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Figure 4.5. Effect o f molybdenum or iron supplementation on super oxide dismutase
activity o f growing lambs
Repeated Measures Analysis: Treatment effect P = <0.01
Time effect P = <0.001
Time X Treatment effect P = NS
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4.3.8. Haptoglobin concentration
There was no effect of 500 mg kg’^  Fe or 5 mg kg‘^  Mo on haptoglobin concentration in 
growing lambs following immunisation with KLH at weeks 4 and 8 (Table 4.8.). An 
increase in haptoglobin concentration occured post-immunisation at week 5, but this was 
not significantly different between dietary treatments.
Table 4.8. Effect o f molybdenum or iron supplementation on haptoglobin
Treatment
Week Control Fe 5 Mo H-value Significance
4 0.010 0.010 0.010 1.5010 NS
5 0.120 0.035 0.020 1.4890 NS
6 0.010 0.010 0.010 0.6612 NS
8 0.010 0.010 0.010 0.2201 NS
9 0.015 0.010 0.010 1.0620 NS
10 0.010 0.010 0.010 0.2979 NS
All figures quoted as median values
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43.9. Lymphocyte Transformation Test (LTT)
There was no effect of dietary treatment on lymphocyte transformation tests (LTT) to Con 
A, PWM or KLH during weeks 6, 9 or 12 (Table 4.9.) in growing lambs.
Table 4.9. Effect o f treatment on in vitro lymphocyte transformation test (LTT) 
response (OD 507nm and reference wavelength o f OD 630nm) to Control, 
Conconavalin A (Con A), Pokweed Mitogen (PWM) and Keyhole Limpet
Control
Treatment
Fe 5 Mo s.e.d. Significance
Control
Wk6 1.099 1.062 1.077 0.1856 NS
Wk9 0.497 0.690 0.727 0.1619 NS
Wkl2 1.280 1.360 1.190 0.3750 NS
Con A
Wk6 0.685 0.808 0.698 0.1388 NS
Wk9 0.268 0.388 0.371 0.1344 NS
Wkl2 1.100 1.080 1.000 0.9680 NS
PWM
Wk6 0.765 0.735 0.953 0.1701 NS
Wk9 0.393 0.643 0.571 0.1466 NS
Wkl2 1.250 1.190 1.080 0.3900 NS
KLH
Wk6 0.956 0.867 1.062 0.1792 NS
Wk9 0.465 0.746 0.682 0.1899 NS
Wkl2 1.210 1.300 1.140 0.3890 NS
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4.3.10. Neutrophil Function Test
The population of cells showing the mean fluorescence intensity (MFI) (Fig. 4.6 and Fig. 
4.7) could not be identified as neutrophils as there was no known commercial antibody 
marker available that was specific to ovine neutrophils. CD 11 a/CD 18 are commonly used 
markers but are also found on other ovine leucocyte populations (Griebel, 1998). Fig 4.6. 
and Fig. 4.7. are examples of cell populations obtained from the carboxylate bead test, 
from lamb (303) which received the control diet during week 12. Two distinct cell 
populations can be identified but it is not known what cell types these are. The lower cell 
populations are likely to be cell debris and the higher cell populations, macrophages and 
neutrophils. No statistical comparisons were therefore made between treatments during 
weeks 8,10 and 12 in fluorescence analysis of neutrophil populations.
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Fig. 4.6. Neutrophil function test -  Carboxylate Fig. 4.7. Neutrophil function test  -
Beads (-) control ; lamb 303 (control diet), Carboxylate beads (+) control ; lamb
week 12 303 (control diet), week 12
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4.3.11. Serum Anti-KLHIgG and IgM responses
There was no effect of 500 mg kg"^  Fe or 5 mg kg'  ^ Mo dietary treatments on anti-KLH 
IgG responses (Fig 4.8) or anti-KLH IgM responses (Fig 4.9) in growing lambs at any 
timepoint. Although primary and secondary responses can been seen post- immunisation 
with KLH at weeks 4 and 8, these increases were not significantly different.
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Figure 4.8. Effect o f molybdenum or iron supplementation on anti-KLH IgG 
response in growing lambs
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Figure 4.9. Effect o f molybdenum or iron supplementation on anti-KLH IgM 
response in growing lamb^^^
4.3.12. Trace element concentration in the liver
Liver samples were collected from all lambs at slaughter after 12 weeks on trial. Lambs 
that received either the 500 mg kg"^  Fe or 5 mg kg'^ Mo dietary treatments had lower 
(P<0.001) liver Cu concentrations compared with lambs that received the control diet 
(Table 4.10.). There was no difference in liver Cu concentration between the lambs that 
received the 500 mg kg'^ Fe or 5 mg kg'^ Mo dietary treatments. Lambs that received the 
500 mg kg’^  Fe dietary treatment had higher (P<0.001) liver Fe concentrations compared to 
lambs that received the control diet or the 5 mg kg'* Mo dietary treatment. Lambs that 
received the 5 mg kg'* Mo dietary treatment had higher (P<0.001) liver Mo concentrations 
compared with the lambs that received the control or 500 mg kg'* Fe dietary treatment. 
There were no differences in liver Mo between the control and 500 mg kg'* Fe 
supplemented lambs. Lambs that received the control diet had higher (P<0.01) liver Zn 
concentrations compared with lambs that received the 500 mg kg'* Fe or 5 mg kg'* Mo 
dietary treatments.
Table 4.10. Effect o f molybdenum or iron supplementation on trace element
Treatment
Element
Control Fe 5 Mo S.e.d. Significance
Cu 251.98" 97.33^ 98.80^ 29.901 ***
Fe 109.19" 225.09*^ 86.52= 18.830
Mo 1.528" 1.682^ 2.348" 0.1504 ***
Zn 90.01"
....... ..................i'.cc______________ *
58.10^ 51.96" 10.600 **
* <0.05, **<0.01, ***<0.001
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4.4. Discussion
One level of dietary Mo (5 mg kg'* Mo) was used in this trial as intakes above 1 mg kg'* 
Mo are considered to be deleterious to Cu metabolism (Suttle, 1983b). Previous studies by 
other authors using the same level of dietary Mo have been found to produce significant 
reductions on Cu status in young cattle (Phillippo et ah, 1987a; Humphries et ah, 1983).
Chemical composition of the experimental diets were very similar to values predicted 
during diet formulation and were very similar to chemical analysis obtained from the diet 
in chapter 3. Copper content of the basal diet was found to be 8.59 mg kg'* Cu which was 
higher than the formulated <5 mg kg'* Cu. This increase in Cu content of the basal diet 
may have occurred due to the different feed types used in this study compared to the basal 
diet in chapter 3 where a Cu content of 5.47 mg kg'* Cu was achieved. Feeds used in this 
study were chosen due to availability and because of their low published Cu values. 
Mineral composition of other elements contained within the basal diet were considered 
adequate for growing lambs (Table 4.3.) (ARC, 1980). Iron content of the basal diet in this 
study (197.18 mg kg'* DM) was higher than that of the basal diet in chapter 3 (167.35 mg 
kg'* DM). In contrast to chapter 3, Mo content of the basal diet in this study was lower 
(chapter 3: 1.29 mg kg'* Mo DM; chapter 4, 0.88 mg kg'* Mo DM). Therefore, these 
differences in basal diet composition may affect Cu metabolism, Cu status and 
physiological effects.
The inclusion of 500 mg kg'* Fe or 5 mg kg'* Mo had no significant effect on lamb DLWG 
which is in accordance with results obtained in chapter 3 and other authors (Bremner et at. 
1987). The results from this study showed that although Hb and He values for all lambs 
were considered to be within the normal reference ranges for sheep (Wolfensohn and 
Lloyd, 1998), He and Hb concentrations of lambs that received Fe were higher compared 
to lambs that received the control or 5 Mo dietary treatments. These results contradict
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those obtained in chapter 3, where no differences in He or Hb concentration due to dietary 
treatment were foimd. The results from this study also contradict those of Humphries et al 
(1983) who found no differences in He or Hb concentration in calves that received either 5 
mg kg'* Mo or 800 mg kg'* Fe in their basal diet containing 4 mg kg'* Cu. Phillippo et al 
(1987a) found marginal decreases in Hb concentration in heifers that received 5 mg kg'* 
Mo but no differences in He or Hb in heifers that received 500 mg kg'* Fe. The Fe content 
of the basal diet in this study and in chapter 3 were adequate for a growing lambs (ARC, 
1980) although the Fe content of the basal diet in the current study was higher than that in 
chapter 3.
The increased He and Hb concentrations in lambs in this study clearly show that dietary 
treatment was affecting haemopoesis. The formation of red blood cells in the bone marrow 
(haemopoesis) is stimulated by erythropoietin, which is secreted by the kidneys (Kerr, 
2002). Results from this study showed that lambs that received the Fe dietary treatment 
had the lowest liver Cu concentration in association with the highest He and Hb 
concentrations during the mid-weeks of the trial. In addition, there was a trend for lambs 
that received the Fe dietary treatment to have the lowest CP activity and the lowest Pl-Cu 
concentrations. The essentiality for Cu in Hb formation in rats was first established by Hart 
et al (1928). Later work by Gubler et al (1952) showed that anaemia in swine was due to 
a defect of Fe metabolism, which is now associated with the CP protein. CP, also termed 
‘ferroxidase’ is known to be essential in oxidising ferrous iron into ferric iron before 
incorporation into transferrin (Owen and Hazelrig, 1963). Therefore, in the absence of CP, 
this oxidation stage is hindered and the incorporation of iron into apo-transferrin for 
delivery into the site of Hb synthesis is slowed down. Mills et al (1976) found that 
disturbances in Fe metabolism resulted in a decreased CP activity. The liver acts as the 
main storage site for blood and therefore, if the liver is being affected by dietary 
antagonists, this may result in an increase in Cu release from the liver for the red blood cell 
populations as a homeostatic mechanism to maintain He or Hb concentrations. Anaemia in
1 1 0
ruminant animals has only been reported to develop after prolonged periods of a Cu 
deficiency (Beck, 1941). The Fe level in the basal diet in addition to the 500 mg kg’* Fe 
was also reflected by a significantly higher liver Fe concentration. This finding is in 
agreement with work by Phillippo et al. (1987a) in cattle.
After 12 weeks, lambs fed the control treatment diet were the only treatment group to have 
liver Cu concentrations considered to be within the normal range for sheep (100-500 mg 
kg'* DM) (Underwood, 1977). In accordance with chapter 3 and previous studies by 
Bremner and Young (1978), Phillippo et al. (1987a) and Van Niekerk and Van Niekerk 
(1989a), liver Cu concentrations were found to be significantly reduced by the addition of 
Mo in the diets of the growing lambs. This decrease may be due to the systemic effects of 
circulating TM that may deplete blood and tissue Cu reserves. Liver Cu concentrations 
were also depleted in the Fe supplemented group. The mechanism by which dietary Fe 
alters Cu metabolism is unknown, but may be as a result of a reduction in absorption at the 
intestinal mucosa. Liver Mo was found to be significantly higher in lambs that received an 
additional 5 mg kg~* Mo and liver Zn was found to be significantly higher in lambs that 
received the control diet although it is not known what the biological significance of this 
was.
Results from this study and those of chapter 3 clearly identify an effect of dietary Mo on 
Cu metabolism of growing lambs. It is evident from both studies that there is an inter­
relationship between Pl-Cu concentration, CP activity and liver Cu concentration. In 
chapter 3, an increase in Pl-Cu concentration was shown to be reflected in a decrease in CP 
activity and also a subsequent reduction in liver Cu concentration. Work by other authors 
have found an increase in Pl-Cu concentrations in response to high levels of dietary Mo 
(Bremner and Young, 1978; Van Niekerk and Van Niekerk, 1989a; Du Plessis et al., 
1999a). In the current study, although increases in Pl-Cu concentration were less apparent,
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lambs that received the Mo dietary treatment had fluctuating Pl-Cu concentrations in 
association with a decreasing CP activity. Price et al (1987) suggested that Cu:Mo ratios 
of <1 in sheep would enhance the formation of TM. Therefore, as the Cu:Mo ratio in this 
study was >1, this may account for the lack of effect in Pl-Cu concentration. The 
differences in Pl-Cu concentration and CP activity between the control and Mo treatment 
groups were clearly identified when using the CP:Pl-Cu ratio. It remains unclear if the 
decrease in CP activity observed towards the latter end of the study was due to a reduction 
in CP expression or due to the inhibition of CP by TM. Formation of TM within the rumen 
(Suttle, 1974b; Dick et al, 1975) causes a subsequent decrease in CP activity (Lannon and 
Mason, 1986) as observed in chapter 3. In vitro studies (Kelleher and Mason, 1986; 
Lannon and Mason, 1986) and in vivo studies (Mason et al, 1980, 1982; Lannon and 
Mason, 1986) found that TM are potent inhibitors of both ovine and bovine CP activity. 
Work by Lannon and Mason (1986) found that an increase in albumin bound Cu (Pl-Cu) 
was not related to CP degradation and therefore, a rise in Pl-Cu concentration may be due 
to systemic effects of TM. Although there was no obvious increase in Pl-Cu concentration 
in lambs that received the Mo dietary treatment in this study, liver Cu concentration by 
week 12 was significantly lower than that of the control group (similar to liver Cu 
concentrations obtained in chapter 3). The findings fi*om this study and firom chapter 3 
would suggest that due to homeostatic regulation of the liver to supply Cu to blood and 
tissues, the strong binding affinity of TM for Cu within the rumen, may enhance the 
release of Cu stored in the liver to maintain metabolic functions.
The mechanism by which dietary Fe reduces Pl-Cu concentration remains unclear. The 
distinct decrease in Pl-Cu concentration in Fe supplemented lambs in this study and in 
chapter 3, is also in accordance with other authors (Humphries et al, 1983; Bremner et al, 
1987; Phillippo et al, 1987a). Although Pl-Cu concentration returned to baseline levels 
(week 1) by the end of the study, Pl-Cu concentration in Fe-supplemented lambs was 
distinctly lower than all other treatment groups throughout the trial period. The reduction
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in Pl-Cu concentration coupled with a decrease in CP activity occurred from the onset of 
this study, similar to results obtained in chapter 3. Results from this study, chapter 3 and 
work by Humphries et al. (1983), Bremner et al. (1987) and Phillippo et al. (1987a) have 
shown a relationship in a decrease in Pl-Cu concentration in association with a decrease in 
liver Cu concentration. It would seem plausible that a decrease in liver Cu concentration 
arises from similar homeostatic mechanisms within the liver as observed in Mo- 
supplemented lambs. It has been suggested that high Fe intakes may reduce Cu absorption 
by insoluble Fe x Cu compounds (Suttle and Peter, 1985). Therefore, the importance of 
these studies indicate that Fe can also be a potent antagonist to Cu metabolism, but the 
underlying mechanisms by which this occurs remain unclear.
The CP:Pl-Cu ratio was again, useful in identifying lambs receiving intakes of dietary Mo. 
These results are in accordance with chapter 3. Where significant differences did occur, 
there was a trend for the lambs that received 5 mg kg'* Mo to have a significantly lower 
CP:Pl-Cu ratio compared to the lambs that received 500 mg kg'* Fe or the control diet.
The way in which dietary Mo affects immune function has been found to be variable. This 
current study identified that lambs that received the 5 mg kg'* Mo dietary treatment had 
depressed SOD activities compared to the lambs that received the control or the 500 mg 
kg'* Fe dietary treatments from week 1 to week 12 inclusive. CuZnSOD (SODi) is an 
important intracellular protein required to catalyse the dismutation of the superoxide 
radicle (’02*) to prevent lipid peroxidation in the cell membrane (McCord and Fridovich, 
1969). The findings from this study are in accordance with Arthington et al (1996) who 
found that Mo-supplemented heifers had decreased SOD activities after 129 days on trial 
and may therefore reduce the ability of SOD to catalyse the dismutation of the superoxide 
radical, causing cellular damage and an increased susceptibility to infection due to a 
reduction in neutrophil viability. Jones and Suttle (1981) suggested that the reduction in
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SOD activity in Cu deficient sheep and cattle increased extracellular O2" and subsequently 
increased the oxidative damage to normal cells due to the inability of SOD to remove these 
toxic by-products produced during the respiratory burst. Boyne and Arthur (1986) found 
that Mo or Fe severely impaired neutrophil candidacidal activity of cattle in vitro and also 
reduced SOD activity.
Another explanation for the decrease in SOD activity in this study could be due to the 
CuZnSOD chaperone, CCS. Unlike the anti-oxidant enzyme, CP, SOD activity has not 
been reported to be inhibited by TTM in vitro. Ceruloplasmin is a soluble protein in 
plasma, whereas SOD is cellular. Therefore, the mechanism by which TM accesses the 
protein may account for the differences in CP and SOD activity. CuZnSOD is dependent 
upon a specific Cu chaperone within the hepatocyte (CC5) which transports Cu in the 
cytoplasm to the SOD protein (Rosenzweig, 2002). Therefore, a reduction in Cu 
availability in addition to disturbances in incorporation of Cu into SOD may occur if CCS 
cannot effectively perform its’ role as a Cu chaperone. It is possible that the formation of 
TM in the presence of high levels of dietary Mo may reduce the Cu which is incorporated 
into SOD (similar to that of CP and ATOX 1) by affecting the Cu chaperone, CCS, by an 
as yet unknown mechanism.
Due to the lack of a commercial CDna/CDigg monoclonal antibody available to identify 
neutrophil populations on the FACscan, it was not possible to distinguish neutrophil 
populations fi*om other cell types. Based on findings by other authors, it would seem 
plausible that a decrease in SOD activity due to dietary treatment may alter the fimction of 
neutrophils, leading to an impaired immune function.
Ceruloplasmin and SOD play critical roles in prevention of oxidative tissue damage 
resulting firom infection and inflammation (Suttle and Jones, 1986). In this study, KLH did 
not induce an acute inflammatory response. The acute phase protein, haptoglobin, (a major
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responder during an inflammatory response) or CP (a minor responder during an 
inflammatory response) (Connor et al, 1986) remained low after immunisation with KLH. 
Inflammatory responses often reveal an increase in CP activity coupled with an increase in 
Pl-Cu concentration, as observed in Holstein steers challenged with Infectious Bovine 
Rhinotracheitis virus (IBRV) (Stabel et al 1993). Arthington et al (1996) found low CP 
concentrations in heifers due to dietary Mo with no increase in CP activity following BHV- 
1 inoculation, similar to results fi*om this study using KLH. Therefore, the lack of an 
inflammatory response in this study may suggest that KLH did not provoke a significant 
inflammatory response compared with an inoculant such as IBRV. The adjuvant used here 
(alum) is not aggressive at stimulating macrophages compared to others used elsewhere by 
Alexander and Brewer (1995).
KLH has previously been used by other authors to activate both cellular and humoral 
immune responses in calves (Gasbarre, 1986 ; Pollock et al, 1991). The dietary treatments 
in this study had no significant effect on IgG or IgM responses to KLH. Gengelbach and 
Spears (1998) found that calves fed a diet containing 1.1 mg kg~* Cu plus an additional 5 
mg kg “* Mo had lower primary and secondary immune responses to porcine erythrocytes 
compared to calves fed a Cu supplemented diet (10 mg kg~* Cu). Porcine erythrocytes use 
macrophages as antigen presenting cells to T helper cells whereas KLH uses B cells 
initially as antigen presenting cells (Roitt et al, 1998) and may therefore be less sensitive 
to dietary Mo.
This study found no effect of dietary treatment to T or B lymphocyte blastogénie 
responses, similar to findings in calves by Stabel et al (1993). Arthington et al (1996) 
found no response in Mo supplemented heifers to intranasal inoculation with Bovine 
Herpes Virus -1 (BHV-1) in terms of lymphocyte proliferation to the mitogens Con-A or
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PWM, no increase in CP activity or Pl-Cu concentration, but a decrease in SOD activity. 
These findings by Arthington et al. (1996) are similar to those found in this present study. 
Variation in lymphocyte isolation technique and different culture media may alter 
lymphocyte blastogénie responses. Pollock et al. (1994) found that by removing 
homologous serum and replacing the serum with neonatal or fetal calf serum diminished 
any in vivo nutritional influences on lymphocyte blastogénie responses. Therefore, 
interpretation of in vitro studies and the results obtained may be related to culture 
preparation and may be critical in minimising the responses observed to different mitogens 
by different authors.
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4.5. Conclusion
In conclusion, the results from this study identified that dietary Mo or Fe produced no 
significant effects on immune responses in growing lambs. Effects of dietary Mo and Fe on 
innate immunity were inconclusive due to methodology employed and lack of a 
CDiia/CDisa commercial monoclonal antibody. Dietary Fe reduced the antioxidant status 
of SOD and CP that may have caused an increased susceptibility to infection. Humoral 
immunity and lymphocyte blastogénie response were not affected by dietary treatment 
although liver Cu concentration was significantly reduced by dietary Mo and Fe, possibly 
altering haemopoesis.
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Chapter 5
The effect of dietary molybdenum or iron on copper status, pituitary
gland function, ovary morphology and trace element accumulation in
ovary, pituitary, cerebellum and liver of growing lambs
5.1. Introduction
The results from chapters 3 and 4 suggest a systemic effect of Mo on Cu metabolism but 
provide no indication as to where this dietary Mo may accumulate once absorbed. 
Although mineral retention in organs of ruminant animals have previously been researched 
by other authors (Grace and Lee, 1990; Bires et al, 1995; Haywood et al, 1998), few 
studies have investigated the effects of dietary Mo or Fe on trace element accumulation 
and morphology in the brain, pituitary gland and ovary of ruminant animals. The known 
effects of dietary Mo on fertility in cattle have been reported previously (Munro, 1957; 
Phillippo et a/., 1987b; Van Niekerk and Van Niekerk, 1989b) and therefore trace element 
accumulation may alter organ function and hormone or enzyme secretion from these 
specific sites. Work by Pott et al (1999) found that Mo concentration increased linearly 
within the liver, kidney and muscle as dietary Mo intakes increased in sheep.
The formation of TM in the rumen has been well documented (Dick et al, 1975: Suttle, 
1991), but there is scarce information on what effects TM may have on systemic 
accumulation in tissues of ruminant animals. Haywood and Dincer (1997) found that sheep 
that had been treated intravenously with TTM following diets containing high levels of 
dietary Cu had raised Cu and Mo contents in the brain and elevated Mo in the pituitary, 
demonstrating that Mo and Cu had crossed the blood brain barrier. Work by Frank (1998) 
and Frank et al (2000a) in the moose {Aloes alces), found that alterations in Cu containing 
enzymes and clinical symptoms were siitiilar to those often observed in cattle with a 
secondary Cu deficiency. In addition, high levels of Mo caused alterations in endocrine
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fimction, with depressed thyroxine levels and hyperinsulinaemia in the moose (Frank et al, 
2000a).
It is not known if high levels of dietary Mo or Fe will cross the blood-brain barrier, similar 
to intravenous TTM administration, and whether or not dietary Mo or Fe may be retained 
in other tissues. Therefore, the aims of this study were to investigate the effects of the Cu 
antagonists. Mo or Fe on Cu metabolism and trace element accumulation in the pituitary, 
ovary, liver and cerebellum of growing lambs. In addition, their effects on pituitary 
endocrine function and pituitary and ovary morphology were investigated.
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5.2. Materials and methods
5.2.1. Experimental Design and Animals
Fifty Charollais x (Suffolk x Mule) female lambs of approximately 12 weeks of age, with 
an initial mean live weight of 20.6 kg (s.e.d. 1.33) were used in this study. Lambs were 
randomly allocated to one of five dietary treatments (ten lambs per treatment group) (see 
section 5.2.2.) using a completely randomized design. The trial commenced on 26/2/01 for 
a period of twelve weeks. Lambs were housed in individual pens on elevated metal floors 
in a ventilated bam throughout the experimental period. Prior to the start of the trial, lambs 
were adapted from a pelleted lamb creep feed (S.C. Feeds, Stone, UK) containing 18% 
protein, 10% fibre, 4.5% oil and 8.5% ash onto the basal diet over a seven day adaptation 
period (see section 5.2.2.).
5.2.2. Diet Formulation
The raw materials used in this study were chosen because of their published low Cu and 
Mo contents (MAFF, 1992). Based on this information, the diets formulated were 
predicted to provide <5 mg kg'* Cu DM. The basal diet was formulated to provide the 
metabolisable energy (ME) and metabolisable protein (MP) requirements of a 25 kg female 
lamb growing at 200g day'* (AFRC, 1993) and had an ERDP of 94.57 kg'* DM and FME 
of9.92MJkg'*DM.
Lambs were allocated by live weight to one of five dietary treatment groups which were: 
Treatment one: Basal diet (Control)
Treatment two: Basal diet + 500 mg kg'* DM iron and 2 g kg'* DM sulphur (Fe)
Treatment three: Basal diet + 2 mg kg'* DM molybdenum and 2 g kg'* DM sulphur (2 Mo) 
Treatment four: Basal diet + 5 mg kg'* DM molybdenum and 2 g kg'* DM sulphur (5 Mo) 
Treatment five: Basal diet +10 mg kg'* DM molybdenum and 2 g kg'* DM sulphur (10 
Mo)
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Feed samples were obtained from separate tote bags once weekly. All feed samples were 
analysed for dry matter, crude protein, neutral detergent fibre, ether extract, ash and neutral 
cellulase gamanase digestibility as described in sections 2.1.1. to 2.1.6. respectively. The 
raw material and chemical composition of the basal diet is presented in Table 5.1. 
Additional mineral inclusion per treatment diet is presented in Table 5.2.
Ingredient (g kg'*) Basal diet
Straw pellets (NaOH treated) 400
Whole barley 300
Rapeseed meal 200
Molasses 65
Mineral/vitamin Premix* 35
Total 1000
Dry matter (g kg'* DM) 878.1
ME (MJ kg'* DM) 10.56*
Crude protein (g kg'* DM) 138.5
Neutral detergent fibre (g kg'* DM) 435.5
Ether extract (g kg'* DM) 15.7
Ash (g kg'* DM) 90.86
NCGD(gkg'*DM) 737.2
♦Predicted value frotn equation given in AFRC (1993). 
* Mineral premix -  see Table 5.2.
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Table 5.2. Additional mineral inclusion for the control, iron and molybdenum 
treatment diets (kg ton'*)
Ingredient Control
Treatment diet 
Iron 2 Mo 5 Mo 10 Mo
Ammonium molybdate (kg)* - - 0.0016 0.008 0.016
Iron sulphate (kg)* - 2.15 - - -
Ammonium sulphate (kg)* - 6.06 7.078 7.078 7.078
Urea (kg)^ 3.2 0.46 - - -
Sand (kg) 6.8 1.33 2.918 2.914 2.906
Mineral premix^ 25 25 25 25 25
Total (kg)
I t^ T^TT T 1. .. . .  O______1
35 35 35 35 35
^Intensive lamb premix, 25kg ton'* (Frank Wright Ltd, Ashbourne, Derbyshire, UK) containing 8 miu Vit A, 
2.0 miu Vit D3, 30g Vit E, 50g Fe, 60g Mn, 2g Co, 60g Zn, 5g I, 0.4g Se, 2,500g Ammonium Chloride,
20.42 % Ca, 2 % P, 0.13 % S, 30 % salt
"Urea (Trouw Nutrition, Northwich, Cheshire, UK)
The mineral composition of the basal diet was determined by ICP-ES (see section 2.3). 
Molybdenum was supplemented as reagent grade ammonium molybdate 
(NH4)6Mo7024.4H20), iron was supplemented as reagent grade iron sulphate (FeSO4.7H20), 
and additional sulphur was supplemented as reagent grade ammonium sulphate 
(NH4)2S04) (all BDH Laboratory Supplies, Poole, Dorset, UK). The nitrogen content of 
the mineral mix was balanced with urea (Trouw Nutrition, Northwich, Cheshire, UK) and 
sand was used as an inert material to balance mass.
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Table 5.3. Analysed mineral composition o f the basal diet
Element Content
Calcium (g kg'*) 8.30
Phosphorus (g kg'*) 3.80
Sulphur (g kg'*) 2.70
Magnesium (mg kg'*) 0.17
Copper (mg kg'*) 6.09
Molybdenum (mg kg'*) 0.94
Iron (mg kg'*) 194.22
Zinc (mg kg'*) 59.99
Cobalt (mg kg'*) 2.19
Selenium (mg kg'*) 0.09
Manganese (mg kg'*) 59.71
Fresh tap water was offered ad libitum. Copper content of the water was 35pg/l (Dee 
Valley Group Laboratory, Rhostyllen, Wrexham, UK).
5.2.3. Experimental Routine
All lambs were fed at 08:00 and 15:00 daily into individual feed boxes to prevent mineral 
contamination. All feed was weighed into individual feed buckets using metric scales, 
calibrated using metric standard weights (F.J. Thornton and Co. Ltd., Wolverhampton, 
UK). Food refusals were weighed back twice weekly (section 2.2.11.) on Monday and 
Thursdays to determine individual lamb food intakes. The quantity of feed offered was 
rationed and recalculated weekly according to the live weight of the lamb taken on the day 
of live weight determination (see section 5.2.3.1.) in order to achieve a growth rate of 200 
g day'*.
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5.2.3.1. Liveweight determination
All lambs were weighed once weekly on Mondays at 11:00 using the Standard Operating 
Procedure as described in section 2.2.11. Daily Liveweight Gain (DLWG) was calculated 
using regression analysis.
5.2.3.2. Blood collection and analysis
Blood samples were collected once weekly on Tuesdays at 10:00 as described in section
2.2. Fresh whole blood was used to assess haematocrit (He) (section 2.2.1.) and the 
remaining blood prepared as described in section 2.2. and stored at -20°C for subsequent 
analysis. Frozen samples were thoroughly defrosted and whole blood was subsequently 
analysed for superoxide dismutase activity (SOD) (section 2.2.5.) and haemoglobin 
concentration (Hb) (section 2.2.3.), plasma analysed for plasma copper concentration (Pl- 
Cu) (section 2.2.6.), and serum analysed for ceruloplasmin activity (CP) (section 2.2.4). 
The intra assay coefiBcient of variation for respective standards were: SOD 3.38 %, Pl-Cu 
5.59 %, Hb 2.14 % and CP 7.46 %.
5.2.4. Necropsy
All fifty lambs were sent to a commercial slaughterhouse after 13 weeks on trial. All lambs 
were electrically stunned and killed by exsanguination. Livers, ovaries, brains and 
pituitaries were removed and cleaned. The brains were removed following the method of 
McCumin and Bassert (2002). The cerebellum, ovary and pituitary samples were 
immediately fixed in fresh 10% buffered formalin (HD Supplies, Aylesbury, Bucks, UK) 
and subsequently analysed for trace element concentration as described in section 2.2.9. 
Livers were stored in clean plastic bags at -20°C and subsequently analysed for trace 
element determination (see section 2.2.9). Only 25 of the 50 cerebellums were analysed for 
trace element determination.
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5.2.5. Histology
Tissue samples were removed from the 10% neutral buffered formalin. Multiple pituitary 
and ovary tissue sections were processed in a Leitz Rotary Microtome 1512 (non­
automated) tissue processor (Leica, UK) and cut 5 pm thick. Tissues were stained as 
described in section 5.2.5.1. Ovary sections were prepared from only the Control and 10 
Mo dietary treatment groups. Pituitary sections from all dietary treatment groups were 
prepared.
5.2.5.1. Haematoxylin and Eosin (H+E) stain
Ovary and pituitary sections were placed in metal slide staining racks (R.A. Lamb, East 
Sussex, UK) deparaffinized for five minutes, hydrated and stained for five minutes in 
Mayer’s haemalum (Merck, Darmstadt, Germany). All sections were then “blued” in 
running water for five minutes after which they were stained in 1% aqueous eosin with 
acetic acid for five minutes. After the final washing, all sections were dehydrated through 
graded alcohols (96% and 100% ethanol) and finally in xylene (BDH Laboratory Supplies, 
Poole, Dorset, UK) and mounted in DPX (a synthetic resin medium) (Merck, Darmstadt, 
Germany). Pituitary sections stained with Haematoxylin and Eosin (H+E) stain identified 
basophils with blue staining and acidophils with red staining.
5.2.5.2. Periodic Acid Schiff (PAS) /  Orange G Method
Pituitary tissue sections were placed in metal slide staining racks (R.A. Lamb, East Sussex, 
UK) and treated with 1% periodic acid for ten minutes (Product 29460, Merck, Darmstadt, 
Germany). Sections were washed with distilled water and subsequently treated with 
Feulgen stain (Schiff) (Product 35120, Merck, Darmstadt, Germany) for twenty minutes. 
Tissue sections were then thoroughly washed in running tap water for five minutes, 
stained in Mayers Haemalum (Lillie, 1965) for two minutes and then “blued” in running 
tap water for five minutes. Sections were then stained in 2% orange G (Merck, Darmstadt,
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Germany) in 5% phosphotimgstic acid (Merck, Darmstadt, Germany) for twenty seconds 
and then placed in tap water until the section was pale yellow in colour, and then 
dehydrated through graded alcohols (96% and 100% ethanol) to xylene (BDH Laboratory 
Supplies, Poole, Dorset, UK) and mounted in DPX (a synthetic resin medium) (Merck, 
Darmstadt, Germany). Pituitary sections stained with PAS/orange G identified basophils 
with magenta staining, acidophils with yellow / pale orange staining, and chromophobes as 
pale blue / grey staining.
5.2.6. Adrenocorticotrophic Hormone (ACTH) immunohistochemistry on the pituitary 
gland
Pituitary gland tissue samples were fixed in 10% neutral buffered formalin as described in 
section 5.1.4. (prepared twice for positive and negative controls). This method employed 
the monoclonal mouse antibody (MAb) (DAKO Corporation, Carpinteria, California, 
USA) according to the method of A. Kipar (Department of Veterinary Pathology, 
University of Liverpool, UK, personal comm.). This method used immunohistochemistry 
(IHC) and the mouse monoclonal antibody to identify corticotrophs in the 
adenohypophysis that stained for anti-ACTH (adrenocorticotropin). Methods for the 
preparation of Phosphate Buffered Saline (PBS), Imidazole/HCL buffer 0.1 M, DAB 
solution and Papanicolaou’s stain are described in Appendix 3.
All tissue sections were placed in metal slide staining racks (R.A. Lamb, East Sussex, UK) 
and placed in xylene (BDH Laboratory Supplies, Poole, Dorset, UK) for deparaffmation 
for five minutes, and then subsequently placed twice in 100% ethanol and once in 96% 
ethanol (BDH Laboratory Supplies, Poole, Dorset, UK) for rehydration. All samples were 
placed in methanol (containing fi*eshly added 0.5% Hydrogen peroxide) (BDH Laboratory 
Supplies, Poole, Dorset, UK) and left at room temperature for thirty minutes. Tissue 
sections were then thoroughly washed in distilled water and placed into coverplates on 
Shandon Sequenza racks (Thermo Shandon, Runcorn, Cheshire, UK) before undergoing a 
fiirther wash in distilled water for five minutes. For all positive tissue sample sections, 100
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pi of a non-specific binding antiserum using 10% rat serum (Jackson ImmunoResearch 
Laboratories Inc., PA, USA) in PBS was carefully pipetted onto each section and left for 
ten minutes at room temperature. To all positive sample sections, 98 pi of ACTH Mab 
(1:20 in Tris buffered saline, see appendix 3) (DAKO Corporation, Carpinteria, California, 
USA) was pipetted onto each section and left to incubate overnight in the fridge at 4°C. For 
the negative controls, TBS was pipetted onto each section in place of the ACTH Mab. 
Following incubation, all slides were thoroughly washed in TBS (still in the Sequenza 
racks) for five minutes. To all positive and negative controls, 98pl of AffiniPure Rat Anti- 
Mouse IgG (1:100 in TBS) (Jackson ImmunoResearch Laboratories Inc., PA, USA) was 
added and incubated at room temperature for 30 minutes, and subsequently washed with 
TBS. To all sections (positive and negative controls), 98 pi of (1:500 in TBS) PAP Mouse 
(Mouse Peroxidase-Anti-Peroxidase) (Jackson ImmunoResearch Laboratories Inc., PA, 
USA) was carefully pipetted to each slide and incubated for a further 30 minutes at room 
temperature. All slides were thoroughly washed in TBS, and subsequently removed from 
the coverplates and placed in tissue section racks. All slides were then placed in a glass 
dish containing a magnetic stirrer and incubated for 10 minutes in 3,3’- 
diaminobencidintetrahydrochloride (DAB) (Fluka, Gillingham, Dorset, UK) containing 
0.01% Hydrogen peroxide (30%) (BDH Laboratory Supplies, Poole, Dorset, UK) in O.IM 
imidazole / HCl buffer O.IM buffer (pH 7.1) at room temperature. Following incubation, 
all sections were thoroughly washed three times each for five minutes in TBS and once in 
tap water for five minutes. All slides were subsequently counterstained for 30 seconds with 
Pananicolaou’s haematoxylin lb stain (Merck, Darmstadt, Germany), followed by a final 
rinse in tap water. To complete the procedure, all slides were dehydrated sequentially in 
96% ethanol, 100% ethanol and twice in xylene and cover slips placed carefully on each 
slide for subsequent analysis. All slides were initially subjectively assessed with the naked 
eye for ACTH reactivity and subsequently under the light microscope.
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5.2.7. Statistical analysis
Statistical analysis was performed using Genstat version 5.0. All haematology and enzyme 
parameters and trace element concentrations were analysed by analysis of variance 
(ANOVA) and repeated measures (where appropriate) using a completely randomized 
design. Daily liveweight gain (DLWG) was determined by regression analysis. In all 
graphs, error bars refer to 2x s.e.d. Differences between treatments was calculated using a 
protected least significant difference (LSD) (Snedecor and Cochran, 1989).
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5.3. Results
5.3.1. Growth rate and performance characteristics
There was no effect of dietary treatment on lamb live weight at any time point (Fig 5.1.). 
There was no significant effect of 2, 5 or 10 mg kg'* Mo or 500 mg kg'* Fe on total gain, 
DLWG, daily dry matter intake (DMI), total DMI, or food conversion efficiency (FCE) 
(Table 5.4.). The DLWG for all treatment groups was slightly less than the 200 g day * as 
formulated by AFRC (1993) (Table 5.4.).
Table 5.4. Effect o f molybdenum or iron supplementation on food intake and
Treatment
Control Fe 2 Mo 5 Mo 10 Mo s.e.d.
Initial wt 22.7 22.8 22.8 22.6 23.2 1.40 NS
Slaughter wt 40.9 39.9 40.6 41.1 40.3 2.17 NS
Total gain 18.2 17.1 17.7 18.5 17.1 1.18 NS
DLWG 0.19 0.18 0.19 0.19 0.18 0.012 NS
Daily DMI 1.47 1.44 1.47 1.48 1.48 0.061 NS
Total DMI 133.9 131.3 134.2 134.4 135.1 5.54 NS
FCE* 0.13 0.13 0.13 0.14 0.13 0.007 NS
*FCE calculated as Total gain (kg) divided by Total DMI (kg)
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Figure 5.1. Effect o f molybdenum or iron supplementation on live weight o f
growing lambs
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5.3.2. Haematocrit
There was no significant effect of the 2, 5 or 10 mg kg'  ^ Mo or 500 mg kg'  ^ Fe dietary 
treatments on haematocrit (He) % in growing lambs during the experimental period (Table
5.5,). All He were considered to be within the normal reference ranges for lambs 
(Appendix 1). Repeated measures analysis indicated that there was no significant effect of 
dietary treatment or time x treatment interaction on He but there was an effect of time 
(P<0.001) on He in growing lambs (Table 5.5.).
Table 5.5. Effect o f molybdenum or iron supplementation on haematocrit (%) o f
Treatment
Week
Control Fe 2 Mo 5 Mo 10 Mo s.e.d. Significance
0 36.4 36.7 37.6 363 38.0 1.33 NS
2 35.2 35.1 35.4 35.0 35.5 1.22 NS
4 34.1 35J 34.6 34.4 35.1 1.04 NS
6 32.4 35.3 33J) 32.9 34.4 1.08 NS
8 32.8 35.0 33.7 32.6 333 1.33 NS
10 31.8 34.2 32.7 30.8 33.2 1.15 NS
12 32.2 32.8 34.0 31.2 32.1 1.22 NS
Repeated Measures Analysis Treatment effect 
Time effect
P = NS 
P = <0.001
Time X Treatment effect P = NS
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5.3.3. Haemoglobin Concentration
There was no effect of the 2, 5 or 10 mg kg'^ Mo or 500 mg kg'^ Fe treatments on Hb 
concentration in growing lambs during the experimental period (Table 5.6.). All Hb 
concentrations were considered to be within the normal reference ranges for lambs 
(Appendix 1). Repeated measures analysis indicated that there was no effect of dietary 
treatment and no time x treatment interaction on Hb concentration but there was an effect 
of time on Hb concentration in growing lambs.
Table 5.6. Effect o f molybdenum or iron supplementation on haemoglobin
Treatment
Week
Control Fe 2 Mo 5 Mo 10 Mo s.e.d. Significance
0 11.9 11.1 11.2 11.2 12.3 0.71 NS
2 13.0 12.9 12.0 13.1 13.3 0.62 NS
4 12.1 12.4 12.0 12.3 12.3 0.41 NS
6 13.5 14.2 13.1 13.8 13.8 0.91 NS
8 11.4 11.7 11.7 10.8 11.3 0.54 NS
10 12.7 12.5 11.7 12.0 12.1 0.78 NS
12 13.7 13.3 13.3 12.0 13.7 1.09 NS
Repeated Measures Analysis: Treatment effect 
Time effect
P=NS 
P = <0.001
Time X Treatment effect P = NS
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5.3.4. Plasma Copper Concentration
Lambs that received the 10 mg kg"^  Mo dietary treatment had higher Pl-Cu concentrations 
compared to all other dietary treatment groups at week 6 (P<0.05), week 8 (P<0.05) and 
week 12 (P<0.001) (Fig. 5.2.). There were no differences in Pl-Cu concentration between 
the lambs that received the control, 500 mg kg"^  Fe, 2 mg kg'^ Mo or 5 mg kg'^ Mo dietary 
treatments at any time point. There was a sharp increase in the mean PLCu concentrations 
between week 10 and 12 in lambs that received the 10 mg kg"^  Mo dietary treatment whilst 
PLCu concentrations of all other treatment groups remained similar to Pl-Cu 
concentrations from the previous week. Repeated measures analysis indicated that there 
was an effect of treatment (P<0.01), a time x treatment interaction (P<0.001) and an effect 
(P<0.001) of time on Pl-Cu concentration. These differences were due to the increased Pl- 
Cu concentrations in the 10 Mo dietary treatment group compared to all other dietary 
treatment groups.
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Figure 5.2. Effect o f molybdenum or iron supplementation on plasma copper
concentration o f growing lambs
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Repeated Measures Analysis Treatment effect 
Time effect
P = <0.01 
P = <0.001
Time X Treatment effect P = <0.001
5.3.5. Ceruloplasmin Activity
There was no significant effect of dietary treatment on ceruloplasmin (CP) activity at any 
time point from weeks 2 to 10 inclusive (Fig 5.3.). At week 12, the lambs that received the 
5 mg kg"^  Mo dietary treatment diet had a lower (P<0.05) CP activity compared to the 
lambs that received the control, 500 mg kg’  ^ Fe, 2 mg kg'* Mo or 10 mg kg'* Mo dietary 
treatments. Repeated measures analysis indicated that there was no effect of dietary 
treatment and no time x treatment interaction but there was an effect of time (P<0.001) on 
mean CP activity. This was due to the decrease in CP activity from week 0 to week 12 in 
all treatment groups.
hJ 20
s.e.d.
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Figure 5.3. Effect o f molybdenum or iron supplementation on ceruloplasmin
activity o f growing lambs
Repeated Measures Analysis Treatment effect P = NS
Time effect P = <0.001
Time X Treatment effect P=NS
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5.3.6. Ceruloplasmin to Plasma Copper ratio (CP:Pl-Cu)
At week 2, lambs that received the 5 mg kg'* Mo dietary treatment had a lower (P<0.01) 
CP:Pl-Cu ratio compared with the lambs that received the control or 500 mg kg'* Fe dietary 
treatments (Table 5.7.). In addition, at week 2, lambs that received the 10 mg kg'* Mo 
dietary treatment had a lower (P<0.01) CP:Pl-Cu ratio compared with the lambs that 
received the 500 mg kg'* Fe dietary treatment. At week 6, the lambs that received the 500 
mg kg'* Fe dietary treatment had a higher (P<0.001) CP:Pl-Cu ratio compared to all other 
dietary treatment groups. At week 6, lambs that received the 5 or 10 mg kg'* Mo dietary 
treatments had lower CP:Pl-Cu ratios compared to lambs that received the control, 500 mg 
kg'* Fe or 2 mg kg'* Mo dietary treatments. At week 8, lambs that received the 500 mg kg'* 
Fe dietaiy treatment had a higher (P<0.01) CP:Pl-Cu ratio compared to lambs that received 
the 2, 5 or 10 mg kg'* Mo dietary treatments. Repeated measures analysis indicated that 
there was an effect (P<0.001) of dietary treatment, an effect of time (P<0.001) and a time x 
treatment interaction (P<0.05) on CPiPFCu ratio. The CPiPFCu ratio decreased in all 
dietary treatment groups over time, particularly in the lambs that received the 5 mg kg'* Mo 
dietary treatment.
Table 5.7. Effect o f molybdenum or iron supplementation on ceruloplasmin to plasma
Treatment
Control Fe 2 Mo 5 Mo 10 Mo S.e.d. Significance
Week
0 1.34 1.47 1.29 1.27 1.36 0.086 NS
2 0.94*° 1.04* 0.92*» 0.78*)° 0.80*° 0.075 **
4 0.97 1.05 1.29 1.15 1.10 0.147 NS
6 1.18*^ 1.41° 1.19* 0.99* 0.98* 0.057 H* H*
8 1.21**) 1.48*» 1.16* 1.04* 0.91* 0.149 **
10 1.16 1.23 1.22 1.02 1.01 0.081 NS
12
a,b » X___
1.17 1.37 1.11 0.86 1.16 0.165 NS
* <0.05, **<0.01, *** <0.001
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Repeated Measures Analysis Treatment effect P = <0.001
Time effect P = <0.001
Time X Treatment effect P = <0.05
5.3.7. Super oxide Dismutase A ctivity
There was no effect of treatment on superoxide dismutase (SOD) activity at any timepoint 
throughout the trial (Fig 5.4.). Although there were fluctuations in SOD activity over the 
trial period, these changes followed a similar pattern for all treatments. Repeated measures 
analysis indicated that there was no effect of treatment and no time x treatment interaction, 
but there was an effect of time (P<0.001) on SOD activity. This could be seen by the 
decrease in SOD activity in all treatment groups over time, except for the sharp increase in 
SOD activity between weeks 6 and 8.
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Figure 5.4. Effect o f molybdenum or iron supplementation on super oxide dismutase 
activity o f growing lambs
Repeated Measures Analysis Treatment effect P = NS
Time effect P = <0.001
Time X Treatment effect P = NS
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5.3.8. Trace element accumulation in the liver
Liver Cu concentrations were higher (P<0.001) in lambs that received the control dietary 
treatment compared to all other dietary treatment groups (Table 5.8.). Lambs that received 
the 5 mg kg'* Mo dietary treatment had lower (P<0.001) Cu concentrations in the liver 
compared with lambs that had received the control, 500 mg kg'* Fe, 2 mg kg'* Mo or 10 mg 
kg'* Mo dietary treatments. Lambs that received the 10 mg kg'* Mo dietary treatment had 
higher (P<0.001) liver Mo concentrations compared to all other dietary treatment groups. 
Lambs that received the 5 mg kg'* Mo dietary treatment had higher (P<0.001) liver Mo 
concentrations compared to lambs that received the control, 500 mg kg'* Fe and 2 mg kg'* 
Mo dietary treatments. Liver iron concentration was higher (P<0.001) in lambs that 
received the 500 mg kg'* Fe dietary treatment compared to all other dietary treatments. 
There were no differences in liver iron concentration between the control, 2 mg kg'* Mo, 5 
mg kg'* Mo or 10 mg kg'* Mo dietary treatments. There was no effect of dietary treatment 
on zinc concentration in the liver.
Table 5.8. Effect o f molybdenum or iron supplementation on trace element
Treatment
Control Fe 2 Mo 5 Mo 10 Mo S.e.d. Significance
Copper 215.1" 82.5" 77.7* 29.4^ 82.1" 26.64 4*
Molybdenum 3.76'’ 3.51* 4.2l"" 4.94" 6.77" 0.32
Zinc 106.1 102.4 109.2 114.7 115.1 6.90 NS
Iron
a,bxTk;i____
203.0“ 520.1" 201.2“ 2()6.1* 189.0“ 35.5 4* 4"
* <0.05, **<0.01, *** <0.001
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5.3.9. Trace element accumulation in the ovary
Lambs that received the 10 mg kg'* Mo dietary treatment had a higher (P<0.05) ovary Cu 
concentrations compared to lambs that had received the control, 500 mg kg'* Fe, 2 mg kg'* 
Mo or 5 mg kg'* Mo dietary treatments (Table 5.9.). There were no differences in ovary Cu 
concentration between the lambs that received the control, 500 mg kg'* Fe, 2 mg kg'* Mo or 
5 mg kg'* Mo dietary treatments. Lambs that received the 10 mg kg'* Mo dietary treatment 
had a higher (P<0.001) ovary Mo concentration compared to lambs that had received the 
control, 500 mg kg'* Fe, 2 mg kg'* Mo or 5 mg kg'* Mo dietary treatments. Lambs that 
received the 5 mg kg'* Mo dietary treatment had higher (P<0.001) ovary Mo concentration 
compared to lambs that received the control, 500 mg kg'* Fe or 2 mg kg'* Mo dietary 
treatments. There were no effects of dietary treatment on ovary Zn concentration. Lambs 
that received the 500 mg kg'* Fe dietary treatment had higher (P<0.05) ovary Fe 
concentrations compared to the 2 mg kg'* Mo and 10 mg kg'* Mo dietary treatments.
Table 5.9. Effect o f molybdenum or iron supplementation on trace element
Treatment
Control Fe 2 Mo 5 Mo 10 Mo S.e.d. Significance
Copper 7.02* 6.30* 5.55* 6.35* 8.05" 0.730 *
Molybdenum 0.24* 0.33* 0.30* 0.48" 0.85" 0.067 4» 4* 4*
Zinc 17.46 19.41 19.98 20.82 19.49 2.208 NS
Iron 31 7ab 40.4*" 26.6* 32.2“" 27.0“ 4.42 *
* <0.05, **<0.01, *** <0.001
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5.3.10. Trace element accumulation in the cerebellum
There were no significant effects of dietary treatment on copper, molybdenum, zinc or iron 
accumulation in the cerebellum of growing lambs (Table 5.10.).
Table 5.10. Effect o f molybdenum or iron supplementation on trace element
____________ accumulation in the cerebellum o f growing lambs (pg/gDM± s.e.d.)______
Treatment
Control Fe 2 Mo 5 Mo 10 Mo s.e.d. Significance
Copper 15.21 14.21 11.86 12.61 13.40 2.389 NS
Molybdenum 0.15 0.07 0.06 0.17 0.14 0.037 NS
Zinc 62.20 61.12 57.83 58.01 53.76 7.490 NS
Iron 97.26 78.85 7Z38 101.18 124.05 37.902 NS
« = 5 lambs per treatment group 
Means within a row with different superscripts are significantly different (P<0.05) 
* <0.05, **<0.01, ***<0.001
5.3.11. Trace element accumulation in the pituitary gland
There were no significant effects of dietary treatment on copper, molybdenum, zinc or iron 
accumulation in the pituitary gland of growing lambs (Table 5.11.).
Table 5.11. Effect o f molybdenum or iron supplementation on trace element
____________ accumulation in the pituitary o f growing lambs (pg/g DM ± s.e.d.)
Treatment
Control Fe 2 Mo 5 Mo 10 Mo s.e.d. Significance
Copper 11.43 13.05 10.07 12.36 12.81 2.214 NS
Molybdenum 0.43 0.50 0.49 0.48 0.59 0.089 NS
Zinc 43.3 51.0 36.3 40.2 63.5 11.86 NS
Iron 150.0 152.1 135.1 153.0 166.0 33.30 NS
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5.4. Histopathology -  Ovary
Ovary sections were examined for identification of primordial follicles, primary and 
secondary follicles and atretic follicles and graded according to number of follicles counted 
(Table 5.12.). Example slides of follicle types are presented in Figs. 5.5 to 5.8. Through 
general observation, the number of primordial follicles present in the ovary of the control 
animals was generally higher than the lambs that received the 10 mg kg'* Mo dietary 
treatment. The proportion of primary follicles was the same for both treatment groups. 
Atretic follicles in the ovary were more abundant in the lambs that received the 10 mg kg'* 
Mo dietary treatment compared to the lambs that received the control treatment diet.
Lamb no. Treatment Primordial
follicle
Primary
follicle
Secondary
follicle
Atretic
follicle
14 Control + + + ++ +
52 Control + + + + + +
105 Control +-H- + + + +
119 Control ++ + + + +
121 Control ++ + + + + -
125 Control + + + +++ + -H-+
156 Control + + + + +
Average^ Control 2.0 1.5 1.8 1.1
1 10 Mo + + + +
15 10 Mo + + + + + + +
53 10 Mo + + + + + -H- +
63 10 Mo + + + + + -H-
70 10 Mo ++ + + +
73 10 Mo + + 4- + +
104 10 Mo + + ++ + +
123 10 Mo + -H-+ + + -H-
158 10 Mo + + -H- +
162 10 Mo + + + +
Average‘s 10 Mo 1.6 1.4 1.5 1.4
Follicle number: (none - ; <5 + ; 6-10 ++;11 plus +++)
Average: No, of follicles / no. of samples 
Number of subjects used: Control (7) and 10 Mo (10)
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Fig. 5.5. Light microscope ovary section: Ovarian primary follicle 
(lamb tag no. 125, control treatment) (H^E) x 40
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Fig. 5.6. Light microscope ovary section: Ovarian primary follicle 
(lamb tag no. 53, 10 Mo treatment) (H+E) x 80
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Fig. 5.7. Light microscope ovary section: Ovarian atretic follicle 
(lamb tag no. 156, control treatment) (H+E) x 40
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Fig. 5.8. Light microscope ovary section: Ovarian atretic follicle 
(lamb tag no. 53, 10 Mo treatment) (H+E) x 40
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5.5. Histopathology-pituitary gland
Sections stained with H+E stain identified basophils with blue staining (haematoxylin) and 
acidophils with red staining (eosin). Sections stained with PAS-Orange G identified 
basophils with magenta staining, acidophils with yellow/pale orange staining and 
chromophobes as pale blue/grey staining.
There was no obvious effect of dietary treatment on basophil and acidophil populations 
when stained with H+E (Fig. 5.9a to 5.13b inclusive). In the example slides (Fig. 5.9a to 
5.13a inclusive) the proportion of basophils to acidophils was greater in the lambs that 
received the control dietary treatment, a greater number of acidophils to basophils in the 
lambs that received the 500 mg kg'* Fe dietary treatment and proportionate numbers of 
basophil to acidophil populations in the lambs that received the 2, 5 and 10 mg kg'* Mo 
dietary treatments. There was a large variation between slides from lambs that received the 
same dietary treatment so no conclusive effect of dietary treatment on pituitary gland 
histopathology could be made. This large variation between sections was also apparent 
when PAS-Orange G was used.
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F/g 5.9. (a) Light Microscope pituitary section from lamb 64 (control treatment): Dark blue 
basophils (glycoprotein contaning cells) in abundance compared to red acidophils, 
H+E, X 40
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F/g 5.9.(b) Light Microscope pituitary section from  lamb 64 (control treatment): Large
population o f  somatotrophs (or acidophils) (yellow-orange) to glycoprotein-producing
(basophil) cells (ACTH,LH,FSH,TSH) (magenta) x 40
144
p . J "  : y ,  y V'
« S î ? -  - i "  f  " V . 1 , .
‘■'■k+tii ÿ 'K
P »  . W *  Ê t  . c ^ '  ^
a
Fig 5.10.(a) Light Microscope pituitary section from lamb 127 (Fe treatment): Red 
acidophils in abundance compared to dark blue basophils (glycoprotein producing cells), 
H+E, X 40
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Fig 5.10.(b) Light Microscope pituitary section from lamb 127 (Fe treatment):
Proportionate number o f basophils (magenta) to acidophils (yellow-orange) x 40
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F/g 5.11. (a) Light Microscope pituitary section from lamb 166 (2 Mo treatment): 
Dark blue basophils (glycoprotein contaning cells) in proportion to red acidophils, 
H+E, X 40
Fig 5.1 l.(b) Light Microscope pituitary section from lamb 166 (2 Mo treatment): 
Large proportion o f glycoprotein-producing basophils (magenta) to acidophils 
(yellow-orange) x 40
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F/g 5.12. (a) Light Microscope pituitary section from lamb 26 (5 Mo treatment): 
Proportionate number o f dark blue basophils (glycoprotein contaning cells) to red 
acidophils, H+E, x 40
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Fig 5.12. (b) Light Microscope pituitary section from lamb 26 (5 Mo treatment): Dis­
proportionate number of acidophils (yellow-orange) to basophils (magenta) and large
number o f chromophobes (grey/pale blue), H+E, x 40
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Fig 5.13. (a) Light Microscope pituitary section from lamb 162 (10 Mo treatment) 
: Proportionate number o f dark blue basophils (glycoprotein contaning 
cells) compared to red acidophils, H+E, x 40
Fig 5.13. (b) Light Microscope pituitary section from lamb 162 (10 Mo treatment):
Proportionate number o f acidophils (yellow-orange) to basophils (magenta) and areas
o f chromophobes (grey/pale blue), H+E, x 40
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5.6. Immunohistochemistry—Adrenocorticotrophic Hormone (ACTH)
ACTH immunostaining of pituitary samples was significantly darker and more intense in 
the lambs that received the Mo dietary treatment compared to the lambs that received the 
control diet or 500 mg kg'* Fe treatment (Fig. 5.14 to 5.18 respectively). ACTH 
immunostaining of the (+) control samples from the control lambs was pale (Fig. 5.14a,b). 
Figs. 5.15(b) to 5.18(b) show a gradual increase in the intensity of ACTH immunostaining 
as dietary Mo is increased in the diet. Fig. 5.18 (b) from the 10 mg kg'* Mo lambs 
illustrates ACTH accumulating in significant proportions in small, discrete areas of the 
pituitary gland when compared to Fig. 5.18 (a) from the respective control lambs.
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Fig. 5.14. (a) Light microscope pituitary section from lamb 105 (control treatment): ACTH 
(-) control. ACTH immunoassay, x 40
Fig. 5.14. (b) Light microscope pituitary section from lamb 105 (control treatment): ACTH
(+) control. ACTH immunoassay, x 40
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Fig. 5.15. (a) Light microscope pituitary section from lamb 92 (Fe treatment):
ACTH (-) control. ACTH immunoassay, x 40
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Fig. 5.15. (b) Light microscope pituitary section from lamb 92 (Fe treatment):
ACTH (+) control. ACTH immunoassay, x 40
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Fig. 5.16. (a) Light microscope pituitary section from lamb 13 (2 Mo treatment):
ACTH (-) control. ACTH immunoassay, x 40
«
Fig. 5.16 (b) Light microscope pituitary section from lamb 13 (2 Mo treatment):
ACTH (+) control. ACTH immunoassay, x 40
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Fig. 5.17. (a) Light microscope pituitary section from lamb 28 (5 Mo treatment).
ACTH (-) control. ACTH immunoassay, x 40
*
4
Fig. 5.17. (b) Light microscope pituitary section from lamb 28 (5 Mo treatment):
ACTH (+) control. ACTH immunoassay, x 40
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Fig. 5.18. (a) Light microscope pituitary section from lamb 123 (10 Mo treatment): ACTH
(-) control. ACTH immunoassay, x 40
»
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Fig. 5.18.(b) Light microscope pituitary section from lamb 123 (10 Mo treatment): ACTH
(+) control. ACTH immunoassay, x 40
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5.4. Discussion
The aim of this study was to investigate the effects of the Cu antagonists, Mo or Fe, on 
trace element accumulation in different tissues of growing lambs and to investigate the 
effects of these Cu antagonists on pituitary and ovarian tissue pathology. Therefore, the Cu 
parameters used to assess Cu status in this study were similar to those observed in chapters 
3 and 4 and will therefore not be discussed in detail. Similar to chapter 3, Pl-Cu 
concentration was increased by dietary Mo. As in previous chapters, the CP:Pl-Cu ratio 
was a very usefid indicator when assessing Cu status of the animal. The ratio identified 
lambs that had a lowered Cu status due to dietary Mo as compared to lambs that received 
the control or Fe dietary treatments. Also in accordance with chapter 3, SOD activity was 
unaffected by dietary treatment.
Chemical analysis of the control diet was within the normal range for ruminant feedstuffs 
as specified by ARC (1990). The basal diet was formulated to provide a Cu content of <5 
mg kg'* DM, but chemical analysis indicated that the mean Cu content was 6.09 mg kg'* 
DM. This level was marginally higher than the 1-5.1 mg kg'* Cu DM as recommended by 
the ARC (1980) for a growing lamb. All other mineral elements were considered to be 
within the normal ranges for a growing lamb (ARC, 1980).
Normal mean concentration of liver copper in sheep range fi'om 100-500 mg kg'* DM 
(Underwood, 1977), although sheep are considered to be Cu deficient if their liver Cu 
concentration is less than 50 pg g'* DM. In this study, the results confirm those obtained in 
chapter 3 and 4 that dietary Fe and Mo significantly reduced liver Cu concentrations, 
although only the lambs receiving the 5 mg kg'* Mo dietary treatment would have been 
considered severely deficient (<50 pg g'* DM). These findings are consistent with those of 
Ivan and Veira (1985), Van Niekerk and Van Niekerk (1989a) and Bremner and Young 
(1978). An increase in Pl-Cu concentrations in association with a decrease in liver Cu
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concentration in lambs that received the 10 mg kg“^ dietary treatment may suggest that 
absorbed TM may cause liver Cu to be released into the plasma as discussed in chapter 3. 
Liver stores become depleted of Cu as the Cu released becomes bound to circulating TM, 
resulting in an increased Pl-Cu concentration. It is not clear why the liver Cu concentration 
of lambs from the 5 Mo group was lower than the 10 Mo group.
Increasing the dietary Mo content of the diet (2, 5 and 10 mg kg'^) resulted in a graduated 
accumulation of Mo in the liver. These findings are in accordance with Van Niekerk and 
Van Niekerk (1989a) in ewes and Ivan and Veira (1985) in wethers who concluded that 
supplementary Mo increased Mo retention within the liver. At present, it is not known if 
high Mo concentrations in the liver become toxic over time, subsequently causing necrosis 
and cellular damage. Mo accumulation in livers of Mo supplemented lambs may be stored 
in an inert form (Van Ryssen and Stielau, 1981; Suttle, 1974b), or may be stored for later 
use as important components of specific Mo containing enzymes including xanthine 
oxidase (Abumrad, 1984). There have been no studies investigating the spéciation of Mo 
within the liver or bioavailability of absorbed TM. In this current study, dietary Fe also 
resulted in significantly higher iron being retained in the liver compared to control and Mo 
fed lambs. There was no effect of dietary treatment on zinc accumulation in the liver.
In this study, Cu concentration within the ovary of lambs that received 10 Mo was 
significantly higher than that of the Fe and 2 and 5 Mo dietary treatment groups. Dietary 
Mo increased Mo concentration in association with an increase in Cu concentration within 
the ovary. The accumulation of Mo and Cu may have been due to Cu bound TM 
complexes within the blood that may have been deposited or retained within the ovary. 
Work by Kendall et al. (2003) found that TTM prevented FSH induced differentiation of 
bovine ovary granulosa cells in vitro and that TTM altered the morphology of the cultured 
cells. In addition, TM depressed oestradiol production in a dose dependent manner 
(Kendall et al, 2003). Impaired reproductive performance in cattle and sheep due to
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dietary Mo has previously been reported by other authors (Munro, 1957; Van Niekerk and 
Van Niekerk, 1989a, b; Phillippo et al, 1982, 1987a, b). Although the precise mechanisms 
by which high dietary Mo may affect reproductive performance are not fully understood, it 
is plausible that Mo accumulation in the ovary may affect hormone release and have direct 
effects on the endocrine control of the pituitary gland. Molybdenum has been found to 
delay the onset of puberty in heifers (Phillippo et al, 1987b), show low conception rates in 
dairy cows (Allcroft and Parker, 1949) and show a high incidence of anoestrus in heifers 
(Munro, 1957; Phillippo et al, 1987b) and ewes (du Plessis et a l, 1999a). Phillippo et al 
(1987b) found that Mo delayed the onset of first oestrus in cattle by at least six weeks and 
4-6 weeks in sheep (Van Niekerk and Van Niekerk, 1989b).
Lambs that received the Fe dietary treatment had significantly higher Fe concentrations in 
the ovary compared to other dietary treatments. The consequence of high Fe concentrations 
of the ovary is unknown. Phillippo et al (1987b) and Humphries et al (1983) found that 
an additional 500 mg kg'^ dietary Fe to young cattle did not alter reproductive performance 
to such an extent as 5 mg kg“^ Mo. There was no effect of dietary treatment on zinc 
accumulation in the ovary in this study.
The effect of Mo on ovary histology showed few abnormalities. There was a slightly 
higher incidence of atretic follicles in the lambs that received the 10 mg kg'^ Mo dietary 
treatment, which may suggest that Mo may cause a greater incidence of follicles to 
degenerate and prevent maturation due to alterations in the release of LH and FSH fi*om 
the pituitary. Further research on the direct effects of Mo on hormone accumulation in the 
pituitary, including LH and FSH, during the reproductive cycle is needed to clarify the 
exact mechanisms involved in reproductive abnormalities. Phillippo et al (1987b) 
suggested that the presence of Mo rather than the change in Cu status interferes with the 
events that control the oestrous cycles, causing a decrease in LH release and altered 
ovarian steroid secretion.
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The pituitary gland, and the specific trophic hormones that it secretes, regulates processes 
including growth, metabolism, protein synthesis and ovarian fimction. These hormones 
include luteinising hormone (LH), oestrogen, thyroid stimulating hormone (TSH), follicle 
stimulating hormone (FSH) and progesterone. Therefore, the decrease in production or 
expression of hormones involved with reproductive fimction and growth in ruminants may 
be altered due to high Mo intakes. For the onset of puberty to occur and for the first 
ovulation to take place, a surge in LH is required (Moffor and Rodway, 1991). Phillippo et 
al. (1987b) and du Plessis et al. (1999a) showed that the secretion of LH was reduced in 
animals that received dietary Mo. The neuroendocrine regulation and release of hormones 
from the anterior pituitary gland may be directly linked to activities within the ovary that 
may be directly affected by dietary antagonists.
Adrenocorticotrophic hormone (ACTH) is released from the anterior pituitary gland and 
then acts upon the adrenal glands. Within the pituitary, the cuproenzyme, peptidylglycine 
a-amidating monooxygensase (PAM) is a bifunctional protein containing PHM 
(peptidyglycine a-hydroxylating mono-oxygenase) (Bradbury et al., 1982) and PAL 
(peptidylamido-glycolate lyase) (Katopodis et al, 1990), both essential in a two step 
conversion of a peptidylglycine substrate into an amidated product. Pituitary cells express 
high levels of PAM and store PAM and its amidating products in secretory granules (Braas 
et al, 1989; Eipper et al, 1993) but require Cu for effective functioning and release of 
pituitary hormones. Findings from this study reveal that the effects of dietary Mo and the 
possible formation of TM, may reduce the Cu that is bound to PHM resulting in 
accumulation of hormones or their releasing factors in the cells of the pituitary gland. 
Lambs that received the dietary Mo in this study had obvious accumulation of ACTH 
within the pituitary cells compared to other dietary treatment groups, possibly as a direct 
result of the failure of PAM to release the hormone. Although ACTH was the only 
hormone studied, a similar mechanism for hormone release may occur for other hormones
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released from the anterior pituitary gland, including LH and FSH. The failure to secrete 
hormones (or the respective trophic hormones) may consequently alter adrenal and ovarian 
activity. A reduction in PAM activity may also account for the lower LH release as seen in 
lambs receiving intravenous TTM (Moffor and Rodway, 1991) as it is known that PAM is 
regulated by oestrogen status (El Meskini et al, 1998). Phillippo et a l (1987a) reported a 
significant reduction in pulsatile release of LH, subsequently delaying puberty, reducing 
conception rates and with an increased anoestrous activity in young cattle due to 
supplementation of 5 mg kg'  ^ Mo. Van Niekerk and Van Niekerk (1989b) suggested that 
Mo and S may reduce the LH and FSH concentrations and also lower receptor sensitivity 
in the ovary. Wise and Ferrell (1984) found that heifers supplemented with Mo had such a 
severe reduction in LH ovulatory peaks that exogenous LH severely affected conception 
rates. Dietary Mo therefore mediates its effects on ovarian steroid morphology and 
production as well as the hypothalamo-pituitary axis with a possible direct effect on PAM 
in the release of pituitary hormones.
Work by Haywood et al (1998) found that TTM given parentally to different breeds of 
sheep resulted in Mo accumulation in the brain, adrenal glands, heart and gonads. In a later 
report, Haywood et al (2004), it was noted that due to tetrathiomolybdate administration, 
pituitaries were small and mis-shapen due to diminuation of the anterior lobe. In this 
current study, immunocytochemistry indicated that affected cells of the pituitary from 
lambs that received Mo seemed to contain swollen cells and darkened mitochondria, which 
were similar to those observed by Van Ryssen et al (1982) in the kidney of sheep that 
were fed high dietary levels of Mo. Mo or TM may therefore alter the morphology of 
pituitary cells types although this was not assessed in this study.
Within the brain, Cu, Fe and Zn play an important role as components of proteins essential 
for neural functioning (Armstrong et al 2001). In this study, there was no effect of dietary
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treatment on Cu, Mo, Zn or Fe accumulation in the cerebellum. These findings are in 
contrast to Haywood et al. (1998) who found that when Mo is given parentally as TTM 
(irrespective of Cu status). Mo is selectively retained in all parts of the brain 
(hypothalamus, cerebellum, cerebrum and medulla oblongata). It was suggested by 
Haywood et al. (1998) that TM may circulate within the bloodstream and cross the blood- 
brain barrier, where Cu or Mo is deposited within areas of the brain. A later report by 
Haywood et al. (2004) similarly found that ammonium tetrathiomolybdate given to Cu 
poisoned sheep caused Cu and Mo content to be raised in all areas of the brain. Therefore, 
the same scenario may occur due to an increased or longer Mo intake in sheep and cattle. 
More research is required to identify if Cu-TM may permeate the blood-brain barrier and 
have localised toxic effects on cells and tissues.
Decreased or increased Cu availability has been implicated to be a causative factor of 
several other neurodegenerative diseases in man and animals, associated with the 
overproduction of reactive oxygen species (ROS) (Sies, 1993). These diseases include 
prion (PrP^) diseases, Alzheimers disease (AD) and Parkinsons disease (PD) (Jellinger, 
1999). Normal prion proteins are Cu dependent proteins which protect the cell against 
oxidative damage (Brown et al. 1999), whereas abnormal apoglycoproteins (PrP^ )^ lack Cu 
and cause severe neurodegenerative disorders in animals and man (Brown et al., 1997). 
Conversely, AD, is exacerbated by marked elevation of brain Cu and Fe which disrupts the 
p-Amyloid cuproprotein (Bush, 2000) and causes deposition of p-amyloid within the 
neocortex (Lovell et al, 1998). The pathology of PD has also been suggested to be caused 
by high levels of Cu and Fe causing the subsequent overproduction of free radicals and 
death of nigral cells (Jellinger, 1999). An abnormal pathogenic apoglycoprotein (PrP^^) 
which lacks Cu has been suggested to be related to animal diseases including sheep 
scrapie, bovine spongiform encephalopathy (BSE) and transmissible mink encephalopathy 
(TME) (Sorenson, 2001). Therefore, the relationship between these diseases and an altered 
Cu metabolism suggest an important role of metals in neurological diseases and the related
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tissue-specific effects as seen in this study. Current findings may be critical in helping 
unravel the pathogenesis of a Mo-induced Cu deficiency in the friture.
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5.5. Conclusion
In conclusion, this study identified that dietary Mo altered Cu metabolism in growing 
lambs as measured by their Cu status. In addition to alterations in blood constituents, 
dietary Mo was found to cause Mo to accumulate in the liver in association with a 
significant reduction in liver Cu concentration. Mo also accumulated in the ovary of Mo 
supplemented lambs. Dietary Fe caused accumulation of Fe in the liver and ovary. Mineral 
retention in the cerebellum and pituitary gland was not affected by dietary treatment. 
Histopathology of the ovary revealed an increase in the number of atretic follicles froril Mo 
supplemented lambs. Pathology of the pituitary gland indicated that ACTH accumulated in 
cells from Mo supplemented lambs, possibly due to the inhibition of the cuproenzyhie 
PAM which prevented the release of this hormone effectively from the anterior pituitary 
gland.
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Chapter 6
The effect of molybdenum or iron on copper status and ceruloplasmin
expression in the liver of growing lambs
6.1. Introduction
Results obtained in previous chapters have demonstrated that dietary Mo reduces 
ceruloplasmin (CP) activity but the mechanism by which this occurs remains unclear. As 
discussed previously, a reduction in CP activity may either be attributable to the effect of 
TM directly on CP within the blood or may be due to a direct effect of TM within the 
hepatocyte, either by altering the ability of the Cu chaperones to distribute Cu effectively 
to CP or by altering the expression of CP directly.
Under normal conditions, CP is synthesised by the hepatocytes in the liver and is secreted 
into the plasma as holo-CP with 6-7 atoms of tightly bound Cu (Lockhart and Mercer, 
1999). CP is known to be produced at a constitutive rate in the liver as shown using dot- 
blot mRNA quantification in Cu sufficient and Cu deficient rats (Gitlin et ah, 1992) but it 
is not known if TM may alter the expression of the protein. CP activity may also be 
reduced as a consequence of systemic TM affecting the Cu chaperone ATOXl (the Cu 
chaperone involved in delivering Cu to the apo-CP protein).
Bissig et al (2001) demonstrated that the gram-positive bacteria Enterococcus hirae, 
encoded two types of Cu P-type ATPases, Cop A and CopB, These ATPases were found to 
act as intracellular Cu ‘pumps’ but were found to be inhibited by di, tri and tetra-TM but 
this inhibition could be reversed by Cu or silver. Mason et al (1982) found that both 
duodenal and intravenous infusions of tri and tetra TM produced rapid decreases in CP 
activity in sheep, but TM were reversible inhibitors of CP activity in vitro.
Therefore, the aim of this study was to investigate the effects of Mo and Fe on hepatic CP 
mRNA expression and Cu status of Scottish Blackface wethers and to investigate whether
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the differences in CP activity as previously reported in chapters 3, 4 and 5 were due to 
alterations in gene expression of CP.
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6.2. Materials and methods
6.2.1. Experimental Design and Animals
Thirty male Scottish Blackface wethers, approximately 14 months old, with an initial mean 
live weight of 35.1 kg (s.e.d. 1.54) were used in this study. All wethers were allocated by 
live weight to one of three dietary treatment groups (section 6.2.2.) for a period of twelve 
weeks. All wethers were individually penned on elevated metal floors in a ventilated bam 
throughout the experimental period. Prior to the start of the trial, wethers were fed the 
basal control diet at 1 kg per day plus hay ad libitum. Hay intake was decreased to zero 
before the trial period began. By day 0 of the trial, all wethers were receiving only the 
control diet. At day 0, all wethers received their allocated treatment diet (see section
6.2.2.).
6.2.2. Diet formulation
The raw materials used for this study were chosen because of their published low Cu and 
Mo contents (MAFF, 1992). Based on this information (Table 6.1.), the diets formulated 
were predicted to provide a Cu content of <5 mg kg'  ^DM. The basal diet was formulated 
to provide the metabolisable energy (ME) and metabolisable protein (MP) requirements of 
a male sheep growing at 150g day'  ^ (AFRC, 1993) and had a predicted ERDP of 99.84 g 
kg'  ^DM and an FME of 9.885 MJ kg'  ^DM.
Lambs were allocated by live weight to one of three dietary treatment groups which were: 
Treatment one: Basal diet (Control)
Treatment two: Basal diet + 500 mg kg'^ DM iron and 2 g kg“^ DM sulphur (Fe)
Treatment three: Basal diet + 5 mg kg'^ DM molybdenum and 2 g kg"^  DM sulphur (5
Mo)
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Feed samples were obtained from separate tote bags once weekly. All feed samples were 
analysed for dry matter, crude protein, neutral detergent fibre, ether extract, ash and neutral 
cellulase gamanase digestibility (NCGD) as described in sections 2.1.1. to 2.1.6 
respectively. The raw material and chemical composition of the basal diet is presented in 
Table 6.1. Additional mineral inclusion per treatment diet is presented in Table 6.2.
Ingredient (g/kg'^) Basal Diet
Straw pellets (NaOH treated) 400
Ground maize 250
Rapeseed meal 270
Molasses 45
Mineral/vitamin premix^ 35
Total 1000
Dry matter (gkg’^DM) 872.6
ME(MJkg’  ^DM) 10.7*
Crude protein (g kg'  ^DM) 153.7
Neutral detergent fibre (g kg'  ^DM) 443.9
Ether extract (g kg'^ DM) 21.6
Ash (g kg"^  DM) 107.3
NCDG (gkg-^DM) 732.3
* Predicted values from equations given in AFRC (1993) 
 ^Mineral premix -  see Table 6.2
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Table 6.2 Additional mineral inclusion for the control, iron and molybdenum treatment 
diets (kg ton
Ingredient Control
Treatment diet 
Fe 5 Mo
Ammonium molybdate (kg) - - 0.008
Iron sulphate (kg) - 2.15 -
Ammonium sulphate (kg) - 6.06 7.078
Urea^ 3.2 0.46 -
Sand (kg) 6.8 1.33 2.914
Mineral Premix^ 25 25 25
Total (kg) 35 35 35
containing 250,000 lU/g Vit A ; 50,000 lU/g Vit D3 ; 4,000 mg kg'^  Vit. E ; 15 mg kg"‘ selenium ; iodine mg 
kg'^  ; cobalt 60mgkg"^ ; manganese 2,000 mg kg'^ ; zinc 2,000 mg kg'* ; phosphorus 2% ; magnesium 5% 
and salt 20.2%.
^Urea (Trouw Nutrition, Northwich, Cheshire, UK)
The mineral composition of the basal diet was determined by ICP-ES (see section 2.3) and 
is presented in Table 6.3. Molybdenum was supplemented as reagent grade ammonium 
molybdate (NH4)6Mo7024.4 H2O) , iron was supplemented as reagent grade iron sulphate 
(FeSO4.7H20) and sulphur was supplemented as reagent grade ammonium sulphate 
(NH4)2S04) (all BDH Laboratory Supplies, Poole, Dorset, UK). The nitrogen content of 
the mineral mix was balanced with urea (Trouw Nutrition, Northwich, Cheshire, UK) and 
sand was used as an inert material to balance mass.
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Table 6.3. Analysed mineral composition o f basal diet
Element Content
Calcium (g kg"^ ) 9.90
Phosphorus (g kg'^) 4.10
Sulphur (g kg" )^ 2.80
Magnesium (mg kg'^) 3.30
Copper (mg kg’ )^ 5.50
Molybdenum (mg kg"^ ) 0.67
Iron (mg kg" )^ 206.69
Zinc (mg kg'^) 57.44
Cobalt (mg kg"^ ) 1.41
Selenium (mg kg'^) 0.40
Manganese (mg kg'^) 72.19
Water was offered ad libitum and the copper content of the water was 35pg/l with no 
detectable molybdenum (Dee Valley Group Laboratory, Rhostyllen, Wrexham, UK).
6.2.3. Experimental Routine
All wethers were fed at 08:00 and 15:00 daily. Feed was weighed out into individually 
designated clean plastic buckets to prevent mineral contamination, weighed using metric 
scales (F.J. Thornton and Co. Ltd., Wolverhampton, UK) and calibrated using metric 
standard weights. Food refusals were weighed back twice weekly to determine individual 
lamb food intakes. The quantity of the feed offered was recalculated weekly according to 
the live weight of the animal recorded on the day of live weight determination (see section
6.2.4.) in order to achieve a growth rate of 150 g day
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6.2.3.1. Liveweight determination
All wethers were weighed once weekly on Mondays at 11:00 using the standard operating 
procedure as described in section 2.3. Daily live weight gain was calculated using 
regression analysis.
6.2.3.2. Blood collection and analysis
Blood samples were collected fortnightly from all wethers on Tuesdays at 10:00 as 
described in section 2.2. Fresh whole blood was used to assess haematology profile 
(section 6.2.3.3.), and the remaining blood prepared (serum or plasma) as described in 
section 2.2 and stored at -20°C for subsequent analysis of ceruloplasmin (CP) (section
2.2.4.), superoxide dismutase (SOD) (section 2.2.5.), plasma copper (Pl-Cu) (section 
2.2.6.) and amine oxidase (AMOX) (section 2.2.7). The intra assay coefficient of variation 
for respective standards were: CP 3.42, SOD 3.58, Pl-Cu 6.17 and AMOX 2.43.
6.2.3.3. Haematology profile
Blood samples were collected from all wethers into EDTA vacutainers (Becton Dickinson 
Vacutainer Systems, Plymouth, UK). A haematology profile was obtained using an 
automated Scil Veterinary ABC animal blood counter (ABX Diagnostics, Shefford, 
Bedfordshire, UK). A MINOTROL™ 16 blood control (ABX Diagnostics, Shefford, 
Bedfordshire, UK) was used before every batch of fresh blood samples. Blood was 
obtained and analysed for total white blood cell concentration (WBC), red blood cell 
concentration (RBC), haemoglobin concentration (Hb), haematocrit (He), platelet 
concentration (PLT), mean corpuscular volume (MCV), mean cell haemoglobin (MCH) 
and mean corpuscular haemoglobin concentration (MCHC).
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6.2.4. Liver collection procedure
All wethers were sent to a commercial slaughterhouse after 13 weeks of the trial. All 
wethers were electrically stunned and killed by exsanguination. For each wether, a small 
incision (7 cm) was made through the skin at a site below the sternum to obtain a small 
sections of liver (approximately 100 g) within two minutes from being bled. A sterile liver 
biopsy needle (Cook Inc., Bloomington, IN, USA) was used to obtain five small samples 
of liver (approximately 20-30 mg each) from the 100 g sample, which were then placed 
into 1.5ml RNA-ase free micro-centrifuge tubes and placed immediately on dry ice at - 
80°C for subsequent extraction of the RNA (see section 6.2.4.). Sterile latex gloves were 
used for all procedures to prevent RNA and DNA contamination to the samples. The 
remaining whole liver was removed at a later stage, stored in a clean plastic bag and frozen 
at -20°C for subsequent trace element determination using ICP-MS as described in (section 
2.2.9.).
6.2.5. mRNA and DNA extraction
Total cellular mRNA and DNA was extracted using a SV Total RNA Isolation System kit 
and Wizard® Genomic DNA purification kit respectively (Promega, Madison, WI, USA) 
according to the manufacturer’s instructions. The concentration and quality of the RNA 
and DNA was assessed spectrophotometrically (Beckman DU640, Fullerton, California) 
with the ratio of A260nm/A230nm (RNA only) and A260nm/A280nm being within the 
expected ranges (1.8-2.2 and 1.7-2.1 respectively). DNA was stored at 4°C and RNA was 
stored at -80°C until required.
6.2.5.1. Primer design
Primers were designed using Primer 3 software (http://workbench.sdsc.edu/) for the sheep 
ceruloplasmin (CP) mRNA from conserved regions which flanked intron sites within the 
following sequences: sheep mRNA (EMBL accession no. AF134841), mouse mRNA
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(EMBL accession no. MM49430), rat mRNA (EMBL accession no. RNCERU) and rat 
DNA exon 1 (accession no. RNCERP) after sequence alignment using CLUSTAL W 
(Thompson et al, 1994). p-Actin primers were designed from sheep mRNA (EMBL 
accession no. AF035422), rat mRNA (EMBL accession no. RNACOl) and pig DNA 
(EMBL SSC312193) as described above for the ceruloplasmin gene. Primers were 
designed to be appromimately 20 base pairs (bp) long with a melting temperature of 
approximately 60°C.
6.2.5.2. Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
RT-PCR was performed using the RT-PCR System kit (Promega, Madison, WI, USA) 
according to the manufacturer’s instructions. A ten-fold dilution of extracted RNA 
(approximately 20 ng/gl) and DNA (approximately 20 ng/pl) were amplified (5pi in 25pi 
volume). RNA samples from randomly chosen wethers (ear-tag no. 596 and 704) and DNA 
samples from wethers (ear-tag 313 and 538) were amplified using the following primer 
pairs: (CPFl/CPRl, CPF2/CPR2, baFl/baRl, baF2/baR2).
Table 6.4. Primer design, melting temperature and product size o f sequences used for 
RT-PCR
Primer Name Sequence Product Size 
(DNA)
Estimated Product 
Size 
(cDNA)
CPFl TCTGGGCGAAAGATAAGCAT
CPRl AATGGTAAATCCGGGTCACA { 492 + intron 492
CPF2 GTACCTCAGTCTGGGCGAAA
CPR2 TAAAGGCCCAATGACTCCTG { 551+intron 551
baFl TCCCTGGAGAAGAGCTACGA
baRl GGGCAGTGATTTCTTTCTGC { 350 255
baF2 GAAATCGTCCGTGACATCAA
baR2 AGCACCGTGTTGGGATAGAG { 362 267
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RNA samples were amplified according to the manufacturer’s instructions except anneal 
temperatures of 55°C, 58°C and 60°C were tested to determine suitable primers and 
optimum RT-PCR conditions. All RNA samples were then amplified in a RT-PCR using 
primers CPFl/Rl and baFl/Rl at an anneal temperature of 60°C. DNA samples were 
amplified under the same conditions as detailed by Edwards et al (2001) using the same 
PCR programme as for RNA. PCR products were separated on 2% agarose gel amended 
with 0.05% ethidium bromide by electrophoresis and analysed using a GelDoc 1000 gel 
documentation system (Biorad, Hemel Hempstead, UK). Band intensity was measured on 
an unsaturated image using Molecular Analyst (Biorad) and a ratio of CP to p-actin (ba) 
mRNA product was determined. Control amplifications included a negative control, a 
positive control supplied with the RT-PCR kit and a pure and 10-fold dilution of RNA 
from wether no. 706 which was known to amplify during preliminary experiments.
6.2.6. Statistical Analysis
Statistical analysis was performed using Genstat for Windows (Version 5.0). All 
haematology analysis, enzyme activities, liver trace element concentration and mRNA 
ratio was analysed by analysis of variance (ANOVA) and repeated measures (where 
appropriate) using a completely randomized design. Daily liveweight gain (DLWG) was 
determined by regression analysis. In all graphs, error bars refer to 2x s.e.d. Differences 
between treatments was calculated using a protected least significant difference (LSD) 
(Snedecor and Cochran, 1989).
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6.3. Results
6.3.1. Growth rate and performance characteristics
There was no significant effect of dietary treatement on wether live weight at any weekly 
timepoint (Fig. 6.1). There was no significant effect of dietary treatment on total gain, daily 
live weight gain (DLWG), daily dry matter intake (daily DMI), total dry matter intake or 
food conversion efficiency (FCE ) (Table 6.4). The mean DLWG for all treatments was 
151.7 g day"\ which was similar to the predicted 150 g day'^ as predicted by AFRC (1993) 
(Table 6.5).
Table 6.5. Effect o f molybdenum or iron supplementation on food intake and
Treatment diet
Control Fe 5 Mo s.e.d. Significance
Initial wt 33.2 32.8 33.1 1.11 NS
Slaughter wt 46.2 46.8 46.1 1.77 NS
Total Gain 13.04 14.06 13.08 1.034 NS
DLWG 0.148 0.159 0.148 0.1197 NS
Daily DMI 1.42 1.43 1.43 0.043 NS
Total DMI 119.3 120.5 119.9 3.57 NS
FCE* 0.109 0.117 0.109 0.0073 NS
FCE calculated as Total Gain (kg) divided by Total DMI (kg)
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Fig 6.1. Effect o f molybdenum or iron supplementation on live weight
o f Scottish Blackface wethers
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6.3.2. Haematology profile
All components of the haematology profile were within normal expected ranges for sheep 
(see Appendix 1).
6.3.2.1. Haematocrit (He)
There was no significant effect of 500 mg kg"^  Fe or 5 mg kg'^ Mo on He of wethers (Table
6.6.). Repeated measures analysis indicated that there was an effect (P<0.001) of time due 
to the decrease in He firom week 0 to week 12 in all treatment groups, but no effect of 
treatment and no time x treatment interaction on He.
Table 6.6. Effect o f molybdenum or iron supplementation on haematocrit (%) o f
Treatment
Week Control Fe 5 Mo s.e.d. Significance
0 37.05 39.40 38.54 1.393 NS
2 36.07 37.30 36.34 1.822 NS
4 32.95 32.56 34.56 1.789 NS
6 33.70 34.60 34.55 1.502 NS
8 31.90 32.99 34.33 1.633 NS
10 34.20 34.43 35.82 1.706 NS
12 33.93 35.22 35.25 1.675 NS
Repeated Measures Analysis: Treatment effect 
Time effect
P=N S 
P = <0.001
Time X Treatment effect P = NS
175
6.3.2.2. Haemoglobin (Hb) concentration
There was no significant effect of 500 mg kg'  ^ Fe or 5 mg kg"^  Mo on Hb concentration 
(g/100 ml) (Table 6.7.). Repeated measures analysis indicated that there was an effect 
(P<0.001) of time on Hb concentration possibly due to the small decrease in all treatment 
groups over time but no effect of treatment or time x treatment interaction on Hb 
concentration.
Table 6.7. Effect o f molybdenum or iron supplementation on haemoglobin (Hb)
Treatment
Week Control Fe 5 Mo s.e.d. Significance
0 12.64 12.98 12.58 0.382 NS
2 12.98 12.92 12.76 0.432 NS
4 12.25 11.91 12.26 0.534 NS
6 12.14 12.25 11.87 0.383 NS
8 11.48 11.63 11.60 1.663 NS
10 12.23 12.10 12.32 0.434 NS
12 12.30 12.48 12.16 0.485 NS
Repeated Measures Analysis: Treatment effect 
Time effect
P=N S 
P = <0.001
Time X Treatment effect P = NS
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6.3.23. Red Blood Cell Count (RBC)
There was no significant effect of 500 mg kg'^ Fe or 5 mg kg'* Mo on RBC concentration 
(cells X 10*^  r*) of wethers (Table 6.8.). Repeated measures analysis indicated that there 
was an effect (P<0.001) of time due to the decrease in RBC concentration in all treatment 
groups from week 0 to week 12. There was no effect of treatment or time X treatment 
interaction on RBC concentration.
Table 6.8. Effect o f molybdenum or iron supplementation on red blood cell (RBC)
Treatment
Week Control Fe 5 Mo s.e.d. Significance
0 12.98 13.62 12.88 0.440 NS
2 12.39 12.65 11.92 0.509 NS
4 11.35 11.07 11.39 0.532 NS
6 11.59 11.77 11.39 0.404 NS
8 10.98 11.19 11.28 0.496 NS
10 11.53 11.36 11.43 0.450 NS
12 11.33 11.43 11.11 0.477 NS
Repeated Measures Analysis: Treatment effect 
Time effect
P=N S 
P = <0.001
Time X Treatment effect P = NS
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6.3.2.4. Mean corpuscular volume (MCV)
There was no effect of 500 mg kg"* Fe or 5 mg kg"* Mo on MCV of wethers until week 12 
(Table 6.9.). At week 12, lambs that received 5 mg kg"* Mo had a higher MCV (P<0.05) 
compared to the wethers that received the control or 500 mg kg * Fe dietary treatments. 
Repeated measures analysis indicated that there was an effect (P<0.001) of time with all 
treatment groups having an increase in MCV from week 2 until week 12. There was no 
effect of treatment or time X treatment interaction on MCV.
Table 6.9. Effect o f molybdenum or iron supplementation on mean corpuscular volume
Treatment
Week Control Fe 5 Mo s.e.d. Significance
2 29.8 29.7 29.4 0.24 NS
4 29.5 29.5 29.4 0.24 NS
6 29.5 29.6 29.8 0.28 NS
8 29.4 29.6 29.8 0.34 NS
10 30.0 30.5 30.7 0.42 NS
12 30.0*" 30.1*" 31. 0.40 *
* <0.05, ** <0.01, *** <0.001
Mean corpuscular volume (fl) (MCV) = (Haematocrit % / RBC x lO^ /^l) x 10 (Kerr, 2002)
Repeated Measures Analysis: Treatment effect P = NS
Time effect P = <0.001
Time X Treatment effect P = NS
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63.2.5. Mean Cell Haemoglobin {MCH)
There was no significant effect of 500 mg kg'* Fe or 5 mg kg'* Mo on MCH concentration 
(pg) (Table 6.10.). Repeated measures analysis indicated that there was an effect of time 
(P<0.001) with all treatment groups having an increased MCH fi-om week 0 to week 12. 
There was no effect of treatment or time x treatment interaction on MCH concentration.
Table 6.10. Effect o f molybdenum or iron supplementation on mean cell haemoglobin
Treatment
Week Control Fe 5 Mo s.e.d. Significance
0 9.78 9.54 9.79 0.254 NS
2 10.55 10.23 10.69 0.288 NS
4 10.84 10.73 10.76 0.225 NS
6 10.53 10.40 10.44 0.218 NS
8 10.52 10.40 10.30 0.286 NS
10 10.66 10.63 10.79 0.210 NS
12 10.88 10.91 10.98 0.161 NS
Mean Corpuscular Haemoglobin (MCH) = Haemoglobin content o f the cell (pg) (Kerr, 2002) 
Repeated Measures Analysis: Treatment effect P = NS
Time effect P = <0.001
Time X Treatment effect P = NS
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6.3.2.6. Mean Corpuscular Haemoglobin Concentration (MCHC)
There was no effect of 500 mg kg'* Fe or 5 mg kg'* Mo supplementation on MCHC 
concentration (g / 100 ml) (Table 6.11.). Repeated measures analysis indicated that there 
was an effect of time (P<0.001) with all dietary treatment groups having increased MCHC 
from week 0 to week 12. There was no effect of treatment or time x treatment interaction 
on MCHC concentration.
Table 6.11. Effect o f molybdenum or iron supplementation on mean corpuscular
haemoglobin concentration (g/100 ml) (MCHC) o f Scottish Blackface 
wethers
Treatment
Week Control Fe 5 Mo s.e.d. Significance
0 34.31 32.98 32.72 1.143 NS
2 36.44 34.75 35.19 1.336 NS
4 37.47 36.60 35.58 1.174 NS
6 36.37 35.41 34.55 1.123 NS
8 36.30 35.29 33.95 1.239 NS
10 36.02 35.13 34.61 1.123 NS
12 36.41 35.50 34.64 0.925 NS
MCHC (g/100 ml) = Hb (g/100 ml) / He (decimal fraction) (Kerr, 2002)
Repeated Measures Analysis: Treatment effect P = NS
Time effect P = <0.001
Time X Treatment effect P = NS
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6.3.2.7. Platelet concentration
There was no effect of 500 mg kg’^  Fe or 5 mg kg'  ^Mo on platelet concentration (xlO /^1) 
(Table 6.12.). Repeated measures analysis indicated that there was an effect of time 
(P<0.05) with the control and Fe treatment groups having increased platelet concentrations 
from week 0 to 12. There was no effect of treatment or time x treatment interaction on 
platelet concentration.
Table 6.12. Effect o f molybdenum or iron supplementation on platelet concentration (x
l ( f  /I) o f Scottish Blackface wothQTS
Treatment
Week Control Fe 5 Mo s.e.d. Significance
0 172 128 240 57.6 NS
2 224 212 221 56.6 NS
4 245 222 245 52.4 NS
6 225 269 222 53.9 NS
8 280 273 240 46.6 NS
10 236 246 228 48.8 NS
12 208 251 211 48.5 NS
Repeated Measures Analysis: Treatment effect 
Time effect
P=N S 
= <0.05
Time X Treatment effect P = NS
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6.3.2.8. White Blood cell concentration
There was no effect of 500 mg kg'  ^ Fe or 5 mg kg'  ^Mo on WBC concentration (x 10  ^/I). 
From week 8 to week 12 inclusive, there was a trend for wethers that received the 5 mg kg' 
 ^ Mo dietary treatment to have a lower WBC concentration compared to wethers that 
received the control or 500 mg kg'^ Fe dietary treatments, although this was not 
significantly different (Table 6.13.). Repeated measures analysis indicated that there was 
an effect of time (P<0.001) with the Fe and 5 Mo dietary treatment groups having 
decreasing WBC concentrations from week 0 to week 12 but there was no effect of 
treatment or time x treatment interaction on WBC concentration.
Table 6.13. Effect o f molybdenum or iron supplementation on white blood cell (WBC)
Treatment
Week Control Fe 5 Mo s.e.d. Significance
0 11.45 11.03 11.50 1.355 NS
2 13.39 12.47 11.13 1.585 NS
4 12.30 10.99 10.64 1.338 NS
6 11.60 11.11 10.05 1.088 NS
8 11.49 10.21 9.66 1.051 NS
10 12.33 10.74 9.43 1.162 NS
12 11.03 9.88 8.69 0.959 NS
Repeated Measures Analysis: Treatment effect 
Time effect
P = NS 
P = <0.001
Time X Treatment effect P = NS
1 8 2
6. s. s. Plasma copper (Pl-Cu) concentration
Wethers that received the 5 mg kg"^  Mo dietary treatment had higher Pl-Cu concentrations 
compared to wethers that received the control or 500 mg kg"^  Fe dietary treatments at week 
2 (P<0.05), week 6 (P<0.01) and week 12 (?<0.01) respectively (Fig. 6.2.). Wethers that 
received the 500 mg kg'^ Fe dietary treatment had lower Pl-Cu concentrations compared to 
the wethers that received the control or 5 mg kg’  ^ Mo dietary treatments at week 10 
(P<0.05) and week 12 (P<0.01). Repeated measures analysis indicated that there was an 
effect of time (P<0.001) with all PFCu concentrations decreasing in all treatment groups 
from week 0. There was an effect of treatment (P<0.05) and a significant time x treatment 
interaction (P<0.05) on PFCu concentration due to the significant decrease in Pl-Cu 
concentration in the Fe dietary treatment group compared to the control and 5 Mo groups.
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Figure 6.2 Effect o f molybdenum or iron supplementation on plasma copper 
concentration o f Scottish Blaclface wethers
Repeated measure analysis: Treatment effect P = <0.05
Time effect P = <0.001
Time X Treatment effect P = <0.05
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6.S.4. Ceruloplasmin activity
Wethers that received the control dietary treatment had higher (P<0.001) CP activity at 
weeks 6,8, 10 and 12 inclusive compared to wethers that received the 500 mg kg'  ^Fe or 5 
mg kg'  ^Mo dietary treatments (Fig. 6.3). There was no difference in CP activity between 
the wethers that received the 500 mg kg"^  Fe or 5 mg kg'  ^ Mo dietary treatments at any 
time point. The control group had a mean CP level of 14.95 mg/dl at week 12. Repeated 
measures analysis indicated that there was an effect of treatment (P<0.001) with the control 
group having higher CP activity than the Fe or 5 Mo treatments, an effect of time 
(P<0.001) and a time x treatment interaction (P<0.001) on CP activity. There was a sharp 
decrease in CP activity from week 0 to week 12 in the Fe and 5 Mo dietary treatment 
groups.
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Figure 6.3. Effect o f molybdenum or iron supplementation on ceruloplasmin 
activity o f Scottish Blaclface wethers
Repeated measure analysis: Treatment effect P = <0.001
Time effect P = <0.001
Time X Treatment effect P = <0.001
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6.3.5. Ceruloplasmin to Plasma Copper Ratio (CP:Pl-Cu ratio)
At week 2, wethers that received the control diet had a higher (P<0.05) CP:Pl-Cu ratio
compared to the wethers that received the 5 mg kg'^ Mo dietary treatment (Table 6.14.).
There was no difference in CP:Pl-Cu ratio between wethers that received the 500 mg kg'^
Fe dietary treatment and wethers that received the control or 5 mg kg'^ Mo dietary
treatments. From week 4 to week 12 inclusive, wethers that received the control diet had a
higher (P<0.001) CPiPl-Cu ratio compared to the wethers that received the 500 mg kg'^ Fe
or the 5 mg kg’  ^Mo dietary treatments. Also, from week 4 to week 12 inclusive, wethers
that received the 500 mg kg'  ^ Fe dietary treatment had a higher (P<0.001) CP:Pl-Cu ratio
compared to wethers that received the 5 mg kg'  ^Mo dietary treatment. Repeated measures
analysis indicated an effect of treatment (P<0.001) due to the low ratios of the 5 Mo group
compared to the control and Fe groups. There was an effect of time (P<0.001) and a
significant time x treatment interaction (P<0.001) due to the decrease in CP:Pl-Cu ratios in
all treatment groups over time, in particular, the Fe and 5 Mo groups.
Table 6.14. Effect o f molybdenum or iron supplementation on ceruloplasmin
to plasma copper ratio (CP: Pl-Cu) o f Scottish Blackface wethers
Treatment
Week Control Fe 5 Mo s.e.d. Significance
0 1.23 1.23 1.23 0.065 NS
2 T37* 1.17'* 1.03^ 0.106 *
4 1.26* 1.18’’ 0.97* 0.065 ***
6 1.10* 0.89'’ 0.67* 0.050 ***
8 1.29* 0.98*’ 0.69* 0.073 4" ^
10 1.20* 0.85’’ 0.59* 0.058 ***
12 
a,b X K__
1.13* 0.80'’
________ _
0.59* 0.062 4* 4- 4"
* <0.05, **<0.01, ***<0.001 
Repeated measure analysis: Treatment effect P = <0.001
Time effect P = <0.001
Time X Treatment effect P = <0.001
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6.3.6. Super oxide Dismutase (SOD) activity
There was no significant effect of 500 mg kg'  ^ Fe or the 5 mg kg"^  Mo on superoxide 
dismutase (SOD) activity at any timepoint (Fig 6.4). Repeated measures analysis indicated 
that there was an effect of time (P<0.001) due to the decrease in SOD activity in all 
treatment groups from week 0 to week 12, but no effect of dietary treatment and no time x 
treatment interaction on SOD activity.
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Fig. 6.4. Effect o f molybdenum or iron supplementation on super oxide dismutase 
activity o f Scottish Blaclface wethers
Repeated measure analysis: Treatment effect 
Time effect
P = NS 
P = <0.001
Time X Treatment effect P = NS
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6.3.7. Amine Oxidase (AMOX) activity
From week 4 to week 12 inclusive, wethers that received the control dietary treatment had 
higher (P<0.001) AMOX activity compared to the wethers that received the 5 mg kg'^ Mo 
dietary treatment (Fig. 6.5.). Wethers that received the 500 mg kg'* Fe dietary treatment 
had lower (P<0.001) AMOX activity compared to wethers that received the control dietary 
treatment at week 2 to week 12 inclusive. At week 2, wethers that received the 500 mg kg'  ^
Fe dietary treatment had lower (P<0.001) AMOX activity compared to the wethers that 
received the 5 mg kg"^  Mo dietary treatment. Repeated measures analysis indicated an 
effect of treatment (P<0.001) due to the decrease in AMOX activity in the Fe and 5 Mo 
treatment groups compared to the control group and an effect of time (P<0.001) and a time 
X treatment interaction (P<0.001).
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Figure 6.5. Effect o f molybdenum or iron supplementation on amine
oxidase activity o f Scottish Blaclface wethers
Repeated measure analysis: Treatment effect P = <0.001
Time effect P = <0.001
Time X Treatment effect P = <0.001
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6.3.8. Trace element content o f the liver
Wethers that received the Fe dietary treatment had lower (P<0.05) liver Cu concentration 
than the wethers that received the control dietary treatment (Table 6.15). There was no 
difference in liver Cu concentration for lambs that received the control dietary treatment 
compared to the wethers that received the 5 mg kg"^  Mo dietary treatment. There were no 
treatment differences in liver Fe, Zn or Mn concentrations. Lambs that received the 5 mg 
kg'^ Mo dietary treatment had higher (P<0.001) liver Mo concentrations compared to the 
wethers that received the control or 500 mg kg'^ Fe dietary treatments. There were no 
differences in liver Mo concentrations between the control or 500 mg kg"^  Fe dietary 
treatment groups.
Table 6.15. Effect o f molybdenum or iron supplementation on trace element content in
Treatment
Element
Control Fe 5 Mo S.e.d. Significance
Cu 146.89* 51.87* 107.10'® 32.401 *
Fe 519.60 576.97 487.01 64.807 NS
Mo 4.66* 4.41* 7.22'’ 0.368 4" 4- 4-
Zn 167.95 149.91 159.81 9.050 NS
* <0.05, **<0.01, ***<0.001
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6.3.9. inRNA expression in the liver
Optimum primers and conditions were determined to be CerFl/Rl and baFl/Rl with an 
anneal of 60°C. Amplification of DNA and RNA extracted from sheep livers produced the 
expected size PCR products when amplified with CerFl/Rl and baFl/Rl either alone or in 
combination. Primer pair CerFl/Rl failed to amplify DNA. These primers were designed 
to amplify across Intron 1 that were of unknown size and may have been too large to allow 
amplification of a DNA product under these conditions (Fig. 6.6.).
500bp
400bp
300bp
200bp
lOObp
fm
Fig. 6.6.
Agarose gel electrophoresis 
showing products from RT-PCR 
analysis of RNA and DNA 
amplification from liver 
extractions of Scottish Blackface 
wethers using primer pairs 
CPFl/Rl and baFl/Rl.
Ml M2 B M2 Ml
Ml 0X 174 Hinc II ((New England Biolabs, Hitchin, UK) 
M2 lOObp ladder 
A RNA (CP, 492bp ; ba, 255bp)
B DNA (ba, 350bp)
RT-PCR amplification of mRNA from all wether replicates followed by ANOVA on the 
CP/ba ratio indicated that there was no effect of dietary treatment on mRNA expression in 
the liver (Table 6.16 and Fig. 6.7.). No DNA products were detectable after gel 
electrophoresis indicating that there was no DNA contamination of the RNA extractions 
(Fig. 6.7.)
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Treatment
Control Fe 5 Mo s.e.d. Significance
0.930 0.932 0.957 0.0854 NS
I
492bp
■_255bp
it
Fig. 6.7. Agarose gel electrophoresis showing products from RT-PCR 
analysis o f RNA liver extractions from Scottish Blackface wethers 
amplified by primers specific to ceruloplasmin (CP) and fi-actin (ba) 
genes: (a) control diet (b) 500 mg kg'  ^iron diet (c) 5 mg kg'  ^Mo diet
Ml 0X 174 Hinc II (New England Biolabs, Hitchin, UK) 
1-10 Individual liver replicates 
LI RT-PCR Kit (+) control (323bp)
L2 Wether 706 - Pure extraction known to amplify 
L3 Wether 706 - 10'^  extraction known to amplify 
L4 RT-PCR Kit (-) control
492bp CPFl/Rl 
255bp baFl/Rl
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6.4. Discussion
Chemical analysis of the control diet was within the normal range for ruminant feedstuffs 
as specified by the AFRC (1993). The basal diet contained 5.5 mg kg'^ Cu and all other 
mineral elements within the basal diet were considered to be adequate for adult male sheep 
(AFRC, 1980), except for selenium levels which were higher than normal requirements.
Similar to results from chapters 3 to 5 inclusive and work by Phillippo et al (1987a) in 
calves, dietary Mo or Fe fed to sheep over a twelve week period had no effect on growth 
rate or performance, induced no clinical symptoms and had no significant effects on the 
haematology profile in Scottish Blackface wethers. However, dietary Mo, and to a lesser 
extent dietary Fe, did alter the Cu status of the sheep used in this study. In accordance with 
chapters 3 and 5 and work by Du Plessis et al (1999a), it was found that dietary Mo 
significantly increased Pl-Cu concentrations with a subsequent decrease in CP activity. 
Dietary Fe was found to reduce CP activity to a similar degree as dietary Mo but the 
mechanism by which this occurs is unclear. This study showed that dietary Fe reduced 
both liver Cu and Pl-Cu concentrations although dietary Mo decreased liver concentrations 
but increased Pl-Cu concentrations. Therefore, the mechanism by which dietary Fe alters 
Cu metabolism remains unclear. The presence of TM within the blood was not confirmed 
experimentally using the TCA-insoluble Cu method due to the unreliability of this test 
(Van Niekerk and Van Niekerk, 1989a). The CP:Pl-Cu ratio as proposed by Mackenzie et 
al (1997) was used as an additional indicator of Cu status and was found to be very useftil 
in identifying animals that had severe TM problems as a consequence of being fed dietary 
Mo. Similarly, the CP:Pl-Cu ratio indicated that wethers fed dietary Fe also had very low 
ratios but the reason for this remains unclear. Serum amine oxidase activity remained 
higher in control fed lambs but SOD activity remained unaltered by dietary treatment, 
similar to findings from chapters 3 and 5.
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As discussed, the mechanism by which dietary Mo alters CP activity remains unclear, and 
therefore, this study aimed to establish if dietary Mo affected mRNA CP expression 
directly. Although, expression of the CP protein is known to occur at a constitutive rate in 
hepatocytes (Gitlin et al, 1992), CP mRNA expression has also been found to a lesser 
extent in the spleen (Kalmovarin et al, 1991), mammary gland (Wooten et al, 1996) 
uterus (Thomas et al, 1995), lung (Fleming et al, 1991) and testis (Aldred et al, 1987). 
P-actin was used in this study as a housekeeping gene to quantify relative expression of the 
CP gene, p-actin has been used previously by other authors as an internal standard to 
monitor the relative expression of genes (Serazin-Leroy et al, 1998) and therefore, primers 
were designed across a known intron from previous mRNA sequences from sheep and rat 
and a DNA sequence from a pig. CP primers suitable for RT-PCR were designed from 
conserved regions within mRNA from sheep, mouse and rat, and also rat DNA exon 1. 
Unfortunately, limited DNA sequences were available from different species to determine 
intron positions and sizes. Therefore, the p-actin primers were designed from a DNA 
sequence from pig that allowed prediction of a DNA PCR product size. For CP, DNA from 
the rat (Exon 1) was used which indicated where the first intron occurred, but not its size. 
The primers were designed across known intron sites so that size difference between 
generic DNA and complimentary DNA could be identified. Using liver samples, P-actin 
produced PCR products of the expected size using CerFl/Rl and baFl/Rl. For CP, RNA 
also produced the expected size products of RNA, but no DNA products. It is not known 
why this failure to produce a DNA product occured but it may have been due to the 
presence of one or more large introns which resulted in a CP DNA product too large to be 
amplified under the conditions used in the RT-PCR. There was no evidence of DNA 
contamination of the RNA extractions as identified by the lack of a 350bp product from p- 
actin DNA.
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Following RT-PCR amplification in this study, results indicated that there was no 
significant difference in relative mRNA expression of CP in the livers of Scottish 
Blackface wethers when assessed using a CP/ba ratio. No differences occurred in 
expression of CP, suggesting that modifications in CP activity, as often seen in ruminant 
animals consuming high intakes of Mo or Fe, either occur as a post-transcriptional defect 
or due to some other form of inhibition post secretion (Bissig et al, 2001). Therefore, the 
mRNA expression of CP did not account for the differences observed in the reduction in 
serum CP activity. The results firom this study confirm those of Gitlin et a l (1992) who 
found that the Cu status of rats was independent of the basal level of hepatic CP mRNA 
expression. Copper-deficient and Cu adequate rats were found to secrete newly synthesised 
CP at identical rates, despite little or no holo-CP in the hepatocytes. Other studies with Cu- 
deficient and Cu-adequate rats found that the rate of biosynthesis and secretion of apo-CP 
release occurred at the same rate, regardless of Cu availability (Holtzman and Gaumnitz, 
1970). If Cu is not available during biosynthesis of CP, an unstable apo-protein, which 
lacks oxidase activity is produced and secreted in the plasma (Gitlin et al, 1992). Similar 
results by Nakamura et al (1995) indicated that CP protein biosynthesis was independent 
of intracellular Cu content in vivo using cultured hepatocytes fi*om Long-Evans Cinnamon 
(EEC) rats. A method of identifying apo and holo-CP was described by Sato and Gitlin 
(1991), although the proportion of apo and holo-protein were not assessed in this study. CP 
activity measured in this study relates to active holo-protein.
Another possible mechanism to account for the decrease in CP activity observed in this 
study may have a failure to incorporate Cu into the newly synthesised apo-protein to 
produce the holo-protein as described in EEC rats (Sato et al, 1993). The secreted apo­
protein may be deficient in Cu and therefore lack true oxidase activity, which may account 
for the reduction in CP activity as observed in this study. Genetic defects in the ATPase
ATP7B (Bull et al 1993), account for the reduction in Cu incorporation into the apo-CP
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protein of human patients with Wilson’s Disease. Wilson’s Disease is an autosomal 
recessive Cu toxicity disorder affecting the liver and nervous system (Stemlieb, 1993). Due 
to mutations in the protein, Cu cannot be incorporated into CP, resulting in low or absent 
serum CP due to reduced Cu incorporation into CP in the hepatocyte (Gibbs and Walshe, 
1979) and an accumulation of Cu in the liver (Schaefer and Gitlin, 1999). The role of 
ATP7B is to incorporate Cu into CP and to regulate Cu levels within the hepatocyte to 
prevent Cu toxicity by the direct removal of Cu into the bile (Mercer, 2001). Studies by 
Lockhart and Mercer (1999) found that the function of ATP7B (to transport Cu into the 
secretory pathway for incorporation into CP) occurred in a similar way for sheep as that of 
human ATP7B. Certain breeds of sheep display an unusual pattern of Cu metabolism 
(Lockhart and Mercer, 1999). Genetic variations in susceptibility to Cu toxicosis in sheep 
breeds has been found to not be due to a gross malfunction of ATP7B (Lockhart et ah, 
2000a), but more likely as a defect in Cu transport or trafficking within the hepatocyte. The 
copper chaperone Sheep Atxl Homologue (SAH) was found to interact with ATP7B, 
facilitating in transporting Cu in the secretory pathway of the hepatocyte (Lockhart et al 
2000a). Two forms of the sheep Wilson disease (ATP7B) homologue (sWNDa and 
sWNDb) were identified by Lockhart et al (2000b) and provided a possible explanation 
for differences in biliary Cu excretion and retention of Cu in the liver by different breeds of 
sheep prone to Cu toxicosis. However, there is no evidence within the literature of 
differential expression of ATP7B between breeds. These two isoforms may account for the 
normal plasma CP levels observed in sheep prone to Cu toxicosis (such as North 
Ronaldsay and Texel). The results also suggested that the tendency of sheep to accumulate 
Cu in the liver was not due to a gross alteration in the structure or expression of ATP7B. 
Therefore, the expression of ATOXl and SAH require further investigation regarding their 
role in facilitating Cu transport within hepatocytes.
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The gram positive bacteria Enterococcus Hirae has been found to encode two different 
ATPases; CopA and Cop B (Bissig et al, 2001). Cop A is involved in the uptake of Cu 
under Cu limiting conditions and CopB is involved in the removal of Cu as it approaches 
toxic levels within the cell, similar to ATP7B. Bissig et al (2001) found that the CopB 
ATPase was strongly inhibited by di, tri and tetrathiomolybdate but this inhibition could be 
reversed by Cu administration. Work by Ogra et al (1999) also found that 
tetrathiomolybdate adminstration to Long Evans Cinammon (LEC) rats was effective at 
reducing Cu accumulation. However, the reduced amounts of Cu in CP were believed to be 
due to the sequestering of Cu from the Cu chaperones, rather than directly removing Cu 
from the CP enzyme. Therefore, more research also needs to be undertaken to determine 
how TM may reduce the Cu available to the specific Cu chaperones or if TM directly 
affects the expression of ATP7B within the hepatocyte.
Dietary Fe was found to significantly reduce liver Cu concentrations in this study when 
compared to the control fed wethers. Similar to findings of chapters 3 to 5 inclusive, 
dietary Fe also acts as a Cu antagonist in reducing liver Cu stores. Dietary Mo reduced 
liver Cu concentrations, but to a lesser extent than dietary Fe, confirming that the 
antagonistic effect of dietary Fe on Cu metabolism requires further investigation. Dietary 
Mo was found to significantly increase the Mo content in the liver compared to the control 
or Fe dietary treatment groups, but similar to chapter 5, the consequence of Mo 
accumulation in the liver remains unclear.
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6.5. Conclusion
In conclusion, the results from this study confirmed those of chapters 3 to 5 inclusive that 
dietary Mo or Fe altered Cu status of Scottish Blackface wethers but induced no clinical 
symptoms. The mRNA expression of CP was found to be produced at a constitutive rate in 
the liver in accordance with findings of Gitlin et al. (1992) and was not affected by dietary 
Mo or Fe. Therefore, further studies are required to determine how dietary Mo and Fe may 
reduce CP activity both within the hepatocyte, post secretion or due to the systemic effect 
of TM within the blood or tissues.
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Chapter 7
General Discussion
7.1. Introduction
These series of studies were designed to investigate the effects of molybdenum (Mo) and 
iron (Fe) on Cu metabolism and physiology of sheep. Although this thesis clearly 
demonstrates that Mo, and to a lesser extent, Fe, are antagonistic minerals in relation to Cu 
metabolism in ruminant animals, the subsequent consequences of these mineral 
interactions in the blood and tissues still remain unclear. Early studies by Ferguson et al. 
(1943) reported high Mo contents in the ‘teart’ pastures of Somerset was the likely cause 
of severe scouring, changes in coat colour and texture, and general loss of condition in 
cattle, and to a lesser degree in sheep. Blakemore and Venn (1950) described a 
‘conditioned’ Cu deficiency on a farm in Suffolk where adult cattle were grazed on poor 
quality, sandy soil pastures but which contained seemingly adequate Cu levels. Similar to 
Ferguson et al. (1943), Blakemore and Venn (1950) described clinical symptoms 
resembling those of cattle grazing pastures of high Mo contents including intermittent 
diarrhoea, poor fertility, loss of condition and emaciation in adults and small calves at 
birth. The link between dietary Mo and clinical Cu deficiency during 1950’s had not been 
confirmed. Later reports by Munro (1957) described infertility problems in dairy herds 
between 1952 and 1955 in cattle grazing a range of light sandy to heavy loams soils. 
Again, clinical symptoms including changes in coat texture and colour and general 
unthriftiness in cattle were observed, although were not directly attributed to high dietary 
Mo intakes. In all of these early studies, all herds responded positively to Cu 
supplementation, either by improvements in reproductive performance or in the general 
condition of the animals. The relationship between clinical Cu deficiency and fertility in 
cattle has now been firmly established (Phillippo et al, 1982,1987b; Van Niekerk and Van
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Niekerk, 1989b) although the reason by which Mo and Fe exert such different clinical 
effects with similar Cu status is not known.
A potential mechanism by which dietary Mo may reduce Cu absorption was described by 
Suttle (1974a) and Dick et al. (1975) who proposed that dietary Mo interacted with Cu and 
sulphur (S) within the rumen to form a series of di-, tri- and tetra-thiomolybdate (TM) 
complexes. These TM complexes had a high affinity for Cu, and consequently, reduced Cu 
absorption within the digestive tract with Cu subsequently being excreted in the faeces. 
When TM was present in excess, it could be absorbed into the blood and tissues as their 
respective ammonium salts. Work at the Rowett Institute by Humphries et al. (1983), 
Bremner et al. (1983; 1987) and Phillippo et al. (1987a; 1987b) proposed that clinical Cu 
deficiency was not due to a low Cu status as suggested by Suttle (1974a), but was 
primarily due to the formation and subsequent absorption of TM produced from high 
dietary Mo intakes, with the net effect of systemically altering Cu-dependent enzyme 
activities and directly altering reproductive performance. Therefore, the four experiments 
undertaken within this study were designed to further investigate the antagonistic effects of 
dietary Mo and Fe and the subsequent systemic effects of absorbed TM, using sheep as a 
model.
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7.2. Composition o f the basal diets
In order to be able to discuss the observed differences due to dietary Mo or Fe in this series 
of studies, it is appropriate to compare the basal diets of the four experiments described in 
chapters 3 to 6 inclusive. Composition of the basal diets is presented in Table 7.1.
Chapter 3 Chapter 4 Chapter 5 Chapter 6
Calcium (g kg'^) 8.60 10.60 8.30 9.90
Phosphorus (g kg'^) 3.00 4.50 3.80 4.10
Sulphur (g kg" )^ 2.20 3.00 2.70 2.80
Magnesium (g kg'^) 1.60 2.00 1.70 3.30
Copper (mg kg’ )^ 5.47 8.59 6.09 5.50
Molybdenum (mg kg’*) 1.29 0.88 0.94 0.67
Iron (mg kg’*) 167.35 197.18 194.22 206.69
Zinc (mg kg’*) 97.44 67.90 59.99 57.44
Cobalt (mg kg’*) 0.52 1.65 2.19 1.41
Selenium (mg kg’*) 0.0065 0.076 0.09 0.40
Manganese (mg kg’*) 98.12 86.51 59.71 72.19
Mineral composition of the basal diets presented in Table 7 indicates that the calcium, 
phosphorus and magnesium contents of the basal diets in chapters 3 and 6 were similar to 
the recommendations for sheep as specified in ARC (1980). The sulphur content of the 
basal diets was approximately 2 to 3 g kg'^ DM as formulated for during diet composition. 
Suttle (1974) found that dietary S intakes above 2 g kg'  ^ reduced availability of Cu in the 
diet. The zinc, cobalt and manganese contents of all basal diets were all within 
recommended ranges for sheep (ARC, 1980). The Cu content of the basal diet in chapter 4 
was higher than the formulated 5 mg kg'  ^Cu. Therefore, this may account for the lack of
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effect on immune function as described in chapter 4 and will be discussed in section 7.4. 
The high Cu:Mo ratio in chapter 4 may have reduced the antagonistic interaction of dietary 
Mo and the subsequent formation and absorption of TM. Molybdenum contents of all basal 
diets were within recommended ranges for sheep (ARC, 1980). However, it is not possible 
to predict from these studies whether these levels of Mo may alter Cu metabolism as part 
of a TM complex, or if they interact to exacerbate the effect of Fe on Cu metabolism. 
Selenium contents of the basal diets in chapters 3 to 5 inclusive were marginally deficient 
and in chapter 6, above recommended levels as specified by ARC (1980). Iron contents of 
all basal diets were relatively similar and would have not contributed independently to the 
alterations in Cu status observed in the Fe supplemented sheep in chapters 3 to 6.
Variations in mineral composition within the basal diets in chapters 3 to 6 may be 
attributable to the dietary components used in the formulation of the diets. These 
differences were due to availability of the feedstuff and time of year in which the study 
was undertaken.
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7. S. Determination o f Cu status
Accurately diagnosing the true Cu status of a ruminant animal has been found to be 
problematic due to the lack of correlation between clinical symptoms and levels of Cu 
within blood, plasma and tissues. Therefore, all studies described within this study 
assessed the Cu status of all animals using a variety of methods, and to establish how these 
parameters were affected by dietary Mo or Fe.
Plasma Cu concentration (Pl-Cu) is currently the most commonly used diagnostic indicator 
of Cu status of an animal, however, Pl-Cu concentration alone has been deemed not to 
accurately reflect Cu status (Herdt et al., 2000). It has traditionally been accepted that a 
low Pl-Cu concentration (<8 pmol 1'*) would indicate a Cu deficiency, although Pl-Cu 
concentrations between 12-24 pmol T* are currently considered to be within a ‘normal’ 
reference range for sheep. According to Suttle (1974), Mo reduced Cu uptake in the small 
intestines. In this series of trials, dietary Mo has been found to increase Pl-Cu 
concentrations, not decrease it. Therefore, Pl-Cu concentration did not reflect this dietary 
antagonism. Terada et al. (1995) demonstrated that 90-95% of Pl-Cu is in CP with Gitlin et 
al. (1992) reporting that CP is a constitutively produced protein in rats, and as reported in 
chapter 6, in sheep. The increase in Pl-Cu concentration in Mo supplemented sheep cannot 
be explained by an increase in liver Cu release alone as the main release mechanism by the 
liver into blood is via CP. This has also been verified in humans suffering from Wilson’s 
Disease where they have the inability to incorporate Cu into CP due to a defect in the 
ATPase, ATP7B.
Pl-Cu concentrations were found to increase due to the presence of dietary Mo in chapters 
3 and 5, confirming findings of Bremner and Young (1978), Van Niekerk and Van Niekerk 
(1989a) and Du Plessis et al. (1999). Dick et al. (1956) suggested that an increase in Pl-Cu 
was often coupled with a decrease in liver Cu concentration. In chapters 3 to 6 inclusive, it 
was found that sheep that received the control diets maintained liver Cu concentrations
considered to be within normal reference ranges (100-500 pg g * DM) by the end of the
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experimental periods. In contrast, it was found that in chapters 3 to 6 inclusive, dietary Mo 
significantly reduced liver Cu concentrations to such an extent that by the end of each 
experimental period, lambs in all three experimental studies had liver Cu concentrations 
indicative of a Cu deficiency using current reference ranges (less than 100 mg kg'* DM). 
Although these increases in Pl-Cu concentration and the decreases in liver Cu 
concentration were observed in these studies due to dietary Mo, no clinical symptoms were 
evident in any of the sheep in chapters 3 to 6. Wentink et al. (1999) suggested that relying 
only on blood Cu concentrations alone may lead to false diagnosis of the Cu status of a 
ruminant animal. Therefore, Pl-Cu concentrations alone should be viewed with caution as 
the Cu bound to TM may not be ‘available’ within the plasma (Price et al, 1987), but may 
ultimately produce diagnostic readings considered to be within the ‘normal’ reference 
ranges for ruminant animals. The lack of effect of dietary treatment on Pl-Cu concentration 
in chapter 5 may have been due to the high Cu concentration in the basal diet, reducing the 
antagonistic effects of the dietary Mo and increasing the Cu:Mo ratio.
Therefore, observations in chapter 3 and 5 contradict those of Humphries et al. (1983) who 
found that dietary Mo decreased plasma and liver Cu concentrations in association with 
alterations in clinical symptoms. These changes included alterations in hair texture and 
colour and reduced growth rates compared to Fe supplemented or control heifers. 
Humphries et al. (1983) suggested that clinical symptoms were not due to a low Cu status 
but were as a result of high dietary Mo intakes that encouraged the formation of TM. Later 
work by Phillippo et al. (1987b) found that although Cu status was reduced in Mo, Fe and 
Mo X Fe supplemented heifers, only Mo supplemented animals had observed systemic 
effects resulting in changes in delayed puberty, reduced conception rate and reductions in 
hormone release.
Although dietary Fe did reduce liver Cu concentrations in chapters 3 to 6 inclusive, these
reductions were not as severe as in sheep that received dietary Mo. No increases in Pl-Cu
concentrations were observed in the Fe dietary treatment groups ^  pbserved in sheep
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receiving dietary Mo. There was a trend for Pl-Cu concentrations to be reduced in sheep 
receiving the Fe dietary treatment, suggesting an alternative mechanism by which dietary 
Fe affects Cu metabolism to that of dietary Mo. Suttle et al (1984) suggested that Fe 
interacted with sulphide in the rumen restricting Cu absorption from the small intestine. 
Work by Gooneratne et al (1994) confirmed that dietary Mo increased biliary Cu 
excretion in cattle. Studies by Gooneratne and Christensen (1984) and Ke and Symonds 
(1987) found that intravenous administration of ammonium TTM increased biliary Cu 
excretion in sheep. Therefore, the current series of studies indicates that dietary Fe not only 
reduces Cu absorption but also reduces CP activity. Dietary Mo is also absorbed, possibly 
as TM and also acts systemically in the blood and tissues.
Ceruloplasmin (CP) is also used diagnostically as an indicator of Cu status (normal range
12-24 mg/dl) due to its’ relative sensitivity to dietary antagonists (Mackenzie et al, 1997).
These series of studies found that in chapters 3, 4 and 6, mean CP activity of the control
sheep was higher than the respective animals that received dietary Mo or Fe, in accordance
with work by Humphries et al (1983). It was reported by Mason et al (1982) that
duodenal infusions of Mo produced rapid decreases in plasma CP activity in sheep. Under
normal conditions, Cu is transported in the blood plasma primarily bound to CP (90-95%)
(Terada et al, 1995) and to a lesser extent, bound to albumin, metallothionein and other
amino acids. Mason et al (1986; 1988) reported that in ruminant animals exposed to
dietary Mo, a new Cu fraction associated with albumin appeared. This was believed to be
due to albumin bound TM acting as powerful ligands by removing Cu from Cu proteins
including metallothionein within the liver. Early studies by Kelleher et al (1983) and
Hynes et al (1984) found that TM bound preferentially to albumin rather than CP. Later
studies by Lannon and Mason (1986) found that tri or TTM administration to steers
produced decreases in CP activity coupled with an increase in Cu bound to plasma
albumin. Gooneratne et al (1981b) suggested that after prolonged exposure to TM, CP
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concentrations decrease in the plasma. Work by Komatsu et al (2000) confirmed the 
finding that circulating Cu-TTM complexes are selectively bound to albumin, suggesting 
an alteration in the fi-actionation of Cu in the blood. Work by Ogra et al (1999; 2000) 
found that Cu within CP was decreased by TM in Long Evans Cinnamon (LEC) rats and 
the Cu found in the plasma was in the form of a Cu-thiomolybdate-albumin complex. CP 
was also found to be reduced by TM which was suggested to be as a result of TM 
sequestering Cu from its’ respective Cu chaperone, ATOXl, within the liver and not as a 
result of direct removal of Cu firom the CP enzyme (Ogra et al, 1999; 2000). Again, this 
finding confirms early studies of Kelleher and Mason (1986) that CP is reversibly inhibited 
by TM. Evidence from this study and the work cited above clearly show that dietary Mo, in 
the form of TM, may inhibit CP activity by a number of possible mechanisms:
1. Direct inhibition of CP that exists in plasma
2. Removal of Cu firom CP present in plasma
3. Reduction in Cu available to the trans-golgi network (TON) for incorporation
into CP
Possibly, TM works by acting at all three levels. However, what can be concluded from 
chapter 6 is that dietary Mo or Fe does not alter the expression of the CP gene. Previous 
studies have found that sheep with low CP activities due to dietary Mo responded well to 
Cu supplementation (Moeini, 1997).
The most sensitive indicator of the effects of dietary Mo used in this series of experiments
was the CP:Pl-Cu ratio as described by Mackenzie et al (1997) for cattle and sheep which
took in to consideration the systemic effect of absorbed TM. A CP:Pl-Cu ratio of <2.0 was
suggested by Mackenzie et al (1997) to be indicative of fi'ee TM being absorbed into the
blood, reducing the activities of the Cu enzymes. Based on the predicted CP:Pl-Cu ratio of
2:1, results fi*om chapters 3 to 6 found significant differences between dietary treatments in
the CP:Pl-Cu ratio and identified those animals that received dietary Mo to have been
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possibly affected by TM, although TM was not directly measured. Mackenzie et al (1997) 
suggested that CP:Pl-Cu ratios of <1.5 were indicative of TM problems, with ratios of <1 
indicating severe TM problems. Results obtained in chapters 3 to 6 inclusive indicated that 
all sheep that received dietary Mo had CP:Pl-Cu ratios by the end of the respective 
experimental periods to be indicative of TM problems which were not apparent from either 
the Pl-Cu or CP concentrations alone. Although CP:Pl-Cu ratios in sheep that received 
dietary Fe were found to decrease, this may have been due to an alteration in Cu 
metabolism resulting in a decrease in available Cu due to Cu bound within a Cu x Fe 
complex. Therefore, the use of the CP:Pl-Cu ratios may be more useful as a diagnostic aid 
than other current methods in identifying animals with systemic alterations in their blood 
due to high dietary Mo or Fe.
Using data obtained from chapters 3 to 6 inclusive. Fig 7.1 indicates the relationship 
between the CP:Pl-Cu ratio and liver Cu concentrations for all treatment groups at the end 
of each respective trial. These results indicate that the regression coefficient of the CPiPl- 
Cu ratio to liver Cu concentration was poorly correlated (r  ^= 0.2444; y=103.72x) although 
Fig. 7.1 indicates that the CP:Pl-Cu ratios from the control treatment groups were often 
associated with higher liver Cu concentrations. It is clear that both the dietary antagonists 
Mo and Fe reduced liver Cu concentrations when compared to the respective control 
groups but a reduction in the CP:Pl-Cu concentration was not always apparent. Figure 7.1 
also indicates that by the end of each experimental period, the CP:Pl-Cu ratios for all 
dietary treatment groups (albeit one control subject) were within the 0.5 to 1.5 range. This 
data suggests that the ratio proposed by Mackenzie et al (1997) for cattle may need 
adjusting for sheep as this data indicates that control animals that were not subjected to the 
dietary antagonists Mo or Fe had ratios lower than the 2.0 as proposed by Mackenzie et al 
(1997).
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Cu-Zn SOD (SODi) reference ranges in sheep range from 1100-3000 U g/Hb (D.V.
Illingworth, personal communication) based on studies by Suttle and McMurray (1983)
and Suttle (1986). SOD activity has previously been suggested to be more reliable
indicator of Cu status than other diagnostic procedures due to the slow rate of decline
during a Cu deficiency (Suttle and McMurray, 1983). The antagonistic effect of TM in
reducing Cu enzyme activities would suggest that SOD activity should decline at a similar
rate to that of CP. However, it must be taken into consideration that CP is free within the
blood plasma whereas SOD is contained within the erythrocyte. TM is known to
preferentially complex to free Cu ions, but little is knovm regarding the mechanism by
which TM may cross cell membranes and sequester the Cu from SOD within the
erythrocyte. Ogra et al. (1996) found that in vitro studies using liver supernatants from
206
300 1
1
250 -
1
200 -
§u 150 -
Ô
1
100 -
1Ph 50 -
Fig. 7.1.
0.5 1
CP:Pl-Cu ratio
1.5
y -  103.72x 
= 0.2444
o
The relationship between the CP:Pl-Cu ratio and liver Cu concentrations 
from sheep that received diets containing dietary Mo or Fe (using data 
acquiredfrom chapters 3 to 6 inclusive).
(Key: Control treatment - black circle; Fe treatment — blue diamond; 2 Mo 
-  green square; 5 Mo -  red circle ; 10 Mo -  grey diamond)
Cu-Zn SOD (SODi) reference ranges in sheep range from 1100-3000 U g/Hb (D.V. 
Illingworth, personal communication) based on studies by Suttle and McMurray (1983) 
and Suttle (1986). SOD activity has previously been suggested to be more reliable 
indicator of Cu status than other diagnostic procedures due to the slow rate of decline 
during a Cu deficiency (Suttle and McMurray, 1983). The antagonistic effect of TM in 
reducing Cu enzyme activities would suggest that SOD activity should decline at a similar 
rate to that of CP. However, it must be taken into consideration that CP is free within the 
blood plasma whereas SOD is contained within the erythrocyte. TM is known to 
preferentially complex to free Cu ions, but little is known regarding the mechanism by 
which TM may cross cell membranes and sequester the Cu from SOD within the
erythrocyte. Ogra et al. (1996) found that in vitro studies using liver supernatants from
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LEG rats indicated that TTM did not remove Cu from SOD as long as Cu bound to
metallothionein was present. Results from chapter 3, 4 and 6 indicated that SOD activity
was relatively insensitive to either dietary Mo or Fe and few reductions were observed.
The lack of effect on SOD activity may also have been due to the experimental time period
of these four studies. The life span of erythrocytes in lambs is between 90-120 days (Kerr,
2002) and therefore, the effect of dietary Mo on erythrocyte populations and reductions in
SOD activity may only become apparent after longer exposure to these dietary antagonists.
Bremner et al (1987) found similar results to those observed in chapters 3, 4 and 6, in that
SOD activity was unaffected by dietary Mo or Fe treatments in weaned calves. Rigo et al
(1978) suggested that Cu was incorporated into SOD during erythropoeisis. Reductions in
Cu availability due to Cu being bound to TM within the plasma may therefore reduce the
Cu available for incorporation into SOD during erythropoesis. This may further explain
why SOD activities are often observed to decline after long periods of time. Moeini (1997)
found that dairy heifers supplemented with Mo and Fe had significantly lower SOD
activities compared to the respective control heifers after 48 days. However, this was due
to the SOD activity in the control heifers increasing after 48 days, with no subsequent
change in SOD activity of the treated heifers from day 0. Humphries et al (1983) found
that erythrocyte SOD activities of heifer calves declined by approximately 50% after 16
weeks of being fed diets containing dietary Mo or Fe, with further decreases occurring
between 16-32 weeks. Similarly, Andrewartha and Caple (1980) found that lambs that
received dietary Mo had 40% lower SOD activities after 90 days compared to control
sheep. In addition, erythrocyte SOD activity was slow to respond after discontinuation of
the Mo treatment diet, confirming the slow response to changes in SOD activity. Both
Andrewartha and Caple (1980) and Phillippo et al (1982) found that erythrocyte SOD
activities responded to Cu supplementation. However, a 160 day lag period was observed
in Cu repleted sheep, suggesting that Cu may only be incorporated into the enzyme during
erythropoeisis, and not in mature SOD enzymes containing reduced Cu levels
207
(Andrewartha and Caple, 1980). If Cu is not incorporated into the apo-enzyme, increased 
proportions of a SOD protein lacking Cu as one of the prosthetic groups may circulate 
within the blood.
The Cu chaperone, CCS, is involved with the movement of Cu from the cell membrane 
transporter, CTRl, to SOD within the cytoplasm of the cell (Fatemi and Sarkar, 2002). 
Work by Ogra et al (1999) found TM successfully reduced SOD activity in LEC rats, 
similar to that of CP. These findings were suggested to be due to Cu being unavailable for 
incorporation into the Cu chaperones within the hepatocyte, rather than as a direct 
consequence of Cu being removed from the enzyme. Further work is required to elucidate 
the method by which TTM may alter SOD activity in ruminant animals.
Amine oxidase (AMOX) is a Cu-containing enzyme found within the plasma which has 
previously been shown to be relatively resistant to a primary Cu deficiency (Mills et al 
1976). Studies investigating AMOX activity have found that AMOX activity was inhibited 
in Jersey steers following intravenous injection of di and tri-TM after receiving a diet 
containing 25 mg kg'* Mo (Mulryan and Mason, 1986). Later studies revealed inhibition of 
AMOX in vitro by di-TM (Mulryan and Mason, 1987). These studies used very high Mo 
concentrations, which would not normally be representative of Mo intakes in vivo. 
Therefore, chapters 3 and 6 investigated the effects of dietary Mo (which would have been 
representative of normal dietary Mo intakes for ruminant animals) on AMOX activity. 
Both chapter 3 and 6 found that AMOX activity was higher in control fed sheep compared 
to those animals that had received dietary Mo. Again, these findings suggest a systemic 
effect of TM that may reduce AMOX activity in vivo. The biological significance of a 
reduction in AMOX by TM is not known, although it is known that AMOX is important in 
catalysing the oxidative deamination of biogenic amines, the cross linking of collagen and 
regulating intracellular polyamines (Bachrach, 1985).
2 0 8
The homeostatic regulation of the liver in maintaining adequate Cu levels within the blood 
and tissues have already been discussed previously in this section. Results from studies 
presented in chapters 3 to 6 inclusive revealed that liver Cu concentrations were extremely 
sensitive to dietary Mo and Fe intakes. In all studies, dietary Mo was a more potent 
antagonist in reducing liver Cu concentration than dietary Fe. In chapters 3 to 6 inclusive, 
sheep that received the control diet maintained liver Cu concentrations considered to be 
within normal reference ranges for sheep (100-500 pg g‘* DM) (Underwood, 1977). In 
chapters 3, 4 and 5, dietary Mo significantly reduced liver Cu concentrations to such an 
extent that by the end of each respective experimental period, lambs in all three studies had 
liver Cu concentrations indicative of a Cu deficiency (< 100 pg g‘* DM).
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7.4. Systemic effects ofMo or Fe on immune function
An increase in mortality and susceptibility to disease was described by Woolliams et al. 
(1986a) in lambs following grazing on improved pastures. This finding suggested a 
specific link between increased susceptibility to disease following exposure to dietary 
antagonists and the importance of Cu for effective immune fimction. The addition of 
dietary Mo or Fe in chapter 4 produced few effects on the innate and adaptive inunune 
responses in growing lambs. As discussed previously, this may have been due to the high 
Cu concentration within the basal diet that lowered the proportion of dietary Mo absorbed 
as TM into the blood. Although significant alterations in serum CP, plasma Cu and liver 
Cu concentrations were observed in Chapter 4, it would seem that the systemic effect of 
dietary Mo or Fe were not significant enough to alter immune responses within the blood. 
As discussed previously, due to the lack of a suitable CDna/CDiga antibody marker, the 
effects of dietary Mo or Fe on phagocytic function of neutrophils could not be determined. 
Previous studies by Gengelbach et al. (1997) and Boyne and Arthur (1986) found that 
dietary Mo reduced the killing ability of neutrophils. There were no effects of dietary Mo 
or Fe on the response of lymphocytes to mitogen stimulation, similar to findings in steers 
(Ward et al, 1993) and heifers (Arthington et al, 1995, 1996). The humoral immune 
response, as measured by antibody production, was also not affected by dietary treatment 
contradicting the findings of Gengelbach and Spears (1998) who found that the secondary 
antibody response was lower in calves supplemented with Mo.
To date, the systemic effects of absorbed TM on immune function have not been studied
directly in ruminant animals by other authors. Although many authors have found
conflicting effects of dietary Mo or Fe on different immune responses in ruminant animals,
no firm conclusions have been stated regarding the exact mechanism by which absorbed
dietary Mo (as TM) or Fe may alter specific aspects of the immune system. The effects of
dietary Mo on the ruminant immune system are known to be variable and cannot be
accounted for by Cu status alone (J.W. Spears, personal communication).
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7.5 Systemic effects o f Mo or Fe on trace element accumulation in the ovary, pituitary,
cerebellum and liver
Having demonstrated that Mo and Fe produce differential effects on enzyme activities and 
Pl-Cu concentration, the aim of Chapter 5 was to determine if dietary Mo or Fe affected 
mineral retention in the ovary, pituitary, cerebellum and liver, similar to that observed due 
to intravenous TTM administration (Dincer, 1994; Haywood et al., 2004). Results obtained 
from this study revealed that dietary Mo and Fe resulted in an increased mineral retention 
of Mo and Fe respectively within the ovary and the liver. The accumulation of Mo vydthin 
the ovary, possibly due to the systemic effect of absorbed Mo as TM, may account for 
observed alterations in reproductive performance as described by other authors (Phillippo 
et al, 1987b) and is discussed further in section 7.7. The systemic effect of TM may also 
account for the increased retention of Mo within the liver and explain the significant 
reductions obtained in liver Cu concentration.
Mineral retention in the pituitary gland and cerebellum was not affected by dietary 
treatment in this study. These findings contradict those of Haywood et al (2004) who 
found that sheep that received ammonium TTM following Cu poisoning had elevated 
levels of Mo in the pituitary and in all areas of the brain. The lack of mineral accumulation 
in the pituitary gland in chapter 5 was surprising considering the significant alterations 
observed in hormone accumulation (ACTH) in the pituitary (discussed in section 7.7). The 
lack of efifect of dietary treatment on trace element accumulation in the cerebellum may 
have been due to the small sample size (5 lambs per treatment) and have been too small to 
detect changes in mineral concentration in the brain. Further studies would require more 
replicates per treatment group to determine if dietary Mo and the subsequent formation of 
TM may cross the blood-brain barrier and accumulate in the brain. In addition, it would be 
interesting to determine if these minerals accumulated preferentially in other areas of the 
brain, in particular, the hypothalamus, which has a direct influence on the pituitary gland.
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7.6. Effect o f dietary Mo or Fe on histology o f the ovary and pituitary gland 
Within the literature, there have been no previously known reports suggesting a possible 
effect of dietary Mo on histology in the ovary. In chapter 5, histopathological slides of the 
ovary sections could not be analysed by statistics due to the differences being 
morphological and not numerical (S. Haywood, Personal Communication). Results 
indicated a higher proportion of primordial follicles observed in the control fed lambs. 
These results suggested that dietary Mo may reduce the ability of new follicles to mature. 
In addition, a higher proportion of atretic follicles in the ovary of lambs that received 
dietary Mo were observed. This increased incidence of atretic follicles may have again 
been due to a localised toxicity effect of Mo within the ovary, causing degeneration of the 
follicle. Haywood et al. (2004) found an increased incidence of atretic follicles in sheep 
that received intravenous TTM. The findings in chapter 6 may further suggest that dietary 
Mo may alter reproductive performance in ruminant animals. This observation also adds 
additional information with regards to the systemic effects of absorbed Mo as TM, as also 
observed in the hormone release from the pituitary gland (section 7.7) and in Mo 
accumulation within the ovary (section 7.6).
Due to the large variation in pituitary gland histology of lambs receiving the same dietary 
treatment, no obvious effect of dietary treatment was concluded firom this study following 
staining with H+E or PAS-orange G. To obtain conclusive evidence in future studies, more 
replicate samples would be required and a precise methodology to determine total 
basophil, acidophil and chromophobe populations required.
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7.7. Effect o f dietary Mo or Fe on ACTH accumulation in the pituitary gland
Results obtained from chapter 5 indicate significant new evidence regarding the
accumulation of the trophic hormone, ACTH, within the pituitary gland and the possible
relationship between this and increased intakes of dietary Mo. There was a graduated
accumulation of ACTH in pituitary tissue from lambs receiving increasing quantities of
dietary Mo. Haywood et al (2004) found that intravenous TTM administration to Cu-
poisoned sheep resulted in retention of Mo by the pituitary gland and that pituitary glands
were diminuted and of abnormal shape. The pituitary gland regulates the activity of the
endocrine glands by secreting a number of different hormones that regulate growth,
reproductive function and protein synthesis. ACTH is produced from corticotrophs within
the anterior pituitary gland and stimulates growth of cells within the adrenal glands and
regulates the secretion of glucocorticoids (Dellman, 1971). Results from chapter 5 suggest
that a localised effect of absorbed dietary Mo, possibly as TM, within the pituitary may
reduce the ability of the pituitary to release these hormones, in particular ACTH. The
activity of the cupro-enzyme peptidylglycine a-amidating monooxygenase (PAM) has
been found to be in abundance in secretory vesicles of the pituitary gland and has been
found to play an important role in releasing hormones and neuropeptides from the pituitary
gland (Bolkenius et al, 1998). PAM is essential in the bioactivation of neuropeptides by
amidating peptide precursors into their functional proteins prior to release (El Meskini et
al, 2003). Therefore, the observed ACTH accumulation may also suggest that other
hormones produced within the anterior pituitary gland may accumulate and not be released
due to the direct effect of PAM. Other hormones released from the anterior pituitary gland
include luteinising hormone (LH), follicle stimulating hormone (FSH), growth hormone
and thyroid stimulating hormone (TSH). LH induces ovulation in the ovarian follicles
whilst FSH stimulates the development of the ovarian follicles. In studies by other authors,
impaired reproductive performance and infertility in cattle has previously been associated
with failure of LH release due to intakes of dietary Mo (Phillippo et al, 1987b; Van
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Niekerk and Van Niekerk, 1989b). Impaired release of LH was previously observed in 
heifers following intakes of dietary Mo resulting in delayed puberty and decreased 
conception rate (Phillippo et al, 1987b). Moffor and Rodway (1991) found a decrease in 
pulsatile release of LH in lambs that received intravenous TTM, fiirther suggesting that 
TM may alter hormone release from the pituitary. It remains unclear if reduced LH 
ovulatory peaks are due a direct effect of LH release from the pituitary gland or if the 
effect of TM is having an effect on oestrogen receptor activity as demonstrated in vitro by 
Shyamala and Leonard (1980).
Until now, it was not known how dietary Mo may affect pituitary hormone release. 
Intravenous administration of ammonium TTM was found to deplete ACTH-positive cells 
in sheep (Haywood et al, 2004), a finding that contradicts those found in chapter 5. Future 
studies therefore need to concentrate on the systemic effect of dietary Mo and how other 
hormones, particularly those associated with the reproductive hormones, are directly 
affected by dietary Mo. More work also needs to focus on the effects of TM on PAM 
activity in ruminant animals, and how reduced PAM activity may alter the release of the 
reproductive hormones including LH and FSH.
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7.8. Effect o f Mo or Fe on ceruloplasmin expression in the liver
Throughout this series of studies, and from results obtained by previous authors 
(Humphries et al, 1983; Mackenzie et al. 1997), the activity of the cupro-enzyme, CP, has 
been found to be reduced by dietary Mo. Although CP is known to be produced at a 
constitutive rate in the liver of rats (Gitlin et al, 1992), the mechanism by which the 
dietary antagonists Mo or Fe reduced CP activity remained unclear. Studies by Lannon and 
Mason (1986) found that CP could be reversibly inhibited by TM production in vivo and in 
vitro, and therefore, chapter 6 was undertaken to determine if dietary Mo or Fe altered the 
expression of CP in the liver of growing lambs. Results obtained from this study revealed 
that CP was expressed at a constitutive rate in the liver and was not affected by dietary 
treatment. Therefore, the reductions in serum CP activity observed in chapters 3 and 5 
suggest that CP was either being released as the apo-protein, deficient of Cu at the active 
sites and lacking true oxidase activity, or that TM may systemically reduce CP activity by 
an as yet, unknown mechanism. TM was not directly affecting the expression of CP within 
the hepatocyte. This novel finding may now eliminate the possibility that CP expression is 
altered within the hepatocyte, and therefore, future work needs to focus on the mechanisms 
by which TM systemically reduces the activity of CP.
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7.9. Conclusion and further work
This series of studies has produced some fundamental novel findings with respect to the 
antagonistic interactions of dietary Mo and Fe on Cu metabolism and physiology of sheep. 
Alterations in Cu in blood and tissues due to dietary Mo and Fe have been confirmed in 
these studies. These alterations were observed in Pl-Cu concentrations, CP activity and 
alterations in mineral accumulation within the liver and ovary. ACTH also accumulated in 
the corticotrophs of the pituitary due to increasing intakes of dietary Mo. The findings not 
only confirm theories and observations noted from previous authors within the literature, 
but have generated ideas for future studies to determine the complex antagonistic 
interactions of dietary Mo and Fe on Cu metabolism.
The precise mechanism by which dietary Fe alters Cu metabolism was out of the scope of 
this thesis but would be of interest for future studies. This work has generated ideas, 
particularly with respect to mechanisms in which dietary Mo may alter reproductive 
performance, both within the ovary and the direct influences of the pituitary gland. These 
important effects that would dramatically affect the performance of a ruminant animal may 
be ignored if Pl-Cu had been used as the sole criteria for determining Cu status. Future 
studies would also be beneficial in determining one reliable diagnostic test to determine the 
true Cu status in ruminant animals, taking into consideration the proportion of absorbed 
TM. Additional studies are also required to elucidate the direct effects of TM on the Cu 
chaperones within the hepatocyte and to determine if the systemic effect of TM is directly 
responsible for CP inhibition.
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Appendix 1:
Table: 7.2 Blood reference ranges for ovine samples
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Appendix 2 Laboratory Techniques
Tris-buffered saline (TBS, pH 7.6)
Stock solution (xlO):
60.57 g Tris
610 ml distilled water
390m lH C llN
Phosphate buffered saline (0.1 M PBS, pH 7.2)
Stock solution (xlO):
80 g Sodium Chloride 
2 g Potassium Chloride
11.5 g disodium hydrogen phosphate 
2 g Potassium dihydrogen phosphate
Dissolve in 1000 ml of distilled water
Imidazole/HCl buffer (O.IM, pH 7.1)
6.81 g Imidazol in 1000 ml distilled water
Add 500 ml of O.IM HCl until pH 7.2 is maintained
Diaminobenzidintetrahydrochloride Solution (DAB)
Dilute 100 mg DAB in 200 ml of O.IM Imidazole/HCl buffer (O.IM, pH 7.1)
Mix thoroughly using magnetic stirrer
Filter and add 70pl Hydrogen Peroxide directly before use
Papanicolaou’s solution
Mix Papanicolaou’s solution and distilled water (1:20) and filter
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